Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFGE8,Lactadherin,39455,-0.0931276882637717,0.00376165189432605,-0.100500525976651,-0.0857548505508927,1.1752458611218e-132
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS15,Enteropeptidase,39428,-0.183653099488489,0.00820772324857297,-0.199740237055692,-0.167565961921286,4.14230450540049e-109
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCG,Pro-glucagon,39123,-0.232956561038052,0.0111739256020644,-0.254857455218098,-0.211055666858005,3.77179885022967e-95
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,39621,0.214615474208395,0.0105739988196728,0.193890436521837,0.235340511894954,2.18162261515781e-90
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,37255,-0.0688388489125623,0.00377990635079861,-0.0762474653601276,-0.061430232464997,3.48220820885146e-73
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9,Complement component C9,37243,0.0785933759759463,0.00438491531171798,0.0699989419649791,0.0871878099869136,5.68350265599485e-71
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYY,Peptide YY,36847,-0.145851278555564,0.00854379288171572,-0.162597112603726,-0.129105444507401,1.33253588851477e-64
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHBG,Sex hormone-binding globulin,37243,0.0785175358852167,0.00484585672668517,0.0690196567009138,0.0880154150695197,1.83183177175436e-58
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIP,Gastric inhibitory polypeptide,36916,-0.0752721262679668,0.00464565061307651,-0.0843776014695968,-0.0661666510663368,1.90596588042888e-58
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRP,Agouti-related protein,39636,-0.076502253102922,0.00474799359516221,-0.0858083205494399,-0.067196185656404,6.29267157082122e-58
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPY,Pro-neuropeptide Y,39601,-0.095947152468367,0.00595761369699174,-0.107624075314471,-0.0842702296222632,7.11648754664806e-58
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR3,Anterior gradient protein 3,39106,-0.086437205451734,0.00539142750183559,-0.0970044033553317,-0.0758700075481362,2.33475535581524e-57
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPM,Carboxypeptidase M,39534,-0.048853269518684,0.00309799178715176,-0.0549253334215014,-0.0427812056158665,1.40556187348368e-55
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,39526,0.0528452947384425,0.00338834580235138,0.0462041369658338,0.0594864525110512,2.0563087602242e-54
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES1,Liver carboxylesterase 1,39479,-0.107165269734459,0.00692737338236031,-0.120742921563885,-0.0935876179050329,1.43493211438722e-53
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,39601,-0.0513271301046445,0.00332932522185927,-0.0578526075394887,-0.0448016526698004,3.20591832495593e-53
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF9,Protein turtle homolog A,37247,-0.109477251979787,0.00720364021685071,-0.123596386804814,-0.0953581171547596,1.03833313148901e-51
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH1,Somatotropin,39458,0.23821903107891,0.0158049150959164,0.207241397490914,0.269196664666907,5.80063695635849e-51
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,39541,0.0361385320145029,0.00243682660395138,0.0313623518707582,0.0409147121582476,2.08301310175131e-49
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP1,Neuropilin-1,39545,0.0370047014276521,0.00255214186890565,0.0320025033645971,0.0420068994907072,2.53926140187768e-47
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLR,Low-density lipoprotein receptor,39482,-0.0679980131055499,0.00470903926535066,-0.0772277300656372,-0.0587682961454627,5.98446308080143e-47
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FURIN,Furin,39531,-0.0434407962923853,0.00303473638591991,-0.0493888796087883,-0.0374927129759823,3.56396036972885e-46
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPA,Apolipoprotein(a),37006,0.225518464984113,0.0159051644517809,0.194344342658622,0.256692587309603,2.76469894512215e-45
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA2,Apolipoprotein A-II,37243,0.0604877546384696,0.00428302352910694,0.05209302852142,0.0688824807555193,5.98972553322529e-45
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN1,CCN family member 1,39403,-0.0953158162549925,0.00695361600045562,-0.108944903615886,-0.0816867288940995,1.6573006871702e-42
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO3,Beta-enolase,36916,-0.0693731267581923,0.00510732069923458,-0.0793834753286921,-0.0593627781876925,9.99478548148506e-42
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1A,Meprin A subunit alpha,37164,-0.0832626428381792,0.0061858981179348,-0.0953870031493314,-0.071138282527027,5.12819359403031e-41
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MET,Hepatocyte growth factor receptor,39502,0.0241604180616393,0.00181649162191399,0.0206000944826879,0.0277207416405907,3.86891875319706e-40
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH,Parathyroid hormone,36861,-0.0942729475022716,0.00711698114095044,-0.108222230538534,-0.0803236644660087,8.83620180756662e-40
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOF,Apolipoprotein F,37243,0.0286142676828296,0.00216041804254248,0.0243798483194464,0.0328486870462129,8.83809829026612e-40
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RB,Interleukin-17 receptor B,39258,0.0638566038045748,0.0048534574147213,0.0543438272717211,0.0733693803374286,2.58007664153418e-39
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,39428,-0.0538650590392228,0.00410015965412158,-0.0619013719613011,-0.0458287461171445,3.31547727189012e-39
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,39187,-0.0637342527137253,0.00491402552360923,-0.0733657427399994,-0.0541027626874512,2.93697169049494e-38
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBC,Inhibin beta C chain,39455,-0.0495124781039009,0.00383313881738244,-0.0570254301859705,-0.0419995260218314,5.75531318563211e-38
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,39617,0.0743928137075168,0.00577669071664034,0.0630704999029018,0.0857151275121319,9.42892364726065e-38
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSZ,Cathepsin Z,39471,-0.0361515740879373,0.00281535211423999,-0.0416696642318476,-0.0306334839440269,1.52497810980956e-37
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,39319,-0.0843550130131309,0.00661809259535606,-0.0973264745000288,-0.071383551526233,5.11824875663818e-37
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSE,Cathepsin E,36955,-0.0585586633992931,0.00463860090007907,-0.0676503211634481,-0.0494670056351381,2.5858591714575e-36
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPL,Lipoprotein lipase,39485,0.0521604622280171,0.00414615858172015,0.0440339914078456,0.0602869330481886,4.11304548589792e-36
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",36916,-0.064230929843431,0.00515051098800649,-0.0743259313799237,-0.0541359283069383,1.75418856957031e-35
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,39462,-0.0600877584791788,0.00485509271370861,-0.0696037401980477,-0.0505717767603099,5.20748828151486e-35
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF21,Fibroblast growth factor 21,39568,-0.130692151535122,0.0106506507032767,-0.151567426913544,-0.109816876156699,1.89524259367567e-34
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,39458,-0.114529391401788,0.00938539165369847,-0.132924759043037,-0.0961340237605392,4.34856717635756e-34
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,39455,-0.0585854625695716,0.00480613257897173,-0.0680054824243563,-0.049165442714787,5.10656188783283e-34
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADIPOQ,Adiponectin,37269,0.0724924121166196,0.00599274631150878,0.0607466293460624,0.0842381948871768,1.67369977110026e-33
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,39123,-0.0642336432204159,0.00532762414890395,-0.0746757865522676,-0.0537914998885642,2.56915872415921e-33
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,39428,-0.0378274416110555,0.00314044589513631,-0.0439827155655227,-0.0316721676565884,2.92722843268235e-33
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDUA,Alpha-L-iduronidase,39601,-0.0488438875089562,0.00408954442919836,-0.056859394590185,-0.0408283804277274,9.83567004365468e-33
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSD,Cathepsin D,38417,-0.0432510376073306,0.00362430269054569,-0.0503546708808002,-0.0361474043338611,1.13967685282285e-32
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPY,Pancreatic prohormone,39462,-0.108729489738563,0.00912266353337473,-0.126609910263978,-0.0908490692131487,1.32834585951293e-32
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY1,Aminoacylase-1,39485,-0.0646556916737223,0.00542586981184359,-0.0752903965049357,-0.0540209868425089,1.36646068071382e-32
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,39462,-0.0429599881858821,0.0036104638295558,-0.0500364972918115,-0.0358834790799527,1.68193347489822e-32
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREG1,Protein CREG1,39280,-0.0386381075155744,0.00326253047848283,-0.0450326672534008,-0.0322435477777481,3.26838036574041e-32
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EZR,Ezrin,39589,-0.0254034437403429,0.00214552622880923,-0.029608675148809,-0.0211982123318768,3.35527885791069e-32
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37162,-0.0412904714595206,0.00348961378001672,-0.0481301144683534,-0.0344508284506878,3.91395443080619e-32
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,39428,-0.0928269526175761,0.00792426821481989,-0.108358518318623,-0.0772953869165292,1.47904425850992e-31
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,36847,-0.0669300544722009,0.00573270284619485,-0.0781661520507427,-0.055693956893659,2.49132649146454e-31
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUSB,Beta-glucuronidase,39541,-0.0620347251872157,0.00532276297717016,-0.0724673406224692,-0.0516021097519622,2.95877360549367e-31
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,37057,-0.0269506454870861,0.00234095171049139,-0.0315389108396492,-0.022362380134523,1.61789567913029e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THOP1,Thimet oligopeptidase,39420,-0.0309544567832256,0.00271759039888361,-0.0362809339650375,-0.0256279796014137,6.20024176790283e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM1,Isthmin-1,39462,-0.0399344201101026,0.00353223747675086,-0.0468576055645343,-0.0330112346556709,1.61859704008061e-29
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,39355,-0.0758196660758612,0.00670952051674571,-0.0889703262886828,-0.0626690058630396,1.72356454436192e-29
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,39531,-0.0247664453070338,0.00219901916719512,-0.0290765228747362,-0.0204563677393313,2.6313300395151e-29
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR37,Prosaposin receptor GPR37,39187,-0.0686013249985242,0.00609150410470624,-0.0805406730437484,-0.0566619769533,2.66854966731639e-29
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,39268,-0.150553081396338,0.0133809218067138,-0.176779688137497,-0.124326474655179,2.99791809959358e-29
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,39194,-0.056376786407797,0.0050236716114083,-0.0662231827661573,-0.0465303900494367,4.16192421633166e-29
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2AP,CD2-associated protein,39485,-0.0646202844809159,0.00581255118248185,-0.0760128847985804,-0.0532276841632515,1.3349869945894e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM20A,Pseudokinase FAM20A,37247,-0.0283252357729326,0.00254996415508015,-0.0333231655168897,-0.0233273060289755,1.54725337421184e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,39428,-0.079216852890203,0.00717547165667591,-0.0932807773372878,-0.0651529284431182,3.15015065256484e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKB,Creatine kinase B-type,37255,0.0603783980418016,0.00547252371329776,0.049652251563738,0.0711045445198652,3.54749953049154e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHR,Growth hormone receptor,36955,-0.0286135478980233,0.00259370440273247,-0.033697208527379,-0.0235298872686677,3.6152393095565e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39033,-0.0550587458358398,0.004998259625109,-0.0648553347010534,-0.0452621569706261,4.14894260101334e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,37269,0.0253707368508314,0.00231537399952668,0.0208326038117591,0.0299088698899037,8.12517791606292e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBKS,Ribokinase,39125,-0.0490534830448021,0.00450421578508733,-0.0578817459835732,-0.0402252201060309,1.62901890561133e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL11,Eotaxin,39636,-0.0362418198027352,0.00339924665249053,-0.0429043432416166,-0.0295792963638537,1.90676064713694e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIP2,Cysteine-rich protein 2,39355,-0.0347543266432649,0.00327185127867887,-0.0411671551494755,-0.0283414981370543,2.9161342854108e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS8,Prostasin,39414,-0.0389274882614375,0.00367140338158825,-0.0461234388893504,-0.0317315376335245,3.57797705172151e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,39462,-0.0491453137243309,0.00464367009602989,-0.0582469071125495,-0.0400437203361123,4.40172799550192e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,36880,-0.11582220039232,0.0109640263296587,-0.137311691998451,-0.0943327087861895,5.64826521485121e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,39344,-0.0360087254783436,0.00341084362528898,-0.04269397898391,-0.0293234719727772,5.81553954258154e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,36955,-0.0460102236052618,0.00439442129562822,-0.0546232893446931,-0.0373971578658305,1.51084513877979e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLB1,Beta-galactosidase,39355,-0.0386682872735009,0.00370188124382656,-0.0459239745114009,-0.0314126000356008,1.87952610978028e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,36955,0.0286329673223569,0.0027495054171984,0.023243936704648,0.0340219979400658,2.71975989830699e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,39123,-0.0750410029451201,0.00732587866882119,-0.0893997251360097,-0.0606822807542306,1.53451602465028e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG2,Secretogranin-2,39509,-0.0299583682213726,0.00293694055844415,-0.0357147717159232,-0.0242019647268221,2.36627351355246e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,39566,-0.0284312294010047,0.00279363368805843,-0.0339067514295992,-0.0229557073724102,3.0027240865389e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,39462,-0.0252710163087507,0.00248821080813747,-0.0301479094927001,-0.0203941231248012,3.71836698729898e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,37203,-0.0687783895475092,0.00679829168342885,-0.0821030412470297,-0.0554537378479886,5.71918710047588e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC13,Mucin-13,39104,-0.0459484526793019,0.00454923037836776,-0.0548649442209027,-0.0370319611377011,6.59689895037499e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,38988,-0.0926384697679778,0.00918104331722467,-0.110633314669738,-0.0746436248662175,7.3159129643658e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,39541,0.0187987640874494,0.0018727122490691,0.015128248079274,0.0224692800956249,1.22763225055927e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPB1,Beta-ureidopropionase,37247,-0.0822100318988276,0.00826172105627219,-0.0984030051691211,-0.0660170586285341,3.04110052553868e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3B,Protein FAM3B,39428,-0.0323088904906833,0.00325340980963054,-0.0386855737175591,-0.0259322072638074,3.60698744928256e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,39289,-0.0413864132929394,0.00416751427392224,-0.049554741269827,-0.0332180853160518,3.61466257527895e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL27,C-C motif chemokine 27,39485,-0.0530678464304803,0.00537278445627019,-0.0635985039647699,-0.0425371888961907,6.14182520729799e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,39187,-0.0748325231250854,0.00764990871605231,-0.0898263442085479,-0.0598387020416229,1.57310158148578e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,39516,0.040272735755355,0.00412117868519501,0.0321952255323728,0.0483502459783372,1.72948220313998e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLA,Alpha-galactosidase A,36928,-0.0319244308621,0.00326687616135888,-0.0383275081383634,-0.0255213535858366,1.78496357252502e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,39531,-0.0190068077138327,0.00194660216097203,-0.0228221479493378,-0.0151914674783275,1.87117622261728e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA3,Glutathione S-transferase A3,39123,-0.0669231721938625,0.00689140085022814,-0.0804303178603096,-0.0534160265274153,3.15411404082108e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELE,E-selectin,39654,-0.0438928777434819,0.00452834844260562,-0.0527684406909889,-0.0350173147959749,3.74598453092273e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORT1,Sortilin,39458,-0.0319046967069205,0.00329809422509424,-0.0383689613881052,-0.0254404320257357,4.525072041656e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,39601,-0.0286320609877165,0.00296463725551202,-0.0344427500085201,-0.022821371966913,5.26848370244286e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,39526,0.0509061264313503,0.0052724050500194,0.0405722125333123,0.0612400403293883,5.41022943356465e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,37255,-0.0269616671308481,0.00279677673841658,-0.0324433495381446,-0.0214799847235516,6.41561126993903e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,39485,-0.0556524645109565,0.00582169932590449,-0.0670629951897293,-0.0442419338321837,1.36305782376924e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,36947,-0.0394699183942824,0.00413123796069667,-0.0475671447972478,-0.0313726919913169,1.47810324039897e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,39187,-0.0426478250165812,0.00447769631030781,-0.0514241097847845,-0.0338715402483779,1.91159030806209e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG2,Desmoglein-2,39455,0.0232312363685154,0.00244360595269305,0.018441768701237,0.0280207040357938,2.25517478545154e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,39462,-0.0474229681194967,0.00499000419397643,-0.0572033763396905,-0.0376425598993029,2.32847582360994e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL2,C-C motif chemokine 2,39330,-0.0455403381715647,0.00479794674376277,-0.0549443137893398,-0.0361363625537897,2.61323632805496e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA2,Carboxypeptidase A2,39518,-0.0551124495195111,0.00581418586081911,-0.0665082538067166,-0.0437166452323057,2.94353450202684e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL13,C-C motif chemokine 13,39606,-0.059834471593135,0.00632280220614584,-0.0722271639171809,-0.0474417792690892,3.41457717718282e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,39589,0.0388017442973959,0.0041114870216084,0.0307432297350435,0.0468602588597484,4.36689668630417e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,39485,-0.0290874251427773,0.00308353355439766,-0.0351311509093967,-0.0230436993761579,4.55076481493089e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG4A,Cysteine protease ATG4A,39123,-0.0510490434446079,0.00542045785469198,-0.0616731408398042,-0.0404249460494116,5.27780418775932e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,39462,-0.0531620807613917,0.00565147551949425,-0.0642389727796004,-0.042085188743183,5.8434205415592e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCTN3,Tectonic-3,37247,-0.0247987745855375,0.00264472831691357,-0.0299824420866881,-0.0196151070843869,7.93978074516249e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,39319,-0.0201517743634873,0.00215400449227868,-0.0243736231683535,-0.0159299255586211,9.4879802409697e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,39428,-0.0573194606381927,0.00613579908445296,-0.0693456268437205,-0.0452932944326649,1.0779951785968e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,39526,-0.0352470695381228,0.00381576071671933,-0.0427259605428927,-0.0277681785333529,2.8609134321771e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,39462,0.0287960810148384,0.00311824025197647,0.0226843301209645,0.0349078319087123,2.92995792355705e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES3,Carboxylesterase 3,39428,-0.0568589419509793,0.00622945102496149,-0.0690686659599039,-0.0446492179420548,7.89375657886565e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,39636,0.0215920193245746,0.0023665135943815,0.0169536526795869,0.0262303859695624,8.13556701042889e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,39428,-0.0491269199607239,0.00538686107765242,-0.0596851676729227,-0.0385686722485252,8.4697968909799e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,37182,-0.0688274535705291,0.00755719853032871,-0.0836395626899733,-0.0540153444510848,9.67222949061714e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,39455,-0.0259063837831952,0.00286457096133021,-0.0315209428674025,-0.020291824698988,1.69671469571287e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFM,Afamin,37269,-0.0152602042475052,0.00168968230868245,-0.0185719815725228,-0.0119484269224877,1.93470707079425e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,39282,-0.0302321367342464,0.00334967340030777,-0.0367974965988496,-0.0236667768696432,2.00697292641553e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF19,Fibroblast growth factor 19,39541,-0.0627298623882915,0.00695955365657659,-0.0763705875551816,-0.0490891372214013,2.23176866341923e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL16,Pro-interleukin-16,39636,-0.0329355866343969,0.00366275345342687,-0.0401145834031135,-0.0257565898656802,2.70901935001739e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,39355,-0.0570278070249949,0.00634900706891983,-0.0694718608800778,-0.044583753169912,2.96810352819473e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGLN1,Egl nine homolog 1,39462,-0.0431050017214188,0.00482947374798117,-0.0525707702674619,-0.0336392331753757,4.94702783006088e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMNL1,Formin-like protein 1,39104,-0.0481816253151858,0.00539875791911963,-0.0587631908366602,-0.0376000597937113,4.99706406974346e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,37164,-0.0464909799322699,0.00522692454683371,-0.0567357520440639,-0.0362462078204758,6.65292059896301e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,37247,-0.0447606271839907,0.00504382707632709,-0.0546465282535918,-0.0348747261143896,7.96170865262249e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA1,Glutathione S-transferase A1,39460,-0.0666135611538869,0.00753915091318078,-0.0813902969437212,-0.0518368253640526,1.10363639630558e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,39589,-0.0534506083181933,0.00604956812245582,-0.0653077618382067,-0.0415934547981799,1.10504962366572e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGL1,Fibrinogen-like protein 1,37243,0.0500175318200498,0.00566098040552742,0.038922010225216,0.0611130534148835,1.12553645402519e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,39462,-0.0491710682583895,0.00556691055813605,-0.0600822129523362,-0.0382599235644429,1.13293235324869e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,39568,-0.0337022864960137,0.00381589967208686,-0.0411814498533039,-0.0262231231387234,1.13888864961262e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS1,Protein MTSS 1,37164,-0.0881270596222486,0.0100177362272306,-0.107761822627621,-0.0684922966168766,1.58344243312687e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,39123,-0.0462139453562429,0.00525748422328943,-0.0565186144338902,-0.0359092762785956,1.65764736768203e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,39355,-0.0432425999085558,0.00492317030377639,-0.0528920137039575,-0.0335931861131541,1.75514758072227e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,37221,-0.0453682153241138,0.00518965347961337,-0.055539936144156,-0.0351964945040716,2.57293494796468e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HJV,Hemojuvelin,37221,-0.0362575058044665,0.0041501078842444,-0.0443917172575855,-0.0281232943513475,2.70120805412923e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,36955,-0.0177782203998991,0.00203502233303338,-0.0217668641726445,-0.0137895766271537,2.71721338168854e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,39433,-0.0434411336126905,0.00498181579579181,-0.0532054925724424,-0.0336767746529385,3.07216694718508e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEG1,Protein HEG homolog 1,36955,-0.020778754833281,0.00238440896432729,-0.0254521964033625,-0.0161053132631995,3.28790562220799e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP5,Retinol-binding protein 5,39428,-0.0439316031857298,0.00505143253560465,-0.0538324109555149,-0.0340307954159447,3.7620330827171e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BECN1,Beclin-1,36916,-0.0479760249538793,0.00551585191338988,-0.0587870947041235,-0.0371649552036351,3.80359025774353e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,36916,-0.0663407789252166,0.00763076084716809,-0.0812970701856661,-0.0513844876647672,3.93857600760129e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN1,Perilipin-1,39104,-0.0280573951173941,0.00323041294193444,-0.0343890044835856,-0.0217257857512026,4.16857470519114e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,39636,-0.06127989756407,0.00705604759113328,-0.0751097508426913,-0.0474500442854488,4.17804676523583e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,39392,0.048605098690611,0.00560711813919332,0.037615147137792,0.0595950502434299,4.82441347114179e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,39428,-0.0824359360546894,0.00951380252944995,-0.101082989012411,-0.0637888830969675,4.9767634960305e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GLB2,Endophilin-B2,37203,-0.0524489973230227,0.0060601374040367,-0.0643268666349346,-0.0405711280111108,5.52788762824304e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCS1,Neuronal calcium sensor 1,39601,-0.0223608929710986,0.00258901536450945,-0.0274353630855371,-0.01728642285666,6.34868924932743e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH9,Myosin-9,37255,-0.087756418954706,0.0101763976117462,-0.107702158273729,-0.0678106796356835,7.2505712789024e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPH,Hephaestin,37247,-0.0195352846266342,0.00226534824502667,-0.0239753671868865,-0.0150952020663819,7.2511407035405e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,39428,-0.0277512283456205,0.00322592807165629,-0.0340740473660668,-0.0214284093251741,8.56068607445924e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRP,Gastrin-releasing peptide,36916,-0.041730409107415,0.00489322403348306,-0.0513211282130418,-0.0321396900017882,1.65686057511329e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,39460,-0.0749485549404276,0.00883217589542607,-0.0922596196954627,-0.0576374901853925,2.33950905064026e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFASC,Neurofascin,39636,-0.0209860480200196,0.00247561908134752,-0.0258382614194607,-0.0161338346205785,2.51907900686742e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37247,-0.0223106346588717,0.00263315463728558,-0.0274716177479514,-0.017149651569792,2.6520031390448e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAST,Gastrin,37203,-0.100602867177776,0.0118734352028168,-0.123874800175297,-0.0773309341802553,2.65364544230587e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,39589,-0.0401035230767071,0.00473492103699945,-0.049383968309226,-0.0308230778441882,2.68329583578642e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPC,C-type natriuretic peptide,39462,-0.0331420912932817,0.00392042534508905,-0.0408261249696562,-0.0254580576169072,3.07919586220763e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN1,Dynactin subunit 1,39601,-0.0504600672203188,0.00597233021804386,-0.0621658344476848,-0.0387542999929529,3.20317337125466e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,36955,-0.0278947613236102,0.00330099551253593,-0.0343647125281807,-0.0214248101190398,3.22230442324634e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX,Glutaredoxin-1,39391,-0.0434603986769093,0.00514445385065502,-0.0535435282241931,-0.0333772691296254,3.23351642284401e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN3,Ataxin-3,37203,-0.0474069311867781,0.00563787094389433,-0.058457158236811,-0.0363567041367452,4.58529125797317e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTYMK,Thymidylate kinase,37247,-0.0524764305531799,0.00625670767559574,-0.0647395775973476,-0.0402132835090123,5.49571875223199e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MME,Neprilysin,39428,-0.0620736584764293,0.00740954895385332,-0.0765963744259818,-0.0475509425268768,5.88075691407474e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBN,Nibrin,39194,-0.0388147837328621,0.00464974942676514,-0.0479282926093218,-0.0297012748564024,7.57275413456474e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FEN1,Flap endonuclease 1,39123,-0.0470465786722614,0.00564178136961011,-0.0581044701566972,-0.0359886871878256,8.1555464536635e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,36955,-0.0556318326536814,0.00669364252920053,-0.0687513720109144,-0.0425122932964484,1.0452047701849e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,39428,-0.0419532190993184,0.00506408810216569,-0.0518788317795631,-0.0320276064190736,1.28616706095123e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,36955,-0.0408043299667165,0.00493030469638986,-0.0504677271716406,-0.0311409327617923,1.39973561042312e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",39104,-0.0407995812065096,0.00493511329353038,-0.0504724032618292,-0.0311267591511901,1.48823658862014e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN3,Contactin-3,39455,-0.0261745804659481,0.00317342590103067,-0.0323944952319682,-0.019954665699928,1.74256135119629e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,39427,-0.0364443187460517,0.00442473343166359,-0.0451167962721124,-0.0277718412199911,1.91868105407914e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELN,Elastin,37247,-0.0262492053328239,0.00318902141943998,-0.0324996873149263,-0.0199987233507216,2.03349822395341e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA2,Carbonic anhydrase 2,39415,-0.0528760953481249,0.00642992174785552,-0.0654787419739217,-0.040273448722328,2.13873425166769e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,39194,-0.0448830169993898,0.00547426053646163,-0.0556125676508546,-0.034153466347925,2.62408929491509e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFC,Platelet-derived growth factor C,39123,-0.0220840672269076,0.00269614871280989,-0.027368518704015,-0.0167996157498002,2.80362330495105e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK13,Kallikrein-13,39166,-0.0322263243593964,0.00393639761727539,-0.0399416636892561,-0.0245109850295366,2.90234559257846e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,39274,-0.0218594070099538,0.0026875039348045,-0.0271269147221706,-0.016591899297737,4.49100393128074e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,39123,-0.0494579875809973,0.00609188629234685,-0.0613980847139971,-0.0375178904479975,5.08574159991562e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADD1,Alpha-adducin,36955,-0.0515816082808925,0.00636186128357831,-0.064050856396706,-0.039112360165079,5.62599316344869e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,39104,-0.0407102742412668,0.0050238153698543,-0.0505569523661813,-0.0308635961163524,5.7612538912984e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,37162,-0.0373536507526772,0.00462218846312895,-0.04641314014041,-0.0282941613649445,6.9800987140118e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,39123,-0.0463886435548914,0.0057544923316326,-0.0576674485248913,-0.0351098385848915,8.12859754551389e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,39104,-0.0195577515287486,0.00242954566286749,-0.0243196610279689,-0.0147958420295283,8.91475974452187e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,39531,-0.0252262254166254,0.00313718971070152,-0.0313751172496003,-0.0190773335836504,9.56672607767121e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,36847,-0.0494563127223727,0.00614928441395697,-0.0615089101737284,-0.037403715271017,9.5906029241067e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA4,Apolipoprotein A-IV,37269,-0.0267776381389072,0.00332969328592912,-0.0333038369793282,-0.0202514392984861,9.60533300688693e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAT,Catalase,37058,-0.0396361745263342,0.00492925016296587,-0.0492975048457473,-0.0299748442069211,9.70180803355312e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAXX,Protein PAXX,36955,-0.0329534869934226,0.00410959500842007,-0.041008293209926,-0.0248986807769193,1.16371717148969e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOA,Elongin-A,39428,-0.0371777239816223,0.0046408302541373,-0.0462737512797314,-0.0280816966835132,1.22105448364984e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHK,Ketohexokinase,36916,-0.0465726621686531,0.00581697709952288,-0.057973937283718,-0.0351713870535883,1.2862199847975e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA1,Carbonic anhydrase 1,39145,-0.0455613581851085,0.00569737283842538,-0.0567282089484222,-0.0343945074217947,1.37045824640718e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX15,Sorting nexin-15,36955,-0.0392608628936208,0.00490879224083982,-0.0488820956856668,-0.0296396301015747,1.37470306784797e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,39432,-0.0217463253790255,0.00272736413844756,-0.0270919590903828,-0.0164006916676683,1.65474925114086e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,39530,-0.0421694578261891,0.00529225266495688,-0.0525422730495045,-0.0317966426028736,1.72529445376772e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSF,Cathepsin F,39531,-0.028900031211175,0.00362812700733766,-0.0360111601455568,-0.0217889022767932,1.76176906641843e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,39123,-0.0506720313226316,0.00638333384635998,-0.0631833656614972,-0.038160696983766,2.19963871741147e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,37162,-0.049012092210458,0.00617491132864883,-0.0611149184146097,-0.0369092660063063,2.23908608222979e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,39563,-0.0218737934135236,0.00275760605321381,-0.0272787012778227,-0.0164688855492246,2.30363507709249e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",39428,-0.0698703335936238,0.00883645188115081,-0.0871897792806794,-0.0525508879065682,2.81845849762536e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,37102,-0.0235383692821748,0.00298304836671317,-0.0293851440809326,-0.0176915944834169,3.25108124239037e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,37162,-0.0387377751015264,0.00491900711903628,-0.0483790290548375,-0.0290965211482152,3.67964288263966e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,39123,-0.0433906432004871,0.0055693346693856,-0.0543065391524829,-0.0324747472484913,7.09260224320675e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EEF1D,Elongation factor 1-delta,37247,-0.0645728951534054,0.00829765434108192,-0.080836297661926,-0.0483094926448849,7.68126687454983e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR,GMP reductase 1,39636,-0.0358538150125653,0.00461266449864801,-0.0448946374299154,-0.0268129925952152,8.16038745273964e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3F,Semaphorin-3F,39485,-0.0182012561655245,0.00234638738787677,-0.0228001754457629,-0.013602336885286,9.24253754870472e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORD,Sorbitol dehydrogenase,39532,-0.0471818949249135,0.00608889880294155,-0.059116136578679,-0.0352476532711481,9.86273529398705e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK4,Dickkopf-related protein 4,39332,-0.0319489526914675,0.00412575639705572,-0.0400354352296967,-0.0238624701532383,1.02701660146069e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPF,Centromere protein F,36992,-0.0381694252624069,0.00494059959748851,-0.0478530004734844,-0.0284858500513295,1.19714325401996e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,39104,-0.0473321666095126,0.00613940533367651,-0.0593654010635186,-0.0352989321555066,1.34335419027567e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",39428,-0.0541157059094628,0.00702669266387182,-0.0678880235306515,-0.040343388288274,1.42928559364776e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,39104,-0.0367839150645442,0.00478082541508531,-0.0461543328781114,-0.027413497250977,1.51610478306067e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDT,D-dopachrome decarboxylase,37255,-0.0285164016872669,0.00371172277019495,-0.035791378316849,-0.0212414250576848,1.66959538596634e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXN,Paxillin,39104,-0.0359590152899537,0.00468442792863256,-0.0451404940300735,-0.0267775365498338,1.74079663014209e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,39428,-0.0382328020629555,0.00499012577958886,-0.0480134485909497,-0.0284521555349614,1.9471418019793e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,36847,-0.0471041146457542,0.00615433326263637,-0.0591666078405215,-0.0350416214509869,2.09533264331662e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMPD3,AMP deaminase 3,37203,-0.0501799001084236,0.00655690661029219,-0.0630314370645963,-0.0373283631522509,2.10464450638642e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,37247,-0.0451200922798869,0.0058971064125092,-0.0566784208484049,-0.0335617637113689,2.13298434775538e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJAP1,Tight junction-associated protein 1,39531,-0.0573588342690382,0.00749856069519089,-0.0720560132316123,-0.042661655306464,2.14237517662178e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,39462,-0.0493127343378571,0.0064507307405163,-0.061956166589269,-0.0366693020864451,2.22398545270621e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F7,Coagulation factor VII,39499,-0.0207284088683139,0.00271874678999083,-0.0260571525766959,-0.0153996651599319,2.60088607402791e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,39428,-0.028686987080238,0.00376543190539748,-0.0360672336148171,-0.021306740545659,2.71944326138816e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTBS,Di-N-acetylchitobiase,37085,-0.0185250073985658,0.00243506446275473,-0.0232977337455651,-0.0137522810515666,2.9897576085565e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCHE,Cholinesterase,37019,-0.0193790506478466,0.00255332618099561,-0.024383569962598,-0.0143745313330952,3.43162847817495e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLK1,Protein delta homolog 1,39654,-0.0365770548305103,0.00482085113784848,-0.0460259230606933,-0.0271281866003273,3.45640028727863e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39123,-0.0426516379917451,0.00562192514473032,-0.0536706112754165,-0.0316326647080737,3.47943497022007e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MVK,Mevalonate kinase,39194,-0.0528032045572306,0.0069629804067727,-0.0664506461545051,-0.0391557629599561,3.56615097689185e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,39462,-0.0631998192552462,0.00834058297735339,-0.0795473618908589,-0.0468522766196336,3.73141154717657e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST13,Hsc70-interacting protein,36955,-0.0390589583684383,0.00515447632049088,-0.0491617319566005,-0.0289561847802762,3.7655037762603e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,39462,0.026637194851361,0.00352681176061739,0.019724643800551,0.0335497459021711,4.50616842006028e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGFR,Opioid growth factor receptor,39428,-0.0226424366198931,0.0029979478342294,-0.0285184143749827,-0.0167664588648034,4.51101013852143e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,39485,-0.0287658149740103,0.0038138437018787,-0.0362409486296925,-0.021290681318328,4.87485637926991e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD6,T-cell differentiation antigen CD6,39623,-0.0363018615913964,0.00482309306123597,-0.0457551239914189,-0.0268485991913739,5.49691151344137e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOE,Apolipoprotein E,37269,-0.0510060838992807,0.00678033544818313,-0.0642955413777196,-0.0377166264208417,5.72517974817341e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,36955,-0.0144366772272706,0.00192349747563512,-0.0182067322795154,-0.0106666221750257,6.53708465347109e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,37203,-0.0436919861504087,0.00582157700561708,-0.0551022770814181,-0.0322816952193992,6.54122136289078e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPACT,Protein IMPACT,37203,-0.038452688114676,0.00513776505172459,-0.0485227076160562,-0.0283826686132958,7.66333208359203e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,36880,-0.0331516635234497,0.00443515796039119,-0.0418445731258164,-0.0244587539210829,8.25364655900426e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,39537,-0.0705119955660505,0.00943527427858662,-0.0890051331520802,-0.0520188579800207,8.25405324018736e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA4,Kallistatin,37052,-0.0162527485208302,0.00217931227957372,-0.0205242005887947,-0.0119812964528657,9.37770993031537e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,39520,-0.0230321887310274,0.00308992489478349,-0.0290884415248031,-0.0169759359372518,9.54991432210068e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC1,Stanniocalcin-1,39589,-0.0279449523554249,0.0037549048491454,-0.0353045658597499,-0.0205853388511,1.04302563766874e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,36880,-0.0565787101506681,0.00763573569737986,-0.0715447521175326,-0.0416126681838035,1.34742757465841e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDI2,Protein DDI1 homolog 2,36955,-0.0524922034245807,0.00708850419512971,-0.0663856716470349,-0.0385987352021265,1.39285372648393e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RFC4,Replication factor C subunit 4,37162,-0.0138019027843725,0.00186566286277596,-0.0174586019954134,-0.0101452035733316,1.47089341246433e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,39123,-0.0334880535403615,0.00452975608950142,-0.0423663754757842,-0.0246097316049387,1.51417543731872e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BACH1,Transcription regulator protein BACH1,39462,-0.0486552345482121,0.00659388503427426,-0.0615792492153897,-0.0357312198810346,1.68035740208469e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,37203,-0.0313282569961306,0.00424751759467651,-0.0396533914816966,-0.0230031225105647,1.73636482894819e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFP,Properdin,37269,-0.0146290862143515,0.00198605953525413,-0.0185217629034496,-0.0107364095252534,1.86736149465987e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,39428,-0.0455823473349072,0.00618966551874632,-0.0577140917516499,-0.0334506029181644,1.87400619115068e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKLR,Pyruvate kinase PKLR,39495,-0.0446231486299047,0.00605960790572395,-0.0564999801251237,-0.0327463171346858,1.87686481383652e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAT,Tissue-type plasminogen activator,39608,-0.0327220931214035,0.00444401513680808,-0.0414323627895474,-0.0240118234532597,1.88810903319259e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLO1,Lactoylglutathione lyase,39187,-0.0396287997449579,0.00538291592235715,-0.0501793149527779,-0.0290782845371379,1.90817411326474e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,37203,-0.0200252838610356,0.00272783489081243,-0.025371840247028,-0.0146787274750432,2.24707502448073e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLUL1,Clusterin-like protein 1,39464,0.0303073695897572,0.00413696281297451,0.0221989224763271,0.0384158167031872,2.49197070267707e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAMBP,STAM-binding protein,39319,-0.0429039108601216,0.00586776149876211,-0.0544047233976954,-0.0314030983225479,2.77022138647485e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILP,Rab-interacting lysosomal protein,39549,-0.0400199847333501,0.00547492534638654,-0.0507508384122677,-0.0292891310544324,2.81191619289758e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,39123,-0.0366564250917157,0.00502029513392726,-0.0464962035542131,-0.0268166466292183,2.98875018062144e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAB2,Stabilin-2,37255,-0.0184118887070433,0.00252464984749233,-0.0233602024081283,-0.0134635750059584,3.21314206188941e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSNAX,Translin-associated protein X,36847,-0.026118676224119,0.00359061330366077,-0.0331562782992941,-0.0190810741489439,3.69569349229779e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,36719,-0.0353116127557789,0.00485909202149409,-0.0448354331179073,-0.0257877923936505,3.89471436406673e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,39403,-0.0168568825530786,0.00232652371959876,-0.0214168690434921,-0.012296896062665,4.51823952586818e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,37255,-0.0352347161073358,0.00486229421970961,-0.0447648127779666,-0.0257046194367049,4.52120151708763e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCXR,L-xylulose reductase,39531,-0.0344671506496259,0.00476274361872186,-0.0438021281423207,-0.0251321731569311,4.8144903367492e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,39187,-0.0248758478974796,0.00343997627750098,-0.0316182014013815,-0.0181334943935776,5.01563463962307e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",39403,-0.0494513782294507,0.00686043730689307,-0.0628978353509611,-0.0360049211079402,5.94118893787407e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD36,Platelet glycoprotein 4,36880,-0.0289892724361615,0.00402226570873083,-0.0368729132252739,-0.021105631647049,6.04154874060264e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,39485,-0.0419385605807892,0.00582284489605255,-0.0533513365770522,-0.0305257845845262,6.19609426983676e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,39194,-0.0456981574041791,0.00635127525526022,-0.0581466569044892,-0.0332496579038691,6.54165982014381e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,39191,-0.0485951437050227,0.00676622487939626,-0.0618569444686394,-0.035333342941406,7.19782287455575e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39123,-0.0440702821792025,0.00614463346369923,-0.056113763768053,-0.032026800590352,7.73555945817763e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,37269,0.0115000854376306,0.00160498015272168,0.00835432433829612,0.0146458465369651,8.18915763284847e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MENT,Protein MENT,36955,0.0140927138720199,0.00196969469482934,0.0102321122701543,0.0179533154738854,8.84880370214453e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPY30,Protein dpy-30 homolog,39530,-0.0387361479609955,0.00542299722867188,-0.0493652225291923,-0.0281070733927986,9.55350272606999e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS4,Thrombospondin-4,39482,-0.0292428096346029,0.00410638235236485,-0.037291319045238,-0.0211943002239678,1.11756614224981e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA1,Apolipoprotein A-I,37269,0.0178315511554635,0.00250554541155127,0.012920682148823,0.022742420162104,1.16312671973098e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A4,Protein S100-A4,39531,-0.0371564599535034,0.00522916539905272,-0.0474056241356467,-0.02690729577136,1.25150519428582e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,39589,-0.0422207296041044,0.00594839196538705,-0.0538795778562631,-0.0305618813519458,1.32352984108992e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",37186,-0.0262410263027757,0.00369954492403564,-0.0334921343538856,-0.0189899182516659,1.38132056290386e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXLNA,Alpha-taxilin,39355,-0.0573755070802906,0.00809352779231156,-0.0732388215532212,-0.0415121926073599,1.4109094468502e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,39355,-0.0379858727049589,0.00536223313473129,-0.0484958496490323,-0.0274758957608856,1.46361721251546e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KEL,Kell blood group glycoprotein,39104,-0.0228749783395138,0.00323358641646146,-0.0292128077157783,-0.0165371489632494,1.57146371781047e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,39432,-0.0421526208179179,0.00596544288392285,-0.0538448888704067,-0.0304603527654291,1.66336047563879e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLVRB,Flavin reductase,39455,-0.0425531437374147,0.00604174039865134,-0.0543949549187713,-0.030711332556058,1.96050912341809e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,39445,-0.0531329579604663,0.00754661505188085,-0.0679243234621528,-0.0383415924587798,1.99678623073776e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,39104,0.0213537645533263,0.00303792130293248,0.0153994387995786,0.0273080903070739,2.17097706286858e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUMB,Protein numb homolog,36880,-0.0529029712653028,0.00754864938915628,-0.0676983240680491,-0.0381076184625565,2.53743978915928e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMN,Protein amnionless,39194,-0.0304271137859055,0.00434231255616869,-0.0389380463959961,-0.0219161811758148,2.53816851494688e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FYB1,FYN-binding protein 1,39434,-0.0581939480798706,0.0083118348311794,-0.0744851443489822,-0.041902751810759,2.64309735702812e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,37203,-0.0395874673956886,0.00565644212764279,-0.0506740939658685,-0.0285008408255088,2.71367317506792e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D17,TBC1 domain family member 17,39104,-0.0291465714782365,0.00417662296166544,-0.0373327524831008,-0.0209603904733723,3.11147983043713e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSO,Cathepsin O,39636,-0.0190276649350518,0.00272782514387359,-0.024374202217044,-0.0136811276530596,3.17607413247809e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,36955,-0.0498557942452144,0.00714762812961596,-0.0638651453792617,-0.0358464431111671,3.2092671071692e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,39499,-0.0167930586256771,0.0024117978103797,-0.0215201823340214,-0.0120659349173329,3.47186946760557e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,37203,-0.0558118356622578,0.00801722872517983,-0.0715256039636102,-0.0400980673609053,3.53187900255619e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,36916,-0.0350886652984621,0.00504873387598421,-0.0449841836953911,-0.025193146901533,3.83493981928964e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD5,Programmed cell death protein 5,39589,-0.0367882639807968,0.00529486772559697,-0.0471662047229668,-0.0264103232386267,3.8586130925545e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEXIM1,Protein HEXIM1,39462,-0.0514718997291049,0.00742190733394048,-0.0660188381036282,-0.0369249613545815,4.2242094316828e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,39123,-0.0286784622799712,0.00413945608529315,-0.0367917962071458,-0.0205651283527966,4.44367148528716e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX2,Peroxiredoxin-2,37030,-0.0394380522102094,0.00569452831323787,-0.0505993277041557,-0.0282767767162632,4.55233213227336e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,39520,-0.0328276632886177,0.00474191668806709,-0.0421218199972292,-0.0235335065800062,4.60469329282499e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",39462,-0.0598877016782224,0.0086565563826817,-0.0768545521882785,-0.0429208511681662,4.75952687881871e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,36880,-0.0496346567181036,0.00718570745632767,-0.0637186433325059,-0.0355506701037014,5.1761676705569e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11R,Junctional adhesion molecule A,39455,-0.035534924531672,0.00514638374251521,-0.0456218366670018,-0.0254480123963422,5.22804713310812e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,39428,-0.0766461959469927,0.0111035953936484,-0.0984092429185436,-0.0548831489754418,5.30261172567429e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,36992,-0.0329261375345289,0.00478521444703361,-0.0423051578507148,-0.023547117218343,6.23436736235391e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,39462,-0.033920087437941,0.00493455908635165,-0.0435918232471902,-0.0242483516286918,6.48939105401755e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,36880,-0.0268523805678024,0.00391419760733077,-0.0345242078781707,-0.0191805532574341,7.19979472965471e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCA,Alpha-synuclein,36955,-0.0707159206392784,0.0103083981490991,-0.0909203810115125,-0.0505114602670442,7.20893380275629e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,36916,-0.0193662345576807,0.00282712238856836,-0.0249073944392747,-0.0138250746760868,7.72347484919616e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,39123,-0.0679545893466522,0.00992694525679706,-0.0874114020499744,-0.04849777664333,7.92512539900452e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,39485,-0.0172908255191886,0.0025289321833797,-0.0222475325986128,-0.0123341184397644,8.38649844419086e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UMOD,Uromodulin,39622,0.03374698546589,0.00493870364571166,0.0240671263202952,0.0434268446114849,8.62236809963695e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP2,Neuropilin-2,39455,0.0180671422270457,0.00264442183998839,0.0128840754206685,0.023250209033423,8.68586471170612e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT1,Deaminated glutathione amidase,36916,-0.0304889932490045,0.00446610826207626,-0.039242565442674,-0.021735421055335,9.08872257794695e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTNB,Dystrobrevin beta,37141,-0.0258203108371504,0.00378427842059342,-0.0332374965415135,-0.0184031251327873,9.31766972004134e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,39479,-0.0360562427453253,0.00529034545467944,-0.046425319836497,-0.0256871656541536,9.75252063702469e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMBS,Porphobilinogen deaminase,39601,-0.0281315619888196,0.0041317044771923,-0.0362297027641165,-0.0200334212135227,1.02182932939913e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,39450,-0.0120703592136294,0.00177563056740889,-0.0155505951257508,-0.00859012330150798,1.10247420788673e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSA,Arylsulfatase A,39455,-0.0275142919888503,0.00406247078845211,-0.0354767347342164,-0.0195518492434841,1.31011755191393e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],39118,-0.0301447502876587,0.00445149423319624,-0.0388696789847233,-0.0214198215905941,1.32001207898569e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,37164,-0.0506552003708725,0.00748053108468938,-0.0653170412968637,-0.0359933594448813,1.32962428715961e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,36990,-0.0258263695085609,0.00381775681109712,-0.0333091728583112,-0.0183435661588105,1.39421028048424e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,39462,-0.063579194322659,0.00940051581708077,-0.0820042053241373,-0.0451541833211807,1.39797563392326e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,39355,-0.0296249338986312,0.00438404281009232,-0.0382176578064121,-0.0210322099908503,1.4565468554541e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,39428,0.0252878643126156,0.00374322187743034,0.0179511494328521,0.032624579192379,1.47448027625795e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZU1,Azurocidin,38967,-0.0478793695793286,0.00708808474145723,-0.0617720156725848,-0.0339867234860725,1.48362170098883e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WDR46,WD repeat-containing protein 46,37162,-0.0218611024480894,0.00323631176908123,-0.0282042735154886,-0.0155179313806902,1.49114281551376e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA3,Carbonic anhydrase 3,39621,-0.0375129444584294,0.00555879300087191,-0.0484081787401383,-0.0266177101767205,1.54904245481636e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS2,Protein MTSS 2,37162,-0.0601686701556523,0.0089156696046145,-0.0776433825806968,-0.0426939577306079,1.55709608218555e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,37221,-0.0372425583473255,0.00552959288716025,-0.0480805604061596,-0.0264045562884915,1.70793395103672e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTG,Protogenin,39601,-0.0153790114464285,0.0022869931044908,-0.0198615179312304,-0.0108965049616265,1.82431439512594e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,39104,-0.0372930741863991,0.00556670588411915,-0.0482038177192726,-0.0263823306535256,2.17045179607418e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,37247,-0.036147820317286,0.00539859031118287,-0.0467290573272044,-0.0255665833073675,2.23470168334144e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,36916,-0.0345571281334676,0.00516511294934319,-0.0446807495141802,-0.0244335067527549,2.3193756317515e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,36992,-0.0267189261856847,0.00399479930961142,-0.034548732832523,-0.0188891195388463,2.35155179187824e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIT,Citron Rho-interacting kinase,36861,-0.0273903342431867,0.00410667979132726,-0.0354394266341881,-0.0193412418521852,2.6719507228341e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES2,Cocaine esterase,39428,-0.0324496417936865,0.00486981294754496,-0.0419944751708746,-0.0229048084164984,2.76853631759695e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37247,-0.0436865973626783,0.00656205043916979,-0.0565482162234511,-0.0308249785019055,2.89969292422162e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37164,-0.0180766159285892,0.00271665934208633,-0.0234012682390784,-0.0127519636181,2.96954466425922e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,39037,-0.0111752972819364,0.00168383307642069,-0.014475610111721,-0.00787498445215187,3.31833959433532e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCLY,Selenocysteine lyase,39549,-0.0288097702501707,0.00435004236890757,-0.0373358532932296,-0.0202836872071119,3.64192745174737e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,36916,-0.0318292423152822,0.00480587608753397,-0.0412487594468488,-0.0224097251837156,3.66472759696015e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37162,-0.0286774222253805,0.00433242357336965,-0.037168972429185,-0.020185872021576,3.75509606154256e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37203,-0.0242367184142165,0.00366240171379434,-0.0314150257732534,-0.0170584110551796,3.79391775201108e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,36955,-0.0249406608353311,0.00377375795423694,-0.0323372264256355,-0.0175440952450267,4.02704973389283e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP2B1,AP-2 complex subunit beta,36861,-0.0295948120136051,0.00447869058147811,-0.0383730455533022,-0.020816578473908,4.05698636774505e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OCLN,Occludin,37221,-0.026117215058778,0.00395424330303682,-0.0338675319327301,-0.0183668981848258,4.13667071187602e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,39330,-0.0532443342630581,0.00806250855928118,-0.0690468510392492,-0.037441817486867,4.13943988529864e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG6,Large proline-rich protein BAG6,39187,-0.021619612314948,0.00327625921150001,-0.028041080369488,-0.015198144260408,4.28444023467066e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,37243,-0.0132641466548473,0.00201239049660953,-0.017208432028202,-0.00931986128149267,4.53284473148088e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,39482,-0.0216435474791584,0.00328477400403425,-0.0280817045270655,-0.0152053904312513,4.57366116125995e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR2,Cadherin-related family member 2,39428,-0.0460539190774811,0.00699323862575024,-0.0597606667839516,-0.0323471713710106,4.68483512119406e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPL,N-acetylneuraminate lyase,37247,-0.0258010151378611,0.00392079689813653,-0.0334857770582087,-0.0181162532175135,4.86964264611263e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,36880,-0.0289922661579795,0.00441351174521352,-0.037642749178598,-0.020341783137361,5.26807930074531e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,36955,-0.0418029580149993,0.00636904569136803,-0.0542862875700807,-0.029319628459918,5.46502496116445e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,36880,-0.0335698286533919,0.00512104413018032,-0.0436070751485454,-0.0235325821582385,5.773670403071e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37162,-0.0429451768410939,0.00655731487167316,-0.0557975139895733,-0.0300928396926145,6.00723220818451e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH2,Cadherin-2,39485,-0.0209230162325782,0.00319592195184031,-0.0271870232581852,-0.0146590092069712,6.06942809802296e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,37203,-0.018784125578035,0.00287569645385266,-0.0244204906275862,-0.0131477605284838,6.73494175131142e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNMBP,Dynamin-binding protein,39355,-0.0365586856119128,0.00560002801295487,-0.0475347405173044,-0.0255826307065213,6.8669585255779e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,39477,0.0200155709738022,0.00306717531524953,0.0140039073559132,0.0260272345916913,6.98360445662073e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX1,Heme oxygenase 1,39321,0.0279433365431813,0.00428351697965806,0.0195476432630515,0.0363390298233111,7.09256973471512e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCR,Breakpoint cluster region protein,39462,-0.0537603069840837,0.00826933631557151,-0.0699682061626039,-0.0375524078055635,8.22179022175636e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',37203,-0.0232691835140887,0.0035819465256698,-0.0302897987044015,-0.0162485683237759,8.54117363249743e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUS,RNA-binding protein FUS,39104,-0.0233080024762849,0.00359492138377847,-0.0303540483884907,-0.0162619565640791,9.2431675295638e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,39355,-0.0304117470390217,0.00469503940977296,-0.0396140242821767,-0.0212094697958667,9.6228490988158e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPK2,SRSF protein kinase 2,39462,-0.0486735073897492,0.00753716869149017,-0.0634463580250699,-0.0339006567544284,1.09504701592974e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,39194,-0.0404425135374835,0.00627104911745534,-0.052733769807696,-0.0281512572672711,1.16034414205139e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHBP1,EH domain-binding protein 1,37247,-0.0436432826578022,0.00677790448392555,-0.0569279754462963,-0.0303585898693082,1.24518475124586e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,39462,-0.0618960457112111,0.00962860744145368,-0.0807681162964604,-0.0430239751259619,1.3289298502962e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYNU,Kynureninase,39636,-0.0259981081849478,0.0040494497001549,-0.0339350295972514,-0.0180611867726442,1.40175344600513e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIT,Vitrin,37247,-0.0214775980329091,0.00334512275820065,-0.0280340386389824,-0.0149211574268358,1.40561409119957e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TALDO1,Transaldolase,37224,-0.0258771058802934,0.00403642188339519,-0.033788492771748,-0.0179657189888389,1.49751379831182e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACHE,Acetylcholinesterase,36955,-0.0186501576748523,0.00290960354833528,-0.0243529806295894,-0.0129473347201151,1.50885110203766e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",36916,-0.0405653199634829,0.00632919109410785,-0.0529705345079343,-0.0281601054190315,1.51514349197045e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,39520,-0.0373084187302669,0.00582308766497048,-0.048721670553609,-0.0258951669069247,1.52834328122028e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA9,Serpin A9,39351,-0.0421052921816147,0.0065766660410358,-0.0549955576220449,-0.0292150267411845,1.57713731775459e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37184,-0.04842578215181,0.00756689601867947,-0.0632568983484218,-0.0335946659551983,1.61151620788694e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP6,Bone morphogenetic protein 6,39169,-0.0246035960292011,0.00384492891238179,-0.0321396566974694,-0.0170675353609328,1.61157802875487e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,37221,-0.0319751384689154,0.00500505986091819,-0.041785055796315,-0.0221652211415157,1.73264855714677e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,37173,-0.0237308454770465,0.00371649028209132,-0.0310151664299455,-0.0164465245241475,1.77028963271743e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN3,Calsyntenin-3,37203,-0.017645576078479,0.00276408317368652,-0.0230631790989045,-0.0122279730580534,1.78640493757462e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF23,Fibroblast growth factor 23,39582,-0.0356664255412059,0.00559461252407872,-0.0466318660884002,-0.0247009849940116,1.88096862587382e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39123,-0.0496507537996715,0.00779112287832824,-0.0649213546411948,-0.0343801529581481,1.91232082490816e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37164,-0.0627836288750937,0.00986471517009067,-0.0821184706084714,-0.0434487871417159,2.02704135506922e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,39507,0.0177209966866321,0.00278871447700878,0.0122551163116949,0.0231868770615693,2.15063984502436e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA4,Carbonic anhydrase 4,39654,0.013471381079527,0.00212524399488255,0.00930590284955721,0.0176368593094968,2.38175410401888e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",39428,-0.0252925454817142,0.00399574034045722,-0.0331241965490103,-0.017460894414418,2.52342139371774e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,39589,-0.0271416317681835,0.0042899724822474,-0.0355499778333884,-0.0187332857029786,2.57397892786157e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCG,Gamma-synuclein,39355,-0.0386055680070516,0.00610447155625461,-0.0505703322573107,-0.0266408037567926,2.61897038940705e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN2,Matrilin-2,39499,-0.0170259596891132,0.00269423344317503,-0.0223066572377363,-0.0117452621404902,2.69959052543361e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,37162,-0.0652287340415203,0.0103377670185074,-0.0854907573977947,-0.0449667106852459,2.8876376351875e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37164,-0.0292022712838427,0.00463146010550821,-0.0382799330906388,-0.0201246094770466,2.9735318361139e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXJ3,Forkhead box protein J3,36880,-0.0248635884454631,0.00394419047854924,-0.0325942017834196,-0.0171329751075066,3.00164402046532e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,36668,-0.0183046191554338,0.00290507447137737,-0.0239985651193334,-0.0126106731915341,3.06069083565558e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,36847,-0.0424338663786374,0.00673859782195977,-0.0556415181096786,-0.0292262146475963,3.13439200631935e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,39462,-0.0458755007120221,0.00729460049517739,-0.0601729176825698,-0.0315780837414745,3.28433974501483e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4R,Reticulon-4 receptor,39601,-0.019358263863669,0.00308051890570895,-0.0253960809188585,-0.0133204468084794,3.38793559006827e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM2,Paralemmin-2,37203,-0.0210646689701776,0.00335245766785106,-0.0276354859991656,-0.0144938519411895,3.42135296299138e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,39428,-0.0349380652325026,0.00556282912040381,-0.045841210308494,-0.0240349201565111,3.46514816595982e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D5,TBC1 domain family member 5,39462,-0.0445784736083749,0.00711551864099184,-0.058524890144719,-0.0306320570720309,3.83079391283467e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA14,Carbonic anhydrase 14,39601,0.0196582792017658,0.00314213257284272,0.0134996993589941,0.0258168590445375,4.04683181044933e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APLP1,Amyloid-like protein 1,39485,0.0296477013086019,0.00474200608939607,0.0203533693733856,0.0389420332438182,4.15792735488034e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,36955,-0.0469504901272637,0.00753059424193892,-0.061710454841464,-0.0321905254130634,4.67416541091536e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,36916,-0.0407324869571518,0.00654169072254858,-0.053554200773347,-0.0279107731409565,4.91983068658229e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLF4,Krueppel-like factor 4,36823,-0.0222383520268107,0.00357156393229052,-0.0292386173341002,-0.0152380867195213,4.92402648062526e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUOM,Fucose mutarotase,36955,-0.0353252025671661,0.00568056020079519,-0.0464591005607247,-0.0241913045736075,5.17552945604503e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,39428,-0.0641195871867696,0.0103126110443749,-0.0843323048337444,-0.0439068695397948,5.18240193981979e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,39654,0.0195313236765654,0.00315309371210187,0.0133512600008458,0.0257113873522851,6.00378171390713e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,39531,-0.0512814253007672,0.00828252662018891,-0.0675151774763375,-0.0350476731251969,6.11307927610796e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXT,Oxytocin-neurophysin 1,39589,-0.0741778050149369,0.0119997829849682,-0.0976973796654746,-0.0506582303643991,6.50843303707858e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QDPR,Dihydropteridine reductase,39420,-0.0245923306143189,0.00398140428835738,-0.0323958830194994,-0.0167887782091385,6.71061794069883e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXIN1,Axin-1,39462,-0.0527319321196984,0.00854008309487044,-0.0694704949856444,-0.0359933692537523,6.80223441703786e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPQ,Carboxypeptidase Q,37243,-0.0203872055880746,0.00330598593754625,-0.0268669380256653,-0.0139074731504839,7.1805333562731e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LG,CMRF35-like molecule 9,39455,0.0210542188224146,0.00341549713238949,0.0143598444429312,0.027748593201898,7.25980945592202e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",39428,0.0236188210283791,0.00383762472584399,0.0160970765657249,0.0311405654910333,7.72134237464615e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL25,C-C motif chemokine 25,39636,-0.0272630205552484,0.00443167418631871,-0.0359491019604331,-0.0185769391500637,7.85024080118685e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSTN,Growth/differentiation factor 8,39187,-0.0285581547399369,0.00465050687852206,-0.0376731482218402,-0.0194431612580337,8.41782307941655e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,39309,-0.016649792123087,0.0027114616096455,-0.0219642568779922,-0.0113353273681818,8.43439943910148e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,37057,-0.0311288772160886,0.00508195230652661,-0.0410895037368808,-0.0211682506952965,9.31619941772071e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GET3,ATPase GET3,37247,-0.0310709906232524,0.00507508745606732,-0.0410181620371443,-0.0211238192093604,9.49587447530014e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB7,Integrin beta-7,39601,-0.0252766888059279,0.004133249514401,-0.0333778578541538,-0.0171755197577019,9.86484117857429e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPPK1,Epiplakin,36916,-0.0406113967145436,0.0066534914058371,-0.0536522398699843,-0.0275705535591029,1.06669857118699e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA,Adenosine deaminase,39636,-0.0188964242931937,0.00309895048225264,-0.0249703672384089,-0.0128224813479786,1.10222236782061e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,37190,-0.0599542913992782,0.00983711868649569,-0.0792350440248097,-0.0406735387737466,1.12808660148451e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,36916,-0.024600018264563,0.00403894956092347,-0.0325163594039731,-0.016683677125153,1.15730034677914e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,39568,-0.0153608826766657,0.00252696881247739,-0.0203137415491214,-0.01040802380421,1.24012744981425e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,39545,-0.0253993014530782,0.00418958264489926,-0.0336108834370808,-0.0171877194690757,1.37223145172181e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37203,-0.0417742359774076,0.006898759539845,-0.0552958046755038,-0.0282526672793114,1.44074017966899e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN1,Pantetheinase,37243,-0.039766279234581,0.00656753826083131,-0.0526386542258104,-0.0268939042433517,1.44374958406853e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,37203,-0.0391351642909128,0.00646968029872605,-0.0518157376764158,-0.0264545909054097,1.49819043504229e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,37203,-0.0355317053688548,0.00587523218472038,-0.0470471604509068,-0.0240162502868029,1.51028808109956e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,39104,-0.0432555868194922,0.00716269534677931,-0.0572944696991797,-0.0292167039398048,1.58811193757091e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R9B,Neurabin-2,39636,-0.0515235390251796,0.00854053554692394,-0.0682629886971505,-0.0347840893532087,1.64861636391912e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYAL1,Hyaluronidase-1,39344,0.0126300447655613,0.0020945970472111,0.00852463455302752,0.016735454978095,1.68021421570475e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KITLG,Kit ligand,39485,0.0200637427558108,0.00332841907785262,0.0135400413632197,0.0265874441484019,1.69872756930452e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,39123,-0.0303112908808662,0.00502928536281125,-0.0401686901919763,-0.0204538915697562,1.71076284080734e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,39459,-0.0408286233286353,0.00678485192942685,-0.0541269331103119,-0.0275303135469587,1.81124596903859e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFI,Complement factor I,37269,-0.0109071243716285,0.00181460365249211,-0.0144637475305131,-0.007350501212744,1.89686718924664e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,39123,-0.0351410163060418,0.00585110668897504,-0.0466091854164329,-0.0236728471956507,1.94798165213332e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39123,-0.0335505211659887,0.00559796928617085,-0.0445225409668836,-0.0225785013650939,2.10393752908461e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",39455,-0.025000420699971,0.00417226520278821,-0.0331780604974359,-0.0168227809025061,2.11954921712116e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3D,Protein FAM3D,37164,-0.0446563054426363,0.00745423638501739,-0.0592666087572703,-0.0300460021280022,2.14551107742574e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",39654,-0.026728867799065,0.00446359169229584,-0.0354775075159648,-0.0179802280821651,2.16959361498987e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,39440,0.0153667504556018,0.00257003791863565,0.010329476135076,0.0204040247761277,2.29341172370851e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,37164,-0.0416102393197447,0.00695948258772677,-0.0552508251916891,-0.0279696534478002,2.30637443711832e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL32,Interleukin-32,39462,0.0232419483923748,0.00388894024147746,0.015619625519079,0.0308642712656706,2.33255994652989e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,36642,-0.0266840068343418,0.0044646277593657,-0.0354346772426986,-0.0179333364259851,2.33981331077773e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,39601,-0.0188341435989374,0.00315997087118627,-0.0250276865064625,-0.0126406006914123,2.57478219219048e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR2,GMP reductase 2,36955,-0.0364888823951685,0.00612293749685073,-0.0484898398889959,-0.024487924901341,2.60022678780723e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,39636,-0.0539498955765713,0.00906222058473954,-0.0717118479226608,-0.0361879432304818,2.68621303223247e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,39636,-0.0223850892942972,0.00376330635895282,-0.0297611697578448,-0.0150090088307497,2.76977220758479e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,36916,-0.0402213554962377,0.00676301498692815,-0.0534768648706168,-0.0269658461218585,2.79988681310388e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,39187,-0.0394847335699442,0.00664188608501878,-0.052502830296581,-0.0264666368433074,2.83035166606021e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,39355,-0.0242464508879718,0.00408135123903782,-0.0322458993164859,-0.0162470024594576,2.89970194728154e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37247,-0.0415395911468628,0.00699678413979175,-0.0552532880608546,-0.027825894232871,2.97890963123247e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",36899,-0.0431212935922913,0.00728044496862942,-0.057390965730805,-0.0288516214537777,3.2468008231806e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYAP1,Synapse-associated protein 1,36955,-0.0304564536221119,0.00514622528531962,-0.0405430551813384,-0.0203698520628855,3.33987989611722e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,37162,-0.0309426824473623,0.00522886446891809,-0.0411912568064417,-0.0206941080882828,3.34951401899525e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,36916,-0.0224175555924206,0.00378928998990124,-0.0298445639726271,-0.0149905472122142,3.38460663784954e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACYP1,Acylphosphatase-1,36909,-0.0353838191933527,0.00598933968560208,-0.0471229249771328,-0.0236447134095726,3.55763054751397e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37221,-0.0253812853774722,0.00429648437798582,-0.0338023947583243,-0.01696017599662,3.56283213495676e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,39526,-0.0145913642576865,0.00247157336263965,-0.0194356480484602,-0.00974708046691282,3.63131116579274e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLKB1,Plasma kallikrein,36989,-0.0134393346584238,0.00228212273256004,-0.0179122952142415,-0.00896637410260615,3.98587388274215e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,36880,-0.0290253221592143,0.00493121332227195,-0.0386905002708673,-0.0193601440475613,4.05763718913444e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,39428,-0.0164224998635156,0.00279601930189764,-0.0219026976952349,-0.0109423020317962,4.3565715764517e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,36861,-0.0636049996327734,0.0108305617759205,-0.0848329007135775,-0.0423770985519694,4.39647964890177e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53,Cellular tumor antigen p53,39123,-0.0230252810778737,0.00392524167172106,-0.030718754754447,-0.0153318074013005,4.5617641917961e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,37243,-0.0321052257564478,0.00547284377137931,-0.0428319995483512,-0.0213784519645443,4.56708360361291e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,37162,-0.0348791009330824,0.00595165657831418,-0.0465443478265781,-0.0232138540395866,4.73196572719886e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,37164,-0.0211043928602469,0.0036014926211932,-0.0281633183977856,-0.0140454673227082,4.74618994031329e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37203,-0.0366718146835244,0.00626764574463758,-0.048956400343014,-0.0243872290240347,5.00712715136005e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,39462,-0.0452957484817995,0.00774309224898068,-0.0604722092898016,-0.0301192876737974,5.02327212598087e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,39485,0.0210373837660401,0.0036042857746008,0.0139729836478225,0.0281017838842577,5.43191556466368e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,37162,-0.0420958664697821,0.00722277860888804,-0.0562525125432026,-0.0279392203963615,5.73845888960275e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP10,Stromelysin-2,39463,0.0316788294023114,0.00544658807558397,0.0210035167741668,0.042354142030456,6.13994620341137e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,39428,0.0105253399621706,0.00181243906263465,0.0069729593994067,0.0140777205249345,6.47833095583187e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3C,Protein FAM3C,39458,-0.0156771054859042,0.00270396770556344,-0.0209768821888085,-0.0103773287829998,6.85348736346492e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBXN1,UBX domain-containing protein 1,36955,-0.0363123836783264,0.00627175333038201,-0.0486050202058752,-0.0240197471507777,7.21513628148883e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK3,Dickkopf-related protein 3,39654,0.015589502791491,0.00269396417692987,0.0103093330047085,0.0208696725782735,7.31412290894622e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG1,Arginase-1,39358,-0.0277746616137698,0.00480572714452914,-0.0371938868170469,-0.0183554364104926,7.64241191703869e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,37203,-0.015304085025302,0.00264825045366249,-0.0204946559144804,-0.0101135141361235,7.69302537134549e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLB,Beta-klotho,39104,0.0384799920190864,0.00668800278004563,0.025371506570197,0.0515884774679758,8.91163300881544e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,36992,-0.0175903571222308,0.00305975060399271,-0.0235874683060565,-0.0115932459384051,9.18915625611006e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39123,-0.0517779888177686,0.00900791955013637,-0.0694335111360359,-0.0341224664995013,9.2072298402989e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",39531,0.0181417167874579,0.00315815433803244,0.0119517342849143,0.0243316992900015,9.40243040814875e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLNS1A,Methylosome subunit pICln,36861,-0.0175517167050508,0.00305574312430606,-0.0235409732286907,-0.011562460181411,9.472257879535e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,36916,-0.0191801300145413,0.00334132124148801,-0.0257291196478578,-0.0126311403812247,9.67217126837351e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,39455,-0.0305145044642879,0.00531770482003447,-0.0409372059115555,-0.0200918030170204,9.74868018021587e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,39591,-0.0426890842648793,0.00744099047685968,-0.0572734255995242,-0.0281047429302343,9.82009545587579e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAN,Neurocan core protein,39589,0.0194565465334618,0.00339179878757433,0.0128086209098161,0.0261044721571075,9.85870577623877e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,39623,-0.0197185710713394,0.00343854456351721,-0.0264581184158331,-0.0129790237268456,9.96223368770872e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,39589,-0.0342041568330565,0.00597908938954762,-0.0459231720365699,-0.0224851416295432,1.08136361065052e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDA,Cytidine deaminase,37228,-0.0237859705095781,0.00416077861906299,-0.0319410966029415,-0.0156308444162146,1.11035053020479e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,36855,-0.025545816396047,0.00447161389854415,-0.0343101796371936,-0.0167814531549005,1.13630411896647e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMB1,Laminin subunit beta-1,36916,-0.0151774818138083,0.00266860623001275,-0.0204079500246333,-0.00994701360298336,1.31872963424865e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,39455,-0.014418891450514,0.00253715035348746,-0.0193917061433495,-0.00944607675767862,1.34730029606863e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,39187,-0.0211243208288368,0.00372322728901024,-0.0284218463152968,-0.0138267953423767,1.42408423818372e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSB,Arylsulfatase B,39428,-0.0283287613352461,0.00499578630865537,-0.0381205025002106,-0.0185370201702816,1.44983840731214e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,36880,-0.0503262240398204,0.00887710031445612,-0.0677253406561544,-0.0329271074234864,1.46643715879293e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF3,Trefoil factor 3,39438,0.0272685682631744,0.00481437165582755,0.0178323998177524,0.0367047367085964,1.50606591628124e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,36955,-0.0192498641188761,0.00339907468423357,-0.0259120504999738,-0.0125876777377783,1.51791594212397e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",36880,-0.0178857939683852,0.00316249745054936,-0.024084288971462,-0.0116872989653085,1.58735572095778e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,39428,-0.0105104798850469,0.00186062376049839,-0.0141573024556238,-0.00686365731447009,1.6441356561364e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,36880,-0.017380958464667,0.00307955975659108,-0.0234168955875855,-0.0113450213417485,1.69803352462104e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,39462,-0.0219862015004721,0.00389873275442396,-0.029627717699143,-0.0143446853018011,1.73800584898338e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX4,Syntaxin-4,39428,-0.0305626394685215,0.00542264598286042,-0.0411910255949279,-0.0199342533421151,1.77067980658466e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,39466,-0.0290685669373436,0.0051633319549407,-0.0391886975690273,-0.0189484363056598,1.83640347415687e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F10,Coagulation factor X,37243,-0.013256741976993,0.00236098067824734,-0.0178842641063578,-0.0086292198476282,2.00736472797289e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS22,Brain-specific serine protease 4,36880,-0.0180553554810399,0.00321582022262475,-0.0243583631173844,-0.0117523478446954,2.01308363586136e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNST,Consortin,39485,-0.0549921043983148,0.00980058881101212,-0.0742012584678986,-0.0357829503287311,2.04590244326609e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,36847,-0.0221169993340053,0.0039416416375371,-0.0298426169435781,-0.0143913817244326,2.05338436040862e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,39104,-0.0257216826033912,0.00458646734145142,-0.034711158592636,-0.0167322066141464,2.08174427515083e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP2,Methionine aminopeptidase 2,39568,-0.0299301223045152,0.00533821694897481,-0.0403930275245058,-0.0194672170845246,2.09751639120307e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,36906,-0.0142891429155828,0.0025541452858548,-0.0192952676758582,-0.00928301815530737,2.25936373404667e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37247,-0.032737363742536,0.00585245871301913,-0.0442081828200535,-0.0212665446650185,2.26736486947738e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBPL,FK506-binding protein-like,37164,-0.0299256539427559,0.00535047932495506,-0.0404125934196678,-0.019438714465844,2.27681369090142e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,36916,-0.0118843775944633,0.00212509477662129,-0.0160495633566411,-0.00771919183228562,2.28665959952773e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL4,Myosin light chain 4,36916,-0.0266610431943848,0.00476759155966943,-0.0360055226513369,-0.0173165637374327,2.29005337782807e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADM,Pro-adrenomedullin,39601,-0.013628259783657,0.00244081674959958,-0.0184122606128722,-0.00884425895444185,2.39797909839126e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLTP,Phospholipid transfer protein,39581,0.0174070635648149,0.00312019343358752,0.0112914844349834,0.0235226426946465,2.46277379710847e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD1,Polycystin-1,37247,-0.0130677895710667,0.00234494366577288,-0.0176638791559815,-0.00847169998615181,2.55814435594885e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTR,Transthyretin,37136,-0.0128309118219625,0.00230626926915137,-0.0173511995894992,-0.00831062405442581,2.69784979438178e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,37164,-0.0427193000516341,0.00768369588982528,-0.0577793439956917,-0.0276592561075766,2.75634016562526e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,39462,0.0247901383645032,0.00446093626222629,0.0160467032905397,0.0335335734384667,2.78865715283171e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNA4,Plexin-A4,39462,-0.0416196115160559,0.00748982480513035,-0.0562996681341114,-0.0269395548980005,2.79408065747957e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,39428,-0.0278789730600828,0.00502369314597206,-0.0377254116261881,-0.0180325344939776,2.91352713949456e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEPR,Leptin receptor,39485,0.0153381805832077,0.00276411470371594,0.0099205157639245,0.020755845402491,2.92097546003886e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NADK,NAD kinase,39485,-0.0270161466895587,0.00487023295356284,-0.0365618032785419,-0.0174704901005755,2.9518250994881e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,39485,-0.0150309741648103,0.00271515633419516,-0.0203526805798329,-0.00970926774978782,3.14725309270369e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YJU2,Splicing factor YJU2,37162,-0.0161126126390992,0.00291051581900698,-0.0218172236443529,-0.0104080016338455,3.15595223582802e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37125,-0.0543324054416241,0.00981959416805743,-0.0735788100110166,-0.0350860008722315,3.20936434685043e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39123,-0.0395529108435521,0.0071510674704725,-0.0535690030856782,-0.025536818601426,3.23762620744545e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,39329,-0.0170393060123261,0.0030821785849933,-0.023080376038913,-0.0109982359857393,3.28730368850984e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZN,Kazrin,37164,-0.0520730239947646,0.00942167981495717,-0.0705395164320807,-0.0336065315574486,3.32290206594125e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH15,Cadherin-15,39553,-0.0222862129381586,0.00404602420895396,-0.0302164203877083,-0.0143560054886088,3.68496034989895e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,39455,-0.0149703787703516,0.00272267084937415,-0.020306813635125,-0.00963394390557831,3.89476562311934e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR3,Small proline-rich protein 3,37203,-0.0354628657885323,0.00645183652527057,-0.0481084653780626,-0.022817266199002,3.94728098007133e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAN,Brevican core protein,39355,0.0167855698251687,0.00306140114673084,0.0107852235775762,0.0227859160727611,4.25047753355954e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",39104,-0.0243465595534651,0.00445165298575779,-0.0330717994055504,-0.0156213197013799,4.59723170894499e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,39434,-0.0436457496709775,0.00798216273672664,-0.0592907886349617,-0.0280007107069932,4.62661289101468e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,36880,-0.0348641586368888,0.00638203236095257,-0.0473729420643559,-0.0223553752094218,4.77540583271399e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL2,Chordin-like protein 2,39485,-0.0281911220133497,0.00516291508033256,-0.0383104355708015,-0.0180718084558978,4.82842202517815e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARF6,ADP-ribosylation factor 6,37164,-0.0520346361477304,0.00952972389030752,-0.0707128949727331,-0.0333563773227276,4.8440686577936e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,39654,-0.0334906329566321,0.00613640531025642,-0.0455179873647347,-0.0214632785485295,4.89906434807624e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS2,Thrombospondin-2,39455,-0.0178911513749973,0.00327986560273703,-0.0243196879563619,-0.0114626147936328,4.97923765011492e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,39485,0.0488992099209991,0.00896541474075116,0.0313269970291268,0.0664714228128714,4.99694932123486e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP43,Centrosomal protein 43,39085,-0.0342828882716819,0.00629030595254775,-0.0466118879386755,-0.0219538886046883,5.11520209137843e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F9,Coagulation factor IX,39498,-0.00892287749840845,0.00163958500676167,-0.0121364641116613,-0.00570929088515558,5.34631786094929e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,39428,-0.0189894510681507,0.00349821748924276,-0.0258459573470665,-0.0121329447892349,5.77717809891402e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN8,Septin-8,37183,-0.0156760046921779,0.00288961007215662,-0.0213396404336048,-0.0100123689507509,5.90291844626869e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,37203,-0.022504122239343,0.00415658434323916,-0.0306510275520918,-0.0143572169265943,6.27170477682944e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG3,Desmoglein-3,39532,-0.0165083040642629,0.00305283007682504,-0.0224918510148399,-0.0105247571136858,6.48688693604795e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,39428,-0.0419370076893659,0.0077585571579084,-0.0571437797188663,-0.0267302356598654,6.57056672437559e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,39636,-0.0159969476145448,0.00296040885361755,-0.0217993489676351,-0.0101945462614544,6.62912020687122e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,39654,0.014218113130096,0.00263458881307567,0.00905431905646773,0.0193819072037244,6.88909883185646e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRN,"Attractin, Isoform 2",37269,-0.00799605457788135,0.00148298325416801,-0.0109027017560506,-0.00508940739971204,7.09643238874514e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37164,-0.0502370836370967,0.00932463800195566,-0.0685133741209298,-0.0319607931532636,7.26921668221807e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB1,Carboxypeptidase B,39654,-0.0275699649358975,0.00511903986968354,-0.0376032830804772,-0.0175366467913177,7.32082310202239e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6AP2,Renin receptor,39123,-0.0204147133183841,0.00379431829680248,-0.0278515771801169,-0.0129778494566512,7.54874930710496e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,39428,-0.0266109318540031,0.00494822489036465,-0.0363094526391179,-0.0169124110688884,7.65015654249588e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AAMDC,Mth938 domain-containing protein,36916,-0.0261358323536583,0.00486007646909553,-0.0356615822330856,-0.0166100824742311,7.68229907212382e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGF,Hepatoma-derived growth factor,39583,-0.0466729856742149,0.00868235160409239,-0.0636903948182359,-0.0296555765301938,7.74532236425514e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR5,Cadherin-related family member 5,39485,-0.0190417628303173,0.00354294355260767,-0.0259859321934283,-0.0120975934672063,7.79149464185694e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37164,-0.0131454342683422,0.00244579309551413,-0.0179391887355499,-0.0083516798011345,7.80596899584915e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G1B,Phospholipase A2,39633,0.0204468868583638,0.00380991986478262,0.0129794439233899,0.0279143297933378,8.1345428897798e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RP2,Protein XRP2,39428,-0.0202454162444804,0.00377268308087076,-0.0276398750829871,-0.0128509574059737,8.15563208394005e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,39104,-0.0413777905086232,0.00773982938614383,-0.0565478561054651,-0.0262077249117813,9.12241241707672e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK14,Kallikrein-14,39601,0.0223053355772722,0.00417334377019866,0.0141255817876829,0.0304850893668616,9.18706515968791e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREH,Trehalase,37255,-0.0361240591306259,0.00675962770345292,-0.0493729294293936,-0.0228751888318581,9.24305954556023e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SWAP70,Switch-associated protein 70,37164,-0.017100349282741,0.00320077687647583,-0.0233738719606336,-0.0108268266048483,9.32229195172837e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,39582,-0.016149875747683,0.00303600683765007,-0.0221004491494771,-0.0101993023458888,1.05565132138731e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENAH,Protein enabled homolog,39194,-0.0229319226709864,0.00431091107730137,-0.0313813083824971,-0.0144825369594757,1.05569146926294e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,39428,-0.0368140335786529,0.00693555716780313,-0.0504077256275471,-0.0232203415297588,1.12406898279902e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,36968,-0.0309809183027787,0.00583794448771337,-0.0424232894986969,-0.0195385471068605,1.13458787062274e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,37162,-0.0277414216991932,0.00522787205934771,-0.0379880509355147,-0.0174947924628717,1.13661520371519e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",36916,-0.0175850165944584,0.00331414188521087,-0.0240807346894717,-0.011089298499445,1.13942912555926e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,39428,-0.0662258351197144,0.0125037499112933,-0.0907331849458493,-0.0417184852935794,1.19727228565142e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPL14,60S ribosomal protein L14,36916,-0.0196850994769057,0.00371862187383174,-0.0269735983496159,-0.0123966006041955,1.21931334938149e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,39485,-0.0169813637726846,0.00321137282798104,-0.0232756545155275,-0.0106870730298418,1.25472392643166e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,39187,-0.0443580849254747,0.00840210370673532,-0.0608262081906759,-0.0278899616602734,1.3144582737771e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,39485,-0.0325897629056438,0.00617798358245927,-0.044698610727264,-0.0204809150840237,1.34490426897604e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPR,Nucleoprotein TPR,36847,-0.0226546414163328,0.00429858089012819,-0.031079859960984,-0.0142294228716815,1.38516164728574e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,39460,-0.029339480753689,0.00556916299259912,-0.0402550402191832,-0.0184239212881947,1.39669821486213e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",39455,0.0115359996572425,0.00219148293880177,0.00724069309719101,0.0158313062172939,1.428853247239e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,39531,0.0131423018849557,0.0024977953561037,0.00824662298699243,0.0180379807829189,1.44792893375168e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELP,P-selectin,39526,-0.0276006778108276,0.00525361380445986,-0.0378977608675689,-0.0173035947540863,1.51139349078271e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,39383,-0.0277970801993773,0.00529239567006755,-0.0381701757127097,-0.0174239846860449,1.52300403532933e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL17,C-C motif chemokine 17,39453,-0.0430928328390581,0.00822839570525064,-0.0592204884213493,-0.0269651772567668,1.653341345729e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39123,-0.0252302566528319,0.00481976079876722,-0.0346769878184157,-0.0157835254872482,1.67484602502618e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD207,C-type lectin domain family 4 member K,39168,-0.0183285631643128,0.00350215310585528,-0.0251927832517891,-0.0114643430768365,1.68603499143963e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,39123,-0.0282794377338875,0.00540579298646193,-0.0388747919873529,-0.0176840834804221,1.70618716954905e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR1,Complement receptor type 1,37216,-0.0171268149198482,0.00328170979031433,-0.0235589661088643,-0.0106946637308321,1.8284157312213e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,39428,-0.0209316884007293,0.00401697748241969,-0.0288049642662719,-0.0130584125351867,1.90518034317412e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDHD2,Phospholipase DDHD2,37221,-0.0312160022979558,0.00599242986835226,-0.0429611648399262,-0.0194708397559854,1.92567240068634e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMCN2,Hemicentin-2,36934,-0.026998925287979,0.00518568615891126,-0.0371628701594451,-0.0168349804165129,1.95564485281426e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA1,BolA-like protein 1,36823,-0.0260537216504363,0.0050068628205589,-0.0358671727787317,-0.0162402705221408,1.985896150699e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL16,C-C motif chemokine 16,39654,-0.0249968629926511,0.00481653476881306,-0.0344372711395246,-0.0155564548457775,2.13227005310695e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39123,-0.0389992739904054,0.00751510440737741,-0.0537288786288651,-0.0242696693519457,2.13726427465611e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR2,Folate receptor beta,39589,0.0138857592783288,0.00267897311331603,0.00863497197622939,0.0191365465804282,2.20869616622383e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI2,Serpin I2,37164,-0.0263674315007393,0.00508775225063581,-0.0363394259119855,-0.0163954370894931,2.22249753451776e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA1,Carboxypeptidase A1,39654,-0.0268966830830641,0.00519510089960104,-0.0370790808462822,-0.0167142853198461,2.27969982473145e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL23,C-C motif chemokine 23,39541,-0.0192409948271325,0.00371980831714744,-0.0265318191287415,-0.0119501705255235,2.33842920077179e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,36861,-0.0321469331514357,0.00622454862861767,-0.0443470484635264,-0.0199468178393451,2.44763703739537e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,39654,-0.0192429229652975,0.00372947476886158,-0.0265526935122662,-0.0119331524183288,2.50475367547746e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,39355,-0.0150306079129104,0.0029152762623546,-0.0207445493871254,-0.00931666643869536,2.55770307816156e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSNL1,Visinin-like protein 1,37203,-0.0176245456304367,0.0034209960783007,-0.0243296979439061,-0.0109193933169673,2.61744147426103e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,39319,-0.052287624984706,0.0101503540597021,-0.072182318941722,-0.0323929310276899,2.61980154536169e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,37221,-0.036609792793996,0.00712296058864533,-0.0505707955477409,-0.0226487900402512,2.79260147833515e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,39504,0.0148769664194045,0.0028954485985002,0.00920188716634413,0.0205520456724649,2.8107142084972e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH2,Neutral ceramidase,39355,-0.0243903248675184,0.00475239135651233,-0.0337050119262825,-0.0150756378087542,2.89942505568526e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,39449,-0.0169167606274101,0.00330115596406627,-0.02338702631698,-0.0104464949378402,3.02040239921804e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",39549,-0.0343296360822789,0.0067040830768782,-0.0474696389129602,-0.0211896332515976,3.08139388319088e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,39355,-0.0439444540282204,0.00860210413049511,-0.0608045781239908,-0.02708432993245,3.28614287971488e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALY,RNA-binding protein Raly,37162,-0.022287693656681,0.00436334217785621,-0.0308398443252792,-0.0137355429880828,3.30406490003616e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,39531,-0.0119613450885997,0.00234614487089802,-0.0165597890355599,-0.00736290114163962,3.46871713743004e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",39194,-0.0269170443392771,0.0052808178746584,-0.0372674473736076,-0.0165666413049467,3.49099442747003e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37221,-0.0303573969123672,0.00595941319956616,-0.0420378467835168,-0.0186769470412175,3.55542424317652e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,36880,-0.0206919385287775,0.00406860994420442,-0.0286664140194181,-0.0127174630381368,3.71507937271849e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39124,-0.0361149275607532,0.00711122986565915,-0.0500529380974452,-0.0221769170240613,3.84935248958952e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,37143,-0.0191529440512941,0.00377124549187774,-0.0265445852153745,-0.0117613028872137,3.85461104452991e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO3,Forkhead box protein O3,39123,-0.044753311165565,0.00881725401584786,-0.0620351290366268,-0.0274714932945032,3.90894673565631e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL20,C-C motif chemokine 20,39636,-0.0408119126717514,0.00804220849602816,-0.0565746413239666,-0.0250491840195363,3.92661712550447e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,39654,0.0146064345462061,0.00287958487848167,0.00896244818438207,0.0202504209080302,3.97435180775623e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA2,Annexin A2,36736,-0.0328228340990578,0.00647175068374316,-0.0455074654391944,-0.0201382027589212,4.00008828661245e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,39498,0.0137499758572264,0.00271185055812348,0.00843474876330435,0.0190652029511484,4.01845461989827e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,39429,0.0165680842375445,0.00327250957189753,0.0101539654766253,0.0229822029984637,4.18030498921812e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,P4HB,Protein disulfide-isomerase,39396,-0.0178022826218389,0.00352149220543884,-0.024704407344499,-0.0109001578991788,4.3474227504506e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSTB,Cystatin-B,39231,-0.0192001969555517,0.00381097138223357,-0.0266697008647295,-0.0117306930463739,4.7563150969198e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",39428,-0.0148178391427661,0.00294366806947797,-0.0205874285589429,-0.0090482497265893,4.86429564240246e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,39654,-0.0178476619265117,0.0035456240560014,-0.0247970850762745,-0.010898238776749,4.86563421951358e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15,Interleukin-15,39462,-0.0150731516268006,0.00299590353000962,-0.0209451225456195,-0.00920118070798179,4.92913399500661e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,39579,-0.0268105984977671,0.00532992796671544,-0.0372572573125294,-0.0163639396830049,4.95584800848885e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,37162,-0.0276547286415323,0.00549899249658601,-0.0384327539348408,-0.0168767033482237,4.99627700608829e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RWDD1,RWD domain-containing protein 1,39589,-0.029330557048561,0.00584869434184031,-0.040793997958568,-0.017867116138554,5.36643370718577e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TADA3,Transcriptional adapter 3,37162,-0.0176869378293038,0.00352887764649811,-0.0246035380164401,-0.0107703376421675,5.45758379934641e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PZP,Pregnancy zone protein,37269,0.0294603510328394,0.00587864888265915,0.0179381992228275,0.0409825028428514,5.47518672276156e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,39462,-0.0171448971469196,0.00342467447776697,-0.0238572591233429,-0.0104325351704963,5.61195567145918e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39123,-0.0203083509953597,0.00405771322023076,-0.028261468907012,-0.0123552330837074,5.65456966681827e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,39520,-0.0324745482431787,0.0064900216052184,-0.0451949905894067,-0.0197541058969506,5.6854666183267e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",39187,-0.0400098274750224,0.0079960101087142,-0.0556820072881023,-0.0243376476619426,5.68813815590106e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGA,Fibrinogen alpha chain,36972,0.0139659933365582,0.00279357758550785,0.00849058126896283,0.0194414054041536,5.83106952824374e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL22,C-C motif chemokine 22,39332,-0.0233495713366858,0.00467211373627991,-0.0325069142597944,-0.0141922284135772,5.86935632521423e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,36688,-0.0156578612317208,0.00313383376536893,-0.0218001754118439,-0.00951554705159771,5.92198371020849e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,36992,-0.0506548653157877,0.0101492685601264,-0.0705474316936355,-0.03076229893794,6.08778052357494e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN2,Dynactin subunit 2,39428,-0.0426734251709317,0.00855497235326354,-0.0594411709833282,-0.0259056793585351,6.1645414466443e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,37247,-0.0332372740678338,0.00666810305507697,-0.0463067560557847,-0.0201677920798829,6.29295804450806e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,37221,-0.0308368557680601,0.00619078663539974,-0.0429707975734436,-0.0187029139626766,6.40544994889781e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPIND1,Heparin cofactor 2,37241,-0.0123584301960394,0.00248259072644578,-0.0172243080198731,-0.00749255237220567,6.50688452981308e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,39378,-0.0201602153254989,0.00405123245546071,-0.0281006309382019,-0.0122197997127959,6.55274144063694e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP20,Centrosomal protein 20,39123,-0.0334363813479893,0.00671938370855135,-0.04660637341675,-0.0202663892792287,6.5610412925998e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,37164,-0.020986850174895,0.00422490962795722,-0.0292676730456912,-0.0127060273040989,6.87356190710193e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,36880,-0.0258975267472067,0.00521540108273121,-0.0361197128693599,-0.0156753406250536,6.94030378773044e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,37221,-0.0406682039936658,0.00820688293885358,-0.0567536945538188,-0.0245827134335128,7.31152746884832e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC4A1,Band 3 anion transport protein,37255,-0.0207881601082473,0.00420260950420011,-0.0290252747364795,-0.0125510454800151,7.65234328128909e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIN2,Bridging integrator 2,39455,-0.0408786419119004,0.00827127233414169,-0.0570903356868182,-0.0246669481369827,7.80619371711443e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB6,Integrin beta-6,39194,-0.0135969071653267,0.00275269893966112,-0.0189921970870625,-0.0082016172435909,7.91886466952769e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO1,Forkhead box protein O1,39462,-0.0379731243355411,0.00769375735616412,-0.0530528887536228,-0.0228933599174595,8.07718883440329e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,36955,-0.0262062159162804,0.00531618648112967,-0.0366259414192945,-0.0157864904132662,8.34919812761022e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBP,Protein AMBP,39582,-0.00896051561205505,0.00181856920304345,-0.0125249112500202,-0.0053961199740899,8.42837832043661e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37221,-0.0262221242411081,0.00532734956271375,-0.0366637293840271,-0.0157805190981892,8.66583511148338e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,37255,-0.0124151594506947,0.00252279794537455,-0.0173598434236288,-0.0074704754777606,8.70916272037329e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,36955,-0.0170717627177701,0.00347747395760559,-0.0238876116746771,-0.0102559137608632,9.25832858718756e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,36899,-0.0251662438331008,0.00512789268762962,-0.0352169135008549,-0.0151155741653468,9.33101515906778e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN4,Cerebellin-4,39601,-0.0140307540337018,0.00286347793089585,-0.0196431707782577,-0.00841833728914593,9.68766969075271e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARK7,Parkinson disease protein 7,39455,-0.0238331510212564,0.00487167046593838,-0.0333816251344957,-0.0142846769080172,1.00753071434249e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,37209,-0.0303273671802185,0.00620012045644172,-0.0424796032748443,-0.0181751310855928,1.01334644567105e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXN,Thioredoxin,37091,-0.0197721002461259,0.00404330244670289,-0.0276969730416635,-0.0118472274505882,1.02031414987244e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,39601,0.0257325528662353,0.00526807726182154,0.0154071214330651,0.0360579842994055,1.04686948782454e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,39477,-0.0169760446795857,0.00347635225867495,-0.0237896951065886,-0.0101623942525828,1.05401981165496e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,37203,-0.00972521238563327,0.00199148629863821,-0.0136285255309642,-0.00582189924030239,1.0553992433008e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",39426,0.0256699903150914,0.00527190012951462,0.0153370660612427,0.03600291456894,1.13188602445173e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,36847,-0.0247725306376348,0.00508818088259583,-0.0347453651675226,-0.014799696107747,1.13753736977557e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,37181,-0.0262891001688511,0.00540571191136906,-0.0368842955151344,-0.0156939048225677,1.1687949063025e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP4,Bone morphogenetic protein 4,39330,-0.0200705090229646,0.00413664787073189,-0.0281783388495992,-0.0119626791963301,1.23537116856945e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,37269,-0.0130384381870314,0.00269046220246783,-0.0183117441038684,-0.00776513227019448,1.27341884834514e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,37269,0.0118251618899193,0.00244012417070335,0.00704251851534078,0.0166078052644979,1.27366961172474e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASHC3,WASH complex subunit 3,37203,-0.0329559903843964,0.00680126444202347,-0.0462864686907624,-0.0196255120780304,1.27735758973776e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL26,C-C motif chemokine 26,39462,-0.0392439255445729,0.00812395046782505,-0.05516686846151,-0.0233209826276358,1.37434659769432e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,39123,-0.0251924700071595,0.00522124285235414,-0.0354261059977736,-0.0149588340165454,1.41414817732352e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,36880,-0.0155356971662849,0.00322096935871759,-0.0218487971093713,-0.00922259722319841,1.4287848328277e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,37164,-0.0365454809069985,0.00758306000712582,-0.0514082785209652,-0.0216826832930319,1.45685911677589e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBIN,Erbin,39428,-0.0447285623663686,0.00930799534825907,-0.0629722332489563,-0.0264848914837808,1.55946621318839e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,39355,-0.00992816586088087,0.00206647844321801,-0.0139784636095882,-0.00587786811217357,1.56736353241854e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,39291,-0.0256945671288963,0.00535344701851021,-0.0361873232851763,-0.0152018109726163,1.60507221406412e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,36848,-0.0124360240712485,0.00259147703380425,-0.0175153190575048,-0.00735672908499216,1.61466967907206e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37164,-0.0604799977089402,0.0126294369435877,-0.0852336941183722,-0.0357263012995082,1.69664157614062e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,37255,-0.0152004096072504,0.00317567853975286,-0.021424739545166,-0.00897607966933479,1.71605625876046e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMA,Granzyme A,39636,-0.0153562036757446,0.00321041881720634,-0.0216486245574691,-0.00906378279402023,1.74112469338306e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,39589,-0.0418293778600062,0.00874528313064107,-0.0589701327960627,-0.0246886229239497,1.74257098006424e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROS1,Vitamin K-dependent protein S,37269,-0.0108941918620351,0.00227786818441181,-0.0153588135034822,-0.0064295702205879,1.74945764304397e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,39187,-0.0421049610288516,0.00880546402715789,-0.0593636705220811,-0.0248462515356222,1.75512277803848e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTD,Biotinidase,37269,-0.0089168725845004,0.00186497400550933,-0.0125722216352987,-0.00526152353370212,1.76161756886921e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37203,-0.0373759887560735,0.00782505772650074,-0.0527131019000149,-0.022038875612132,1.8040429303298e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4C,Semaphorin-4C,39428,0.0122634422870896,0.00258055866211026,0.00720554730935348,0.0173213372648257,2.03041027162947e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP5,Fatty acid-binding protein 5,39552,-0.0297189615422547,0.00627413021124065,-0.0420162567562863,-0.017421666328223,2.19152831709023e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,39330,-0.017136128702921,0.00361770071034259,-0.0242268220951925,-0.0100454353106495,2.19182680838022e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAN,Versican core protein,39589,0.0128939001948721,0.00273042754040314,0.00754226221568198,0.0182455381740623,2.35282960226364e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVR,Poliovirus receptor,39589,-0.015790265955703,0.00334706819498989,-0.0223505196178832,-0.00923001229352284,2.40726968203549e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",39401,-0.0447024805290795,0.00949229167279906,-0.0633073722077657,-0.0260975888503934,2.50746887172996e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENR,Density-regulated protein,36880,-0.0246026487074221,0.00522389091759645,-0.0348414749059111,-0.0143638225089331,2.50838996848416e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,36880,-0.0168038591127002,0.00357043040613034,-0.0238019027087157,-0.0098058155166847,2.54855445590924e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,37221,-0.0264630543625385,0.00562744152122322,-0.037492839744136,-0.015433268980941,2.59683139076277e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHPS,Deoxyhypusine synthase,37162,-0.017495707241985,0.00372278732488868,-0.0247923703987668,-0.0101990440852032,2.63373384962196e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,37221,-0.0322624044102284,0.00687106275922658,-0.0457296874183125,-0.0187951214021443,2.68851688257681e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,39589,-0.0125192669700632,0.00266772694580388,-0.0177480117838388,-0.00729052215628758,2.71771765200547e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,39455,0.011538113351098,0.00246017947955931,0.00671616157116177,0.0163600651310342,2.75683097519859e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5E,5'-nucleotidase,39531,-0.0246842972598288,0.00526457017787724,-0.0350028548084682,-0.0143657397111894,2.77275555825099e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,36880,-0.0372250713020117,0.00795004192131951,-0.0528071534677979,-0.0216429891362254,2.8657147459482e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,37203,-0.0385168942279563,0.00823845985642492,-0.0546642755465492,-0.0223695129093635,2.96599270775093e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,36880,-0.0189986171179135,0.00406612369789978,-0.0269682195657971,-0.0110290146700299,3.00802605605065e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,39455,-0.0222082344115553,0.0047541032171907,-0.0315262767172491,-0.0128901921058616,3.01775938884258e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP2,Retinol-binding protein 2,39428,0.0322894128685643,0.00692661490465872,0.0187132476554333,0.0458655780816954,3.16399184434782e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,37247,-0.0452131555926741,0.00970806451429702,-0.0642409620406963,-0.026185349144652,3.23642603226726e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,39541,-0.0442333492500237,0.00949990968730089,-0.0628531722371335,-0.025613526262914,3.24865622367519e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,37221,-0.0168166521433013,0.00361645169366138,-0.0239048974628776,-0.00972840682372495,3.3519458619951e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,36847,-0.0261313863207988,0.00562191404670314,-0.0371503378523369,-0.0151124347892606,3.38412419239132e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSH,Pro-cathepsin H,39161,-0.0305248257779134,0.00657456550933483,-0.0434109741762096,-0.0176386773796171,3.46580655962512e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,39187,-0.0316526478776676,0.00681867747877585,-0.0450172557360683,-0.0182880400192669,3.47943530921805e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFH,Complement factor H,36595,-0.00975371881678763,0.00210254192351649,-0.0138747009868799,-0.00563273664669531,3.53735143827757e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,36916,-0.0325697828138438,0.00702585435093205,-0.0463404573416706,-0.018799108286017,3.59334960071287e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPHN1,Oligophrenin-1,37203,-0.0449394864935418,0.00969700402422719,-0.0639456143810271,-0.0259333586060565,3.61577378778903e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCOF1,Treacle protein,37247,-0.0128155823726908,0.0027671553823246,-0.018239206922047,-0.00739195782333454,3.66920758289546e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,36861,-0.0182331435780831,0.00394451207897577,-0.0259643872528756,-0.0105018999032905,3.83136010645114e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,39187,-0.0147040707861677,0.00318139317170229,-0.0209396014027042,-0.00846854016963122,3.83472772458616e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A14,Protein S100-A14,37221,-0.0226150253760958,0.00489388982913814,-0.0322070494412066,-0.0130230013109851,3.85495459926535e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS2,Trypsin-2,39526,-0.0210590114074416,0.00455881016321366,-0.0299942793273404,-0.0121237434875429,3.88017683789282e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,37255,-0.0207770070816519,0.00450893596192787,-0.0296145215670306,-0.0119394925962733,4.10560235202469e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,39497,-0.0167089912206547,0.00362670071250855,-0.0238173246171715,-0.00960065782413799,4.11446244827472e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2B3,SH2B adapter protein 3,39123,-0.0409686883161165,0.00890305892387274,-0.0584186838069071,-0.0235186928253259,4.22685031355438e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,39455,-0.0095865642651945,0.00208601232064839,-0.0136751484136653,-0.00549798011672365,4.34936548103252e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOST,Sclerostin,39458,-0.0161146306868252,0.00351073951938992,-0.0229956801448294,-0.00923358122882091,4.46636041448701e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,39531,-0.0232550099159777,0.00506836885687826,-0.0331890128754591,-0.0133210069564963,4.50551022364563e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASC3,Protein CASC3,36861,-0.0172253720668323,0.00375613751011606,-0.0245874015866598,-0.00986334254700482,4.56397205240869e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,37247,-0.0140808927066042,0.00307373149919947,-0.0201054064450351,-0.00805637896817322,4.67035244003391e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,39123,-0.0264797633200911,0.00578781623000676,-0.0378238831309043,-0.0151356435092778,4.79921834340425e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH1,Cadherin-1,38961,-0.0167040927710221,0.0036539847499406,-0.0238659028809057,-0.00954228266113854,4.88307673518468e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,39355,-0.0122050378251401,0.00267034458892845,-0.0174389132194399,-0.00697116243084034,4.90271412432554e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,39541,-0.0519544534807569,0.0113696308889185,-0.0742389300230372,-0.0296699769384765,4.92573948586222e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,36992,-0.0275474659285825,0.0060315200440316,-0.0393692452148845,-0.0157256866422806,4.9887007255354e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EREG,Proepiregulin,39319,-0.033391391905191,0.0073135009640003,-0.0477258537946316,-0.0190569300157504,5.01777381222526e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,39636,-0.0281964632856256,0.00617900483566909,-0.040307312763537,-0.0160856138077141,5.0757822773273e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,39462,-0.0298985167620151,0.00655233863612999,-0.0427411004888299,-0.0170559330352004,5.08202930729333e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,39123,-0.016849270461024,0.00371170057856702,-0.0241242035950154,-0.00957433732703267,5.68356802728269e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGA,Protein O-GlcNAcase,37164,-0.0289408551825233,0.00637777633330216,-0.0414412967957955,-0.0164404135692511,5.73745054469167e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC3B,Tetranectin,36954,-0.00866456207070403,0.00191064053937982,-0.0124094175278885,-0.00491970661351958,5.8166910116602e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YWHAQ,14-3-3 protein theta,36955,-0.030337250089714,0.00669373740434851,-0.0434569754022371,-0.017217524777191,5.89184699572436e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,39526,0.0140418383517023,0.00309876445747507,0.00796826001505117,0.0201154166883535,5.90355890871903e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD6,Programmed cell death protein 6,39485,0.0289019602500206,0.0063862011020603,0.0163850060899824,0.0414189144100588,6.06606664127823e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,39636,-0.0153447079391021,0.00339324772781336,-0.0219954734856163,-0.00869394239258792,6.16837573989079e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG2,Bone marrow proteoglycan,37255,0.021430535424519,0.00474040703004497,0.0121393376456309,0.0307217332034072,6.21526609545528e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,37247,-0.0193853562873784,0.00429194045263328,-0.0277975595745397,-0.0109731530002172,6.3376228406544e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,36847,-0.0275141116882698,0.00609973518663385,-0.0394695926540722,-0.0155586307224675,6.52059138888031e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFLAM,Pikachurin,37164,-0.0126519735646848,0.00280650540940648,-0.0181527241671215,-0.00715122296224812,6.59991219280771e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37247,-0.0125877351874742,0.00279440969334912,-0.0180647781864384,-0.00711069218850988,6.7082634200759e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH17,Cadherin-17,39485,-0.0277397359728723,0.00615940325697628,-0.0398121663565458,-0.0156673055891988,6.73019894549362e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,36847,-0.0150306097349172,0.00333889560440279,-0.0215748451195467,-0.00848637435028774,6.80359989786385e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POSTN,Periostin,37255,0.0154108130037139,0.00342506504188091,0.00869768552162732,0.0221239404858005,6.87387266377536e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,37162,-0.0353580595134351,0.00786314064199152,-0.0507698151717385,-0.0199463038551317,6.96324818173542e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK1,Dickkopf-related protein 1,39589,-0.0243539811200278,0.00541795539382915,-0.0349731736919329,-0.0137347885481227,7.00696027710662e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,39079,-0.028435324905281,0.00632606067399305,-0.0408344038263074,-0.0160362459842546,7.01206715660423e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICA1,Islet cell autoantigen 1,39194,-0.0324569175364268,0.00722780148079713,-0.0466234084387892,-0.0182904266340645,7.15733779058538e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,37210,-0.00807119059816659,0.00179735753087528,-0.0115940113586821,-0.00454836983765103,7.1650304135818e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD63,CD63 antigen,39330,-0.0212462102449391,0.00473313945443214,-0.0305231635756261,-0.0119692569142521,7.21566113959792e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRB1,Chymotrypsinogen B,39455,-0.0216207328373045,0.00482213119432194,-0.0310721099781755,-0.0121693556964335,7.39220689167283e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SBSN,Suprabasin,37237,0.0136576876903647,0.00305155087346829,0.00767664797836691,0.0196387274023626,7.68360464915233e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGF,Hepatocyte growth factor,39636,-0.0139039868441604,0.00310728155614073,-0.0199942586941962,-0.00781371499412453,7.70941050156582e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDCP1,CUB domain-containing protein 1,39355,-0.0197785557293752,0.00442535103973353,-0.0284522437672529,-0.0111048676914975,7.90266405274108e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,39498,0.0110260813520927,0.00246799500502714,0.00618881114223952,0.0158633515619459,7.96686979038764e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,39458,-0.0297377289107639,0.00666179157884083,-0.0427948404052919,-0.0166806174162359,8.1058692904576e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB6,Heat shock protein beta-6,39601,-0.0147964944971524,0.00331707141282936,-0.0212979544662979,-0.00829503452800683,8.22765093294402e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,39343,-0.0382387317563929,0.00858091058221249,-0.0550573164975293,-0.0214201470152564,8.40120260210838e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDN1,Endothelin-1,36916,-0.0117347854437507,0.00263555690572266,-0.0169004769789671,-0.00656909390853424,8.56188388870507e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR15L,Protein GPR15L,37164,-0.024341978993857,0.00546789512903323,-0.0350590534467622,-0.0136249045409519,8.58785037958105e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,39485,-0.0350773872516392,0.00788823170708192,-0.0505383213975198,-0.0196164531057586,8.77837428085314e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP1,Interstitial collagenase,38905,-0.0374792825242216,0.00848498003381035,-0.0541098433904899,-0.0208487216579533,1.0074573389393e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ING1,Inhibitor of growth protein 1,39068,-0.0179301071948495,0.00405924548015757,-0.0258862283359584,-0.00997398605374071,1.00751204252535e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB8,Serpin B8,39636,-0.0218652951330549,0.00495900257808705,-0.0315849401861056,-0.0121456500800043,1.0445996255182e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH9,Protocadherin-9,37164,-0.0135685803798021,0.00307773456216229,-0.0196009401216402,-0.00753622063796404,1.04882095362589e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,37044,0.00324857179330513,0.000737936532564377,0.00180221618947895,0.00469492739713131,1.08022820107431e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37255,-0.0142193796551961,0.00323416323851115,-0.020558339602678,-0.00788041970771429,1.10837116292495e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LARP1,La-related protein 1,37162,-0.0252638497033437,0.00574930068678675,-0.0365324790494457,-0.0139952203572417,1.12058015117749e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,39531,-0.0381334240234263,0.00868599695638929,-0.0551579780579493,-0.0211088699889033,1.14007300974298e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL1,Delta-like protein 1,39531,0.0116846196795109,0.00266628503435044,0.00645870101218403,0.0169105383468378,1.18194172143323e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,36955,-0.016417842276793,0.00375960178941466,-0.0237866617840457,-0.00904902276954023,1.27030399245616e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,39589,-0.0249636831136899,0.00571802571597669,-0.0361710135170042,-0.0137563527103755,1.27506153871652e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,37221,-0.0283546428801144,0.00649931012342807,-0.0410932907220334,-0.0156159950381954,1.29465830779669e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FN1,Fibronectin,37269,-0.0103452959650403,0.00237409901155268,-0.0149985300276835,-0.00569206190239703,1.32539667681544e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRN,Agrin,39541,-0.0131643812232469,0.00302440505362683,-0.0190922151283555,-0.00723654731813833,1.35344998056417e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F13B,Coagulation factor XIII B chain,37196,-0.0101632553364362,0.00233715399103982,-0.0147440771588743,-0.00558243351399818,1.38098216981829e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN2,Calsyntenin-2,39636,-0.0154349929922678,0.00355638339795101,-0.0224055044522517,-0.00846448153228379,1.4335100653899e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL2,Fc receptor-like protein 2,39566,-0.0191438853252268,0.00441660348675126,-0.0278004281592593,-0.0104873424911944,1.47018413553883e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD1,COMM domain-containing protein 1,36916,-0.0241172532287582,0.00556373006731458,-0.0350221641606948,-0.0132123422968216,1.47085656393177e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39123,-0.0259272387754676,0.00598502740836775,-0.0376578924958684,-0.0141965850550668,1.48731580870168e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,39582,-0.0115753258497372,0.00267373320746734,-0.0168158429363732,-0.00633480876310124,1.50562750158727e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,36880,-0.0351758375773607,0.00814713053758323,-0.0511442134310239,-0.0192074617236976,1.58976032329828e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTDH,Protein LYRIC,36880,-0.0358683967438538,0.00832098481372938,-0.0521775269787634,-0.0195592665089442,1.64069580786175e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP10,Caspase-10,39104,-0.0279701781550267,0.00649273912467222,-0.0406959468393842,-0.0152444094706691,1.65873001592477e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRAP,BRCA1-associated protein,37050,-0.0427077727530484,0.00992434738081387,-0.0621594936194436,-0.0232560518866532,1.69517497331113e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37221,-0.0373720567989085,0.00868759058996999,-0.0543997343552497,-0.0203443792425673,1.70695556586778e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,38859,-0.0145881702885872,0.0033945203631386,-0.0212414302003389,-0.00793491037683559,1.73818516367567e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEP,Leptin,39485,-0.0249078855116058,0.00579955312736673,-0.0362750096412446,-0.013540761381967,1.7595283486039e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCA,Calcitonin,39319,-0.0214513338304911,0.00499531806955856,-0.0312421572468258,-0.0116605104141563,1.76366413604472e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,37164,-0.0297944366802902,0.00693849730152947,-0.043393891391288,-0.0161949819692925,1.76723556103243e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,36955,-0.0109507792250792,0.00255019295527837,-0.0159491574174248,-0.00595240103273357,1.76727860790104e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,36992,-0.0299399105471306,0.00699015897023659,-0.0436406221287944,-0.0162391989654669,1.85636906072275e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37164,-0.0306480700812482,0.00716020044338215,-0.0446820629502772,-0.0166140772122191,1.87978164492354e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,39437,-0.0446910268125339,0.0104462074848595,-0.0651655934828585,-0.0242164601422094,1.89574246560665e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,38998,-0.0345585586236205,0.00808794402051968,-0.0504109289038391,-0.018706188343402,1.94219011683519e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,36955,-0.0141197648994604,0.00331346856139028,-0.0206141632797853,-0.00762536651913543,2.04707556611878e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,39462,-0.0144292512541219,0.00338782416356208,-0.0210693866147036,-0.00778911589354021,2.06454911655637e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,39068,-0.0255561312801648,0.00601635838145363,-0.0373481937078139,-0.0137640688525157,2.17241034568299e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",39516,-0.0336818001751394,0.00793545558700075,-0.0492352931256609,-0.018128307224618,2.20422669735504e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR5,Complement factor H-related protein 5,37057,0.0161311095767454,0.00380102445141883,0.00868110165196452,0.0235811175015264,2.21254680621951e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,39589,-0.0186347781759977,0.00439125516623697,-0.0272416383018221,-0.0100279180501732,2.21260901066972e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,39187,-0.0132615378111051,0.00312644566865393,-0.0193893713216668,-0.00713370430054339,2.23157723101746e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMIP,C-Maf-inducing protein,37162,-0.0316257843032932,0.00746204822015045,-0.046251398814788,-0.0170001697917983,2.26891466309502e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,36955,-0.0273378271043988,0.00645160658634962,-0.0399829760136441,-0.0146926781951536,2.27777382766546e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN2,Ficolin-2,39418,-0.0157267710364319,0.00371625586338483,-0.0230106325286661,-0.00844290954419759,2.33120496530006e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,39531,0.0121564957401526,0.00289015897329955,0.00649178415248546,0.0178212073278197,2.61237042970248e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,37083,-0.0117953129095277,0.00280609172878703,-0.0172952526979503,-0.00629537312110509,2.64667046323968e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,37127,-0.0165291802211523,0.00393611418139265,-0.0242439640166819,-0.00881439642562267,2.6949349033288e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLFM4,Olfactomedin-4,36483,-0.0468982528489021,0.0111818958501293,-0.0688147687151554,-0.0249817369826487,2.75891491537086e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,36916,-0.0228115193683152,0.00544032934950706,-0.033474564893349,-0.0121484738432814,2.77142397354595e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOD,Apolipoprotein D,36637,0.0169292982694083,0.00403890980268185,0.00901303505615184,0.0248455614826647,2.7900883542791e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",36928,-0.0324307083202869,0.00774225737477689,-0.0476055327748496,-0.0172558838657242,2.82371178646791e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37221,-0.0164828100177355,0.00394646370738349,-0.0242178788842072,-0.00874774115126389,2.97861280957722e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",37221,-0.0233581157533156,0.00560211699426134,-0.0343382650620679,-0.0123779664445634,3.07262184447533e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,39601,-0.0204483861151702,0.00490659344368751,-0.0300653092647977,-0.0108314629655427,3.09624426431677e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,39355,-0.0107743254068878,0.00258549226869259,-0.0158418902535253,-0.00570676056025036,3.10071015063986e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPART,Spartin,36955,-0.0290548552196836,0.00698115063751696,-0.0427379104692169,-0.0153717999701504,3.17722588646611e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR3,Toll-like receptor 3,39636,-0.0230846608088825,0.00554904205309055,-0.03396078323294,-0.0122085383848251,3.19835308744851e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM3,Dynamin-3,37221,-0.0206920188776871,0.0049748033791818,-0.0304426335008834,-0.0109414042544908,3.21221772739536e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37221,-0.0405826554186912,0.00975897428736767,-0.0597102450219319,-0.0214550658154506,3.22443163643949e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,39194,-0.0320144308539036,0.00770502659148903,-0.0471162829732221,-0.0169125787345851,3.27113751474813e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,39304,-0.0106423389013828,0.00256459152279792,-0.0156689382860668,-0.0056157395166989,3.34735504740665e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,39123,-0.0279264466577808,0.00673132074037069,-0.0411198353089073,-0.0147330580066542,3.36205586890415e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36G,Interleukin-36 gamma,36835,-0.0259359462955514,0.0062513137295518,-0.0381885212054729,-0.0136833713856299,3.36338515364711e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,39123,-0.0349988972975711,0.00844797284412747,-0.0515569240720609,-0.0184408705230812,3.4490086072088e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO1A,Coronin-1A,39130,-0.0338687103059379,0.0081807182761125,-0.0499029181271184,-0.0178345024847574,3.49146542995177e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,39104,-0.0154680956185086,0.00373791505222217,-0.022794409120864,-0.00814178211615314,3.52056373823298e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,39473,-0.0160502395757629,0.00387983298894363,-0.0236547122340924,-0.0084457669174334,3.54041695532779e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,39485,-0.0132147981603973,0.00319876390007874,-0.0194843754045516,-0.00694522091624299,3.62795207538545e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,39428,-0.00795660694900199,0.00192649685579264,-0.0117325407863556,-0.00418067311164842,3.64587582660565e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,39636,-0.0123974602533126,0.00300459522048231,-0.0182864668854579,-0.00650845362116728,3.70827068931926e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DXO,Decapping and exoribonuclease protein,37203,-0.0171442438697352,0.00415544096755796,-0.0252889081661488,-0.00899957957332162,3.71900788972779e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37247,-0.0150530029997989,0.00365121672949365,-0.0222093877896065,-0.00789661820999136,3.76761067805951e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,39427,0.00841135063314602,0.00204060354595117,0.00441176768308172,0.0124109335832103,3.7763399610902e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,37221,-0.0346603410972894,0.0084219857797899,-0.0511674332256776,-0.0181532489689012,3.88835808628479e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39082,-0.0216595464332577,0.00527118682239199,-0.031991072605146,-0.0113280202613694,3.99462195945801e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIF,Macrophage migration inhibitory factor,39432,-0.0256904851396329,0.00625535748743341,-0.0379509858150023,-0.0134299844642634,4.03034355619011e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,36880,-0.0340077403936739,0.00828002230817923,-0.0502365841177052,-0.0177788966696426,4.03042345148536e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,39541,-0.015623485483527,0.00381120058229221,-0.0230934386248197,-0.00815353234223429,4.1646175123687e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL4,C-C motif chemokine 4,39495,-0.0252333826481827,0.00615860739356474,-0.0373042531395696,-0.0131625121567958,4.2026981169039e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD22,B-cell receptor CD22,39636,-0.0151864894944797,0.00371669109722652,-0.0224712040450437,-0.0079017749439157,4.41082725416471e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POF1B,Protein POF1B,36880,-0.0172525820973746,0.00422398989246544,-0.0255316022866069,-0.00897356190814233,4.44625998289378e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMD,Dystrophin,36916,-0.019237405550682,0.00472680586038514,-0.0285019450370369,-0.00997286606432712,4.73329332744162e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,39123,-0.0190556854319976,0.00469128226861079,-0.0282505986784748,-0.00986077218552046,4.89205974824851e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,37216,0.00543568472615065,0.00133818773143279,0.00281283677254238,0.00805853267975893,4.89502456808095e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS4,Galectin-4,39477,-0.0195485108043528,0.00481929164845578,-0.0289943224353261,-0.0101026991733795,5.01071892647091e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,37235,-0.0177025597596227,0.00437197113970215,-0.026271623193439,-0.00913349632580654,5.17176302216817e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",39485,0.0284956026070244,0.00704326620560895,0.0146908008440309,0.042300404370018,5.24067459671965e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,39104,-0.0276712834866294,0.00684801228298438,-0.0410933875612788,-0.01424917941198,5.35465469319442e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,39462,-0.0410125186616057,0.0101499405314102,-0.0609064021031696,-0.0211186352200417,5.35651582913039e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,37203,-0.0391947864477505,0.00972124014743448,-0.0582484171367221,-0.0201411557587789,5.56564686941849e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,39355,-0.0285780748112478,0.007088892985791,-0.0424723050633981,-0.0146838445590974,5.57243175807148e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA5,Integrin alpha-5,39455,-0.00911710081401881,0.00226361528456748,-0.0135537867717711,-0.00468041485626656,5.66090977349927e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIAPIN1,Anamorsin,39531,-0.0233014834246681,0.00579924901275929,-0.0346680114896763,-0.0119349553596599,5.89747485287914e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,39123,-0.0131556264061912,0.0032761939991095,-0.0195769666444458,-0.00673428616793653,5.96098105034993e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37162,-0.012805453753031,0.0031912973378422,-0.0190603965352017,-0.00655051097086028,6.03934764365023e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COCH,Cochlin,37247,-0.0169043148482632,0.00422572143988517,-0.0251867288704381,-0.00862190082608823,6.36079658838582e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,36763,-0.0186578108505009,0.00468156071010664,-0.0278336698423099,-0.00948195185869187,6.77599645328043e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD226,CD226 antigen,36880,-0.0151374741906509,0.00380200537737467,-0.0225894047303052,-0.00768554365099649,6.88874589471473e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,36955,-0.0242164230483548,0.0060888791255277,-0.0361506261343891,-0.0122822199623205,7.01372721599509e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,36916,-0.0369721422490967,0.00929974630451585,-0.0551996450059478,-0.0187446394922457,7.05959125896241e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",39499,0.0124447884444315,0.00313088299613334,0.00630825777201013,0.0185813191168528,7.07526208803113e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,36880,-0.0191512929472739,0.0048198981362376,-0.0285982932942996,-0.00970429260024819,7.12596444460604e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C19orf12,Protein C19orf12,39104,-0.0225199861247516,0.00568167516611729,-0.0336560694503415,-0.0113839027991617,7.41727787753876e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGA4,Pepsin A-4,37243,-0.0246254480526293,0.00622671975579754,-0.0368298187739925,-0.0124210773312661,7.70107016769415e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM3,Junctional adhesion molecule C,36955,-0.0181765849569717,0.00460493322890369,-0.027202254085623,-0.00915091582832052,7.9503899891935e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,39531,0.00982257932124835,0.00249387625311529,0.00493458186514237,0.0147105767773543,8.23000264132618e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,36955,-0.0217756693407691,0.00553097229117282,-0.0326163750314678,-0.0109349636500704,8.29394314452959e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX9,Sorting nexin-9,39485,-0.0246217495586405,0.00625757250481598,-0.0368865916680798,-0.0123569074492011,8.36709055805608e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,39194,-0.0196421360049082,0.00499411466937042,-0.0294306007568743,-0.00985367125294221,8.42564972824515e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS27,Serine protease 27,39440,-0.0144706911893339,0.00368166412863878,-0.0216867528814659,-0.00725462949720194,8.51588414227892e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOC1,Apolipoprotein C-I,37241,-0.0128314583566117,0.00327027779723815,-0.0192412028391985,-0.00642171387402491,8.76700648448778e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,39401,-0.0096672912610582,0.00246572923422885,-0.0145001205601468,-0.00483446196196965,8.86999971383215e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,36861,-0.0289864436607171,0.00740841749454771,-0.0435069419500306,-0.0144659453714036,9.17810294270451e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,37221,-0.0239515616145341,0.00612406084778439,-0.0359547208761915,-0.0119484023528767,9.23681158277486e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,39654,0.00862810069990306,0.00220942862619547,0.00429762059255993,0.0129585808072462,9.45827081418463e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,39601,-0.046417568215283,0.0118872065168108,-0.0697164929882322,-0.0231186434423337,9.46989162842583e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,39428,-0.0131610008128804,0.00337406169979892,-0.0197741617444863,-0.00654783988127455,9.63577203637386e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37221,-0.0271715512627844,0.00696674181148866,-0.0408263652133022,-0.0135167373122666,9.66133241219524e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",39319,-0.0262115873227087,0.00672263626586266,-0.0393879544037996,-0.0130352202416179,9.70134345075649e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,36880,-0.031297733886396,0.00803365907166531,-0.04704370566686,-0.015551762105932,9.83777371594421e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,36916,-0.0167056038796714,0.00428841380997984,-0.0251108949472318,-0.00830031281211087,9.84999900638074e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,36992,-0.0374422130319767,0.00962607316051666,-0.0563093164265894,-0.0185751096373641,0.000100900412100759
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37221,-0.0239994821852577,0.00617778819794501,-0.0361079470532299,-0.0118910173172855,0.000102930254861579
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAP,Prolyl endopeptidase FAP,39654,-0.00958475688693635,0.00247006770676563,-0.014426089592197,-0.0047434241816757,0.000104741181456086
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICALL2,MICAL-like protein 2,36861,-0.0242306681519868,0.00625312697862928,-0.0364867970301002,-0.0119745392738734,0.000107187124375429
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,39485,-0.0233880587577352,0.00604400638020175,-0.0352343112629306,-0.0115418062525398,0.000109461602747804
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTPBP2,GTP-binding protein 2,36861,-0.0281280588825807,0.00728264924876675,-0.0424020514101635,-0.0138540663549979,0.000112877228007767
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,39526,0.015572674300424,0.00403567728173129,0.00766274682823066,0.0234826017726173,0.000114442739919183
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18,Interleukin-18,39415,-0.0166244055881111,0.00431019182027066,-0.0250723815558416,-0.00817642962038061,0.000115268592392839
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK2,Docking protein 2,39485,-0.0422875570432867,0.0109847277468642,-0.0638176234271406,-0.0207574906594328,0.00011876768862226
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBI3_IL27,Interleukin-27,39568,0.0109243616014349,0.00283808095948726,0.00536172292083991,0.01648700028203,0.000118988501425694
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,36861,-0.024029683898894,0.00624260267895847,-0.0362651851496526,-0.0117941826481353,0.000119047426421596
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",39187,-0.0322234171486513,0.00837360432704509,-0.0486356816296597,-0.0158111526676429,0.000119484268841268
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSB,Cathepsin B,39476,0.0188511866264786,0.00490093478635332,0.0092453544452261,0.0284570188077311,0.000120337926283465
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,39123,-0.0126099064335534,0.00327935164358008,-0.0190374356549703,-0.00618237721213642,0.000120941436820212
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,39601,0.0124578172637936,0.00324206192873646,0.00610337588347011,0.018812258644117,0.000122254480390716
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT2,Omega-amidase NIT2,37196,-0.0263250668500279,0.00685120688963441,-0.0397534323537113,-0.0128967013463444,0.000122428840551575
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRADD,Death domain-containing protein CRADD,39319,-0.0266681291831177,0.00694889870980156,-0.0402879706543287,-0.0130482877119066,0.000124681126204558
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,39526,-0.014441878135359,0.00376497416532576,-0.0218212274993975,-0.0070625287713205,0.000125640240432589
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,37162,-0.0152164377172557,0.00396686967431818,-0.0229915022789193,-0.00744137315559206,0.000125719930491948
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON2,Spondin-2,39397,0.0120401587168572,0.00314502894836596,0.00587590197805995,0.0182044154556545,0.000129550249087997
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,36880,-0.0124536576326734,0.00325452446808343,-0.0188325255901169,-0.00607478967522984,0.00013057890672922
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,39541,-0.0363618700949942,0.00951428529353636,-0.0550098692703255,-0.017713870919663,0.000133002963956138
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL3,Follistatin-related protein 3,39416,-0.0108726609229164,0.00284496562256985,-0.0164487935431533,-0.00529652830267952,0.000133060633868083
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL3,C-C motif chemokine 3,39462,-0.0210554115414743,0.00551050342607582,-0.0318559982565829,-0.0102548248263657,0.000133469289719797
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEXN,Nexilin,37243,-0.0237600522778168,0.00622295856383419,-0.0359570510629318,-0.0115630534927018,0.000135102685714496
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,36992,-0.0193157806040224,0.00505907792877824,-0.0292315733444277,-0.00939998786361704,0.000135161515943448
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN2,CCN family member 2,39480,-0.0199874186419848,0.00524334812452001,-0.0302643809660441,-0.0097104563179256,0.00013842098944864
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,37269,0.00647073822867285,0.00169769235458247,0.0031432612136912,0.00979821524365449,0.000138777611060352
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO3,R-spondin-3,39601,0.00989758956248695,0.00259917565736387,0.00480320527405377,0.0149919738509201,0.000140663340346531
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37221,-0.0273477198327047,0.00718220832496375,-0.0414248481496336,-0.0132705915157757,0.000140919506232338
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,39526,0.0095723619941442,0.00251839423366484,0.0046363092961611,0.0145084146921273,0.000144693126589948
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,39601,-0.0203770654816966,0.00536464337797436,-0.0308917665025263,-0.00986236446086681,0.000146201587996508
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE3,Eosinophil cationic protein,39415,-0.0375201733951922,0.00990310410593151,-0.0569302574428179,-0.0181100893475664,0.000152013355868232
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37164,-0.0156266432586877,0.00412611595306681,-0.0237138305266986,-0.00753945599067672,0.00015302367477452
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37247,-0.00909606252009938,0.00240258866531709,-0.0138051363041209,-0.00438698873607788,0.000153826730181638
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,39516,-0.0178781048852658,0.00472382234553744,-0.0271367966825192,-0.00861941308801242,0.000154509586188203
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,37221,-0.0216275039760126,0.00572797988395959,-0.0328543445485734,-0.0104006634034518,0.000160240507531758
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39104,-0.021976982934925,0.00583262666022127,-0.0334089311889587,-0.0105450346808913,0.000165245674654853
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM13A,Protein FAM13A,37164,-0.0229978956581152,0.00610910661409301,-0.0349717446217375,-0.0110240466944929,0.000167615926399784
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,37243,0.00886739222822515,0.00235591428491505,0.00424980022979165,0.0134849842266586,0.000168041287097073
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,36880,-0.014937887405187,0.00397310537886509,-0.0227251739477626,-0.00715060086261145,0.000170861910194808
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE6,Ribonuclease K6,37177,-0.00995561998868497,0.00265322580621193,-0.0151559425688604,-0.00475529740850958,0.000176018916729724
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2L,Ataxin-2-like protein,37221,-0.0163995755809803,0.004377213047693,-0.0249789131544586,-0.00782023800750201,0.000180051420509481
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37164,-0.0221066568718376,0.00590343690986069,-0.0336773932151646,-0.0105359205285107,0.000181399552581717
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL3,Fc receptor-like protein 3,39194,-0.018673939111168,0.0049924627262958,-0.0284591660547077,-0.00888871216762823,0.000184404300311441
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX16,Syntaxin-16,39123,-0.020135846913922,0.00539746220359822,-0.0307148728329745,-0.00955682099486946,0.000191733801889815
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTN,Pleiotrophin,39187,0.017000013184006,0.00455806756523079,0.00806620075615369,0.0259338256118584,0.000192462040951492
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASET2,Ribonuclease T2,39588,-0.00898104863765855,0.00240825207080733,-0.0137012226964409,-0.00426087457887619,0.000192727500330857
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN2,Centrin-2,39104,-0.0227774241833964,0.00611380920227315,-0.0347604902198518,-0.0107943581469411,0.000195606081587915
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,39445,-0.00824151471794249,0.00221348874111099,-0.01257995265052,-0.00390307678536495,0.000197344183266513
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,37162,-0.0154382079833522,0.00414729739202712,-0.0235669108717253,-0.00730950509497899,0.000198131424893175
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",39431,-0.0214609155942896,0.00576754348790058,-0.0327653008305747,-0.0101565303580044,0.000199176428424795
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCA,Tubulin-specific chaperone A,36955,-0.0293064099294897,0.00789151763293753,-0.0447737844900472,-0.0138390353689321,0.000205171882149411
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS8,Galectin-8,39589,-0.0204117957311566,0.00550389154204712,-0.031199423153569,-0.00962416830874428,0.000209143367939887
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,36847,-0.0224124071451555,0.00606609274123862,-0.0343019489179832,-0.0105228653723278,0.000221091751729342
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,39428,-0.0245901871388771,0.00666491181034098,-0.0376534142871454,-0.0115269599906088,0.000225491662798223
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,39636,-0.0186823604278859,0.00507406569515114,-0.0286275291903822,-0.00873719166538971,0.000232276271195967
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,39462,-0.0279515973903835,0.0075978810010231,-0.0428434441523887,-0.0130597506283782,0.000235090823876283
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX2,Heme oxygenase 2,39104,-0.0153008496132554,0.00416085682263159,-0.0234561289856134,-0.00714557024089752,0.000236529372909237
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPOCK1,Testican-1,39355,0.00838866105973423,0.00228519099491348,0.00390968670970381,0.0128676354097646,0.000242561225928049
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNC,Tenascin,39526,0.0157941008453724,0.00431364018921842,0.00733936607450429,0.0242488356162405,0.000251666816564012
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP2,Dipeptidase 2,39428,0.00956606619435207,0.0026159283433007,0.00443884664148269,0.0146932857472215,0.000256204990028869
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCC,Tubulin-specific chaperone C,39355,-0.0269779445916006,0.00737802317442093,-0.0414388700134656,-0.0125170191697356,0.000256534694903108
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,36880,-0.0143729097219213,0.00393836469235462,-0.0220921045189363,-0.00665371492490621,0.000263867498157841
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,36861,-0.0201757613978165,0.00553050524895698,-0.0310155516857721,-0.00933597110986076,0.000265283348320896
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIAE,Sialate O-acetylesterase,39496,-0.0155601509195442,0.00426735973074995,-0.0239241759918141,-0.00719612584727435,0.000266921979746266
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROC,Vitamin K-dependent protein C,39498,-0.00837360071940993,0.00229764035526108,-0.0128769758157216,-0.00387022562309822,0.000268881988203775
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRL,Prolactin,39589,0.0255076731111919,0.00700068200819072,0.0117863363751381,0.0392290098472457,0.000269751661171049
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",36823,-0.0207029232587316,0.0056870316638421,-0.0318495053198621,-0.00955634119760103,0.000273352269682045
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL5,Insulin-like peptide INSL5,37164,-0.0308384192193219,0.00851065395408281,-0.0475193009693242,-0.0141575374693196,0.000291768074665619
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,39194,-0.0144047514706797,0.00397668191053992,-0.0221990480153379,-0.00661045492602143,0.000292970991855573
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,36763,-0.013606874074548,0.00376023931627007,-0.0209769431344373,-0.00623680501465864,0.000297365784921107
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,36880,-0.00935193482902181,0.0025898363415153,-0.0144280140583918,-0.00427585559965183,0.000306203400660317
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTF2,Transcription termination factor 2,36861,-0.0160252815899983,0.00444101781672574,-0.0247296765107807,-0.00732088666921584,0.000309219066489918
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB10,Ras-related protein Rab-10,37247,-0.0175960344330162,0.00488392907480522,-0.0271685354196344,-0.00802353344639792,0.000315948102340208
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,36916,-0.010386443413658,0.00288460324095486,-0.0160402657659295,-0.0047326210613865,0.000318656950290543
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17A,Interleukin-17A,39180,-0.014004902088487,0.00388984349403355,-0.0216289953367928,-0.00638080884018123,0.000318800425125705
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,37164,-0.0173582815802033,0.00482264422226624,-0.0268106642558451,-0.00790589890456142,0.000320253098642856
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,37162,-0.016578443411744,0.0046096444043939,-0.025613346444356,-0.00754354037913194,0.00032378924276434
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO9B,Unconventional myosin-IXb,39194,-0.0217118503325149,0.00603836786633032,-0.0335470513505224,-0.00987664931450751,0.000324640995058796
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLN,Promotilin,39462,-0.0289535077082205,0.00805555816988936,-0.0447424017212036,-0.0131646136952373,0.000326397787967521
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37221,-0.0157987970635269,0.00439772510435343,-0.0244183382680596,-0.00717925585899419,0.000328760596358969
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200,OX-2 membrane glycoprotein,39462,0.00852091496081351,0.00237227406115707,0.00387125780094564,0.0131705721206814,0.00032935474320897
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TF,Serotransferrin,37269,-0.0070999822851034,0.00197789485062609,-0.0109766561923305,-0.00322330837787625,0.000332338047720826
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA1,Annexin A1,36894,-0.0134373785892305,0.00374533540678071,-0.0207782359865206,-0.00609652119194025,0.000334806750202272
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39123,-0.0143912467993615,0.00401257277229399,-0.0222558894330577,-0.00652660416566527,0.000336186017063644
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,39344,-0.0156795907092805,0.00439011653310344,-0.0242842191141633,-0.00707496230439778,0.000355972029540817
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,39428,-0.0290229665760243,0.00812651641710521,-0.0449509387535505,-0.0130949943984981,0.000356203611884208
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLG4,Disks large homolog 4,37203,-0.0227529896590427,0.00637425526648607,-0.0352465299813554,-0.01025944933673,0.000358959309482295
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,37709,0.0101850678638226,0.00285799613503596,0.00458339543915216,0.0157867402884931,0.000366935288426992
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLA2,Src-like-adapter 2,37221,-0.0331139118828508,0.00932745082435317,-0.051395715498583,-0.0148321082671186,0.000386386420289265
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMT,Catechol O-methyltransferase,39032,-0.0274204425931531,0.00772608572874608,-0.0425635706214954,-0.0122773145648107,0.000387805780009929
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,36916,-0.0161858754751664,0.00456814751126162,-0.0251394445972392,-0.00723230635309365,0.000396743488597746
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB44,Ras-related protein Rab-44,37162,-0.0127900520444133,0.00361229511915767,-0.0198701504779623,-0.00570995361086421,0.000400495011983974
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,39531,-0.00855497829313826,0.00241643176316512,-0.0132911845489419,-0.00381877203733462,0.000400823358816855
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB2,Lysosome membrane protein 2,39149,-0.00991212946163201,0.00280270263926848,-0.0154054266345982,-0.00441883228866579,0.000406511071470498
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MITD1,MIT domain-containing protein 1,39355,-0.0310324006477815,0.00877460352077251,-0.0482306235484956,-0.0138341777470674,0.000406519744433046
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,36847,-0.00903526896867076,0.00255641553448323,-0.0140458434162579,-0.00402469452108364,0.000410267672033119
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,39502,-0.0152751153657592,0.00432264661116811,-0.0237475027236487,-0.00680272800786968,0.000410950095759192
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A13,Protein S100-A13,36880,-0.011170485106371,0.00316135160850064,-0.0173667342590322,-0.0049742359537097,0.000411659112898589
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF16,Fibroblast growth factor 16,36880,-0.0156468371394166,0.0044325980386605,-0.0243347292951912,-0.00695894498364206,0.000417145860973614
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37164,0.0221137770562821,0.00626569719307473,0.00983301055785567,0.0343945435547086,0.000418069293263692
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,39428,0.00847575280148243,0.00240911310904464,0.00375389110775493,0.0131976144952099,0.000435764917596721
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,36916,-0.01236209333919,0.0035136539233354,-0.0192488550289274,-0.00547533164945263,0.000435865923953207
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,39654,-0.00947056334064004,0.00269402110152015,-0.0147508446996195,-0.00419028198166055,0.000440369293166901
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,39355,-0.0121339789616444,0.00345425249481635,-0.0189043138514844,-0.0053636440718043,0.000444781847837211
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,39458,0.0100861503648365,0.00287146085684247,0.00445808708542529,0.0157142136442478,0.00044513305813427
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POMC,Pro-opiomelanocortin,36916,-0.0216835313327869,0.0061768439626417,-0.0337901454995646,-0.00957691716600916,0.000448921128731628
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,36955,-0.0126821965191733,0.00361333490855586,-0.0197643329399428,-0.00560006009840383,0.000449968753378604
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37247,-0.0281515622303221,0.00802968598170142,-0.0438897467544569,-0.0124133777061873,0.000456563387068405
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK10,Kallikrein-10,39477,-0.0125010020785661,0.00357677605657194,-0.0195114831494471,-0.00549052100768509,0.000475343503460692
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL1,Follistatin-related protein 1,36916,-0.00710092313389218,0.00203490380736873,-0.0110893345963349,-0.00311251167144948,0.000485484074789176
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,37247,-0.00798575653771142,0.00229200938971273,-0.0124780949415484,-0.00349341813387447,0.00049531252568043
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOMO1,Nodal modulator 1,39455,-0.00749880806278557,0.00215874875062833,-0.0117299556140171,-0.00326766051155404,0.000514816064376603
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,39194,-0.0138806973897793,0.00399731578142786,-0.0217154363213779,-0.00604595845818065,0.000517104699685319
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,39104,-0.0120559858307965,0.00347814279033365,-0.0188731456998505,-0.00523882596174258,0.000529356337843591
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMTN,Smoothelin,37167,-0.0302713401843219,0.00873668994981103,-0.0473952524859515,-0.0131474278826923,0.000532272302979796
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,39541,0.0213316963047092,0.00616075733346443,0.00925661193111896,0.0334067806782995,0.00053664117760006
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESYT2,Extended synaptotagmin-2,37203,-0.0256022973259833,0.00740567973211943,-0.0401174296009374,-0.0110871650510293,0.000547769365791548
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MBL2,Mannose-binding protein C,37077,0.033530795226785,0.0097019267403781,0.0145150188156439,0.052546571637926,0.00054986219680081
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,39433,0.012238605943555,0.00355134519129831,0.00527796936861028,0.0191992425184997,0.000570112415093607
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,39601,0.0102011585940704,0.00296471970682631,0.00439030796869079,0.0160120092194499,0.00058145165117437
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L,Seizure 6-like protein,39531,0.00861901600891651,0.0025077113046784,0.00370390185174684,0.0135341301660862,0.000589771868930833
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,39428,-0.0175730436743046,0.00511701487917388,-0.0276023928374854,-0.00754369451112377,0.000595832976858183
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,39415,-0.0561102948709809,0.016354272697107,-0.0881646693573105,-0.0240559203846512,0.000603149997133455
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,37162,-0.0172075780579316,0.00502321915451256,-0.0270530876007763,-0.007362068515087,0.000615365360211382
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,39419,0.0149308615424786,0.00436347605547972,0.00637844847373829,0.0234832746112188,0.000623786215774882
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,36857,-0.0111074653307656,0.0032470557061333,-0.0174716945147869,-0.00474323614674431,0.000626429083550792
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,36992,-0.0208062941241197,0.00609573306782523,-0.0327539309370572,-0.00885865731118228,0.000643947171885472
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1,DNA topoisomerase 1,37164,-0.0331332629370799,0.00971569786616458,-0.0521760307547625,-0.0140904951193973,0.000650976710323131
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,39187,0.0105703244031157,0.00310040917377247,0.00449352242252164,0.0166471263837097,0.000652966290131631
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,37203,0.0095738842532903,0.00280820993475524,0.00406979278117003,0.0150779757254106,0.00065343904345922
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,39549,0.0104947218961539,0.00308244193732879,0.00445313569898948,0.0165363080933183,0.000664144741741533
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,36847,-0.0110714558073822,0.00325566730392103,-0.0174525637230674,-0.00469034789169696,0.000674326018934105
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,39123,-0.0166796360037581,0.00491068790978095,-0.0263045843069288,-0.00705468770058744,0.000684100086488674
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMMT,MICOS complex subunit MIC60,37162,-0.0136171741836541,0.00400978032649779,-0.0214763436235897,-0.00575800474371839,0.00068590179783097
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,36847,-0.0259899182372709,0.00765846367732976,-0.0410005070448372,-0.0109793294297046,0.000691912113841179
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CX3CL1,Fractalkine,39355,0.010546058120433,0.00310828249450049,0.00445382443121205,0.016638291809654,0.000693395367785957
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPO,Erythropoietin,39462,-0.0240404416531633,0.00708780849174191,-0.0379325462969774,-0.0101483370093491,0.000696137902067593
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,36861,-0.0153360122892858,0.00452139254572992,-0.0241979416789164,-0.00647408289965513,0.000696320075555967
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRAS,Ras-related protein R-Ras,36861,-0.0403702536724987,0.011910411088788,-0.0637146594065232,-0.0170258479384742,0.000702400365365555
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBNL,Drebrin-like protein,39541,-0.0284066981327239,0.00838295819158132,-0.0448372961882233,-0.0119761000772245,0.000704237694689468
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,36916,-0.0101075687394098,0.00298324528556545,-0.015954729499118,-0.00426040797970147,0.000705933699013977
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,39436,-0.00957108944213307,0.00282540521061559,-0.0151088836549396,-0.00403329522932652,0.000707114825301576
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",37201,-0.00684252097399475,0.00202049215965714,-0.0108026856069227,-0.00288235634106676,0.000709881923562327
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA4,Ephrin-A4,39330,-0.00908502273244622,0.002684033840854,-0.0143457290605201,-0.00382431640437237,0.000714039564203137
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN5,CCN family member 5,39455,0.0120846420188076,0.0035749585723992,0.00507772321690513,0.01909156082071,0.000725758356227759
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH1,Acid ceramidase,37145,-0.0140720672082341,0.00417293947099944,-0.022251028571393,-0.00589310584507521,0.000747877255511436
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,36880,-0.0235065894138639,0.00697520112251359,-0.0371779836139905,-0.00983519521373727,0.000753905688991879
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARD3,Partitioning defective 3 homolog,36992,-0.0229016312001881,0.00680252053416232,-0.0362345714471463,-0.00956869095322999,0.000763188195595581
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39123,-0.0177356939510337,0.00527273700400787,-0.0280702584788891,-0.00740112942317825,0.000771131159414576
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",37255,-0.0122707721510737,0.00364968119109703,-0.0194241472856239,-0.00511739701652353,0.000775648190069353
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USO1,General vesicular transport factor p115,39428,-0.0276275875529285,0.00822848499919782,-0.0437554181513563,-0.0114997569545008,0.000788310342144774
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOBR,Apolipoprotein B receptor,36916,0.0128893958067577,0.00384954497711453,0.00534428765161327,0.0204345039619022,0.000815525069109739
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,39104,-0.0187872228887939,0.00562009725141519,-0.0298026135015677,-0.00777183227602014,0.000831260625346156
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,37164,-0.0274677673303129,0.00823097930017025,-0.0436004867586466,-0.0113350479019792,0.000848941411269144
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,37203,-0.0114055620784918,0.00342025905446898,-0.018109269825251,-0.00470185433173259,0.000856328213217839
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,36916,-0.0232858714722453,0.00699314742691031,-0.0369924404289895,-0.00957930251550105,0.000871565860074313
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT2,Angiopoietin-2,39601,-0.0116491496867725,0.00350023005130896,-0.018509600587338,-0.00478869878620691,0.00087645748548547
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAL,Integrin alpha-L,36880,-0.0131721690133717,0.00396215716799997,-0.0209379970626517,-0.00540634096409178,0.000888352983245141
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,37162,-0.0100753926529954,0.00303100434201668,-0.0160161611633481,-0.00413462414264271,0.000889519254147842
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,39478,0.0151173710067527,0.00454995809189625,0.00619945314663604,0.0240352888668693,0.000894181191635046
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,36916,-0.0279836175428267,0.00843014874208161,-0.0445067090773066,-0.0114605260083467,0.000904475219706377
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",39309,-0.0123473517148319,0.00372546105078718,-0.0196492553743748,-0.00504544805528903,0.000920877050270773
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPL,Periplakin,36880,-0.00982939170403594,0.00297040492920921,-0.015651385365286,-0.00400739804278588,0.000938597672478101
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",39462,-0.0289402531883896,0.00874971116458537,-0.046089687070977,-0.0117908193058023,0.000943314722131173
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC79,Protein unc-79 homolog,36763,-0.0170536930843039,0.00515960610167138,-0.0271665210435798,-0.00694086512502801,0.000951691977962439
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,39485,-0.0198863331023605,0.00601690849179411,-0.0316794737462769,-0.00809319245844401,0.00095173212787195
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,39428,-0.025177170766583,0.00762227026629511,-0.0401168204885214,-0.0102375210446446,0.000958441579150062
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,39123,-0.0155065912701606,0.00470210988350128,-0.0247227266418231,-0.0062904558984981,0.000976792420285365
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,36847,0.0097380909840713,0.00296480955653117,0.00392706425327021,0.0155491177148724,0.00102425535879424
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA11,Serpin A11,39654,0.012010463327651,0.00365814959260906,0.00484049012613725,0.0191804365291648,0.00102864897014886
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,37255,-0.00662026016975682,0.00201684077140778,-0.0105732680817161,-0.00266725225779756,0.00103170197101812
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,37243,-0.0139721705456221,0.00425700619324485,-0.022315902684382,-0.00562843840686218,0.00103291688583842
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR4,Complement factor H-related protein 4,37230,0.0218040735489438,0.00665831945252765,0.00875376742198962,0.034854379675898,0.00106051457687894
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,37255,-0.00685554752305022,0.00209497249471114,-0.0109616936126841,-0.00274940143341638,0.00106928335946404
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,37255,0.00626251795153455,0.00191573928959494,0.00250766894392846,0.0100173669591406,0.00108219806762115
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,36955,-0.0243904215733735,0.00746407724027742,-0.0390200129643172,-0.00976083018242974,0.00108714845974393
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,37221,0.0134322046033867,0.00411395553502337,0.00536885175474087,0.0214955574520325,0.00109739201917311
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A12,Protein S100-A12,39270,-0.0226392076235178,0.00693821738719113,-0.0362381137024124,-0.00904030154462315,0.00110500092714211
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNXB,Tenascin-X,39455,-0.00757416895242873,0.00232528250896487,-0.0121317226699999,-0.00301661523485759,0.00112722898552767
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,39589,0.0378869650375615,0.0116555383546717,0.015042109862405,0.060731820212718,0.00115431795143281
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,36825,-0.0121671797248754,0.00374905113895146,-0.0195153199572203,-0.00481903949253053,0.00117596494475508
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNU13,NHP2-like protein 1,36847,-0.0185126580880285,0.00571534749055314,-0.0297147391695127,-0.00731057700654437,0.00120217801554964
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK4,Kallikrein-4,39601,0.0179847917300873,0.00555417145700031,0.00709861567436672,0.0288709677858079,0.00120600649400719
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,37221,-0.0219657363172757,0.00679409270438387,-0.0352821580178681,-0.00864931461668331,0.0012278115897299
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLNK,B-cell linker protein,36880,-0.0113010558346994,0.0034958478894709,-0.0181529176980624,-0.00444919397133646,0.00122942614177746
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,39589,-0.0168844499594516,0.00523103345328882,-0.0271372755278977,-0.00663162439100547,0.00125035129157228
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,39247,-0.00609295723517083,0.00188931858766238,-0.0097960216669891,-0.00238989280335257,0.00126268423926487
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB3,Plexin-B3,39438,-0.0137117107564288,0.00425323783346051,-0.0220480569100114,-0.00537536460284619,0.00126759782777005
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL8,Interleukin-8,39341,-0.0199217354616927,0.0061823952893608,-0.0320392302288399,-0.00780424069454554,0.00127424853308663
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGN,Secretagogin,39194,-0.012864275206648,0.00399444283980045,-0.0206933831726569,-0.00503516724063912,0.00128225380980981
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRKL,Crk-like protein,39495,-0.031164487718098,0.00967688951964479,-0.0501311911766017,-0.0121977842595942,0.00128236077354041
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRP15,RRP15-like protein,36823,0.0267703908604442,0.00831778439677548,0.0104675334427643,0.0430732482781242,0.00129216731473696
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",37247,-0.0185462803517267,0.00576490144127238,-0.0298454871766206,-0.00724707352683284,0.00129814452947045
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,36880,-0.00889662864904874,0.00277159481449976,-0.0143289544854683,-0.0034643028126292,0.00133104116315803
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRY2,Protein sprouty homolog 2,39194,-0.0269150394929815,0.00839698390281026,-0.0433731279424896,-0.0104569510434734,0.00135198780868102
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC5,Glypican-5,39355,-0.0163109768454675,0.00509232772054304,-0.0262919391777318,-0.0063300145132031,0.00136266533061436
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,37099,-0.0170384361053756,0.00532104812551585,-0.0274676904313866,-0.00660918177936449,0.00136775450306148
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABHD14B,Protein ABHD14B,39299,-0.0170264294016168,0.00531776056942141,-0.0274492401176827,-0.00660361868555079,0.00136857429561657
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",39462,-0.0130985409083951,0.00409885830702522,-0.0211323031901645,-0.00506477862662567,0.00139802073339996
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SATB1,DNA-binding protein SATB1,37221,-0.00864475637732648,0.00270538380413056,-0.0139473086334224,-0.00334220412123059,0.0013998161694081
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX6,Syntaxin-6,39123,-0.0199790034198971,0.00626770901108351,-0.0322637130816208,-0.00769429375817342,0.00143755469403498
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,39123,-0.0153346850511754,0.00481296864939184,-0.0247681036039834,-0.0059012664983674,0.0014449782401031
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMS,Spermine synthase,36823,-0.0186726675184789,0.00586097398308911,-0.0301601765253335,-0.0071851585116242,0.00144646535297678
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,39462,-0.0290861417778298,0.0091303777778603,-0.046981682222436,-0.0111906013332237,0.0014472718227082
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",39428,-0.0298012532838809,0.00936206233570745,-0.0481508954618675,-0.0114516111058943,0.0014595817131028
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL5,C-C motif chemokine 5,39526,-0.0290078143504053,0.00911890479763082,-0.0468808677537617,-0.0111347609470489,0.00147032813917523
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,39428,0.0094964417727675,0.00299073366162764,0.00363460379597732,0.0153582797495577,0.00149990904962853
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37247,-0.0213958263370653,0.00674591786558877,-0.0346178253536193,-0.00817382732051133,0.0015192295281892
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22,Interleukin-22,37162,-0.0186838053105115,0.00589399110588065,-0.0302360278780376,-0.00713158274298546,0.00152813671232199
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,39526,-0.0122680235219738,0.00387271316443364,-0.0198585413242637,-0.00467750571968386,0.00153897758557963
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,37119,-0.0138151746104192,0.00436156886095737,-0.0223638495778957,-0.00526649964294279,0.00154132191217817
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF6,SLAM family member 6,39123,-0.0109368563745893,0.00346627391545454,-0.0177307532488802,-0.00414295950029844,0.00160701182012513
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,36880,-0.0228587512525934,0.00724487828708488,-0.0370587126952798,-0.00865878980990708,0.00160792588030079
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,36847,-0.010205917170022,0.00323671524701342,-0.0165498790541683,-0.00386195528587572,0.0016189238671057
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,36880,-0.0115934135328904,0.00368093124501943,-0.0188080387731285,-0.00437878829265233,0.00163888771317116
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAP,Prosaposin,37165,-0.00810695823485838,0.00257518672488478,-0.0131543242156326,-0.00305959225408422,0.00164712626511756
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINK1,Misshapen-like kinase 1,37203,-0.0263909571837714,0.00839285437755059,-0.0428409517637706,-0.00994096260377225,0.00166778181928516
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTP1,Glutathione S-transferase P,39019,0.0199794871805932,0.0063544405090791,0.00752478378279819,0.0324341905783883,0.00166889067020122
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,39455,0.0342250895962228,0.0109025823983772,0.0128560280954036,0.0555941510970421,0.00169754010298417
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,39455,0.0116338105334105,0.00371278156637043,0.00435675866332446,0.0189108624034966,0.00173097832330398
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSV,Cathepsin L2,39559,-0.0120791897716288,0.0038594318024605,-0.0196436761044514,-0.00451470343880624,0.00175267726566225
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINH1,Serpin H1,36992,-0.0366553882595279,0.011715129133533,-0.0596170413612525,-0.0136937351578032,0.00175868220979315
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPP,Lipoma-preferred partner,36847,-0.0190786827239681,0.00609821535863224,-0.0310311848268873,-0.00712618062104895,0.00176067403657042
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN8,Tetraspanin-8,37164,-0.0294897866437579,0.0094317847624851,-0.0479760847782287,-0.0110034885092871,0.00177215580500087
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,39485,-0.00496585048023935,0.00159003564472643,-0.00808232034390316,-0.00184938061657553,0.00179292834262899
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,36880,-0.0261354558215202,0.00838301058836639,-0.0425661565747184,-0.00970475506832212,0.001827031770358
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,39485,-0.0225321579728059,0.00722757791065116,-0.0366982106776822,-0.00836610526792965,0.00182720225849462
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPB,Natriuretic peptides B,39187,0.0364453430625093,0.0116980217004048,0.013517220529716,0.0593734655953027,0.00183977565905192
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37221,-0.0237435779332133,0.00762116333234866,-0.0386810580646166,-0.00880609780180989,0.00184053017770105
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,36916,-0.0252165831043031,0.0080951986626643,-0.0410831724831252,-0.00934999372548111,0.00184359174227978
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,39413,-0.0251911102924104,0.00808926611759392,-0.0410460718828945,-0.00933614870192632,0.00184829963210355
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA1,Ephrin-A1,39427,0.00776612904872023,0.0024954042503604,0.00287513671801385,0.0126571213794266,0.00186065265578165
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,39194,-0.0118947102184176,0.00382428935549151,-0.019390317355181,-0.00439910308165423,0.00187250057015889
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRLB,Fc receptor-like B,39123,-0.0173753710495176,0.0055913426963198,-0.0283344027343044,-0.00641633936473082,0.00189006111471326
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,36861,-0.0204724799541508,0.00658860932053358,-0.0333861542223967,-0.00755880568590502,0.00189260706602808
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37164,-0.0111131742604944,0.00357721117855749,-0.0181245081704671,-0.00410184035052173,0.00189631454947433
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLTA,Clathrin light chain A,39187,-0.0134193536730818,0.00432004105504364,-0.0218866341409673,-0.00495207320519623,0.00189802688289518
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,37221,-0.0146915555943689,0.00473049717469097,-0.0239633300567632,-0.00541978113197457,0.00190238093695285
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,39531,-0.00798526238996868,0.00257753795841991,-0.0130372367884717,-0.00293328799146566,0.00195176747735946
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,37221,-0.0138605532618222,0.00447481448828952,-0.0226311896588697,-0.00508991686477476,0.00195610909007665
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BID,BH3-interacting domain death agonist,39462,-0.0187952017265583,0.00608824751583867,-0.0307281668576021,-0.0068622365955145,0.00202468608298682
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,37247,-0.00910718712070653,0.00295163322539624,-0.0148923882424832,-0.0033219859989299,0.00203661772403804
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37164,-0.0411661316803969,0.0133472738380215,-0.0673267884029191,-0.0150054749578748,0.00204513880835277
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN4,CCN family member 4,39601,-0.0114272087929304,0.00370620605725171,-0.0186913726651437,-0.00416304492071705,0.00205111992194493
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,39531,-0.00887225193771048,0.0028780793884504,-0.0145132875390733,-0.0032312163363477,0.0020550282850658
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,36847,-0.0127871307999567,0.00414889764358722,-0.0209189701813877,-0.00465529141852577,0.00206027853271295
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,37164,-0.0130879832319223,0.00424705133214009,-0.0214122038429169,-0.00476376262092772,0.00206287503905689
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,39541,0.00739287235977453,0.00240071151056598,0.0026874777990652,0.0120982669204839,0.00207755349693103
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,39428,-0.00670027319263996,0.00218297510637376,-0.0109789044011325,-0.00242164198414738,0.00214922396515894
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO2,Roundabout homolog 2,39589,-0.00650880120828804,0.0021219512996505,-0.010667825755603,-0.00234977666097306,0.00216335464331048
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA9,Carbonic anhydrase 9,39601,-0.012563344261799,0.00410401461745858,-0.0206072129120178,-0.00451947561158015,0.00220813547204982
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR1,Cadherin-related family member 1,39104,-0.0122057618721754,0.00398970507928638,-0.0200255838275767,-0.00438593991677411,0.00222244931564269
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,39654,-0.00816660967492355,0.00267109917439565,-0.013401964056739,-0.00293125529310807,0.00223656371718953
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37162,-0.0228157558723994,0.00749118092197678,-0.0374984704794739,-0.00813304126532497,0.00232628675206963
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RETN,Resistin,39411,0.0113751496487576,0.00374614774688885,0.00403270006485545,0.0187175992326597,0.0023975999943
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH5,Cadherin-5,39654,0.00839527603073332,0.00276483491307435,0.0029761996011076,0.013814352460359,0.00239789210980263
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,39194,-0.00880073255351492,0.00289943590167773,-0.0144836269208033,-0.00311783818622657,0.00240695049554444
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TWF2,Twinfilin-2,37255,-0.022786911962436,0.00752180895390014,-0.0375296575120803,-0.00804416641279173,0.00245491496707726
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,39104,-0.0230996771479921,0.00762592863539653,-0.0380464972733693,-0.00815285702261491,0.00245713159299957
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,39410,0.00758178382069854,0.00250401390719414,0.00267391656259802,0.0124896510787991,0.00246718137234806
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,37164,-0.0119549643577235,0.00395839748540944,-0.019713423429126,-0.00419650528632105,0.0025314913576023
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE2,Glia-derived nexin,37247,-0.0176040428898214,0.0058324371610333,-0.0290356197254466,-0.00617246605419609,0.00254697877779413
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,37164,-0.0161241394722225,0.00534341175701029,-0.0265972265159627,-0.00565105242848235,0.00255311433912686
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD93,Complement component C1q receptor,38875,0.00872655143471635,0.00289331351406346,0.00305565694715197,0.0143974459222807,0.00256486425614088
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB1A1,Uteroglobin,39505,0.0154584448720859,0.00514103926203237,0.00538200791850242,0.0255348818256693,0.00264386815631084
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C4BPB,C4b-binding protein beta chain,39531,0.0112388357740047,0.00374381361180433,0.00390096109486817,0.0185767104531411,0.00268673247019568
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK1,Docking protein 1,37203,-0.037011131240037,0.0123304485706952,-0.0611788104385995,-0.0128434520414744,0.00269080643249279
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,39355,0.0318920508003612,0.0106261640590507,0.0110647692446218,0.0527193323561007,0.00269295881177007
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP9,Matrix metalloproteinase-9,39436,0.0167369270181925,0.00558105160103,0.00579806588017373,0.0276757881562113,0.00271415221944802
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,37243,0.00702429274795934,0.00234418652203045,0.00242968716477967,0.011618898331139,0.00273645779168234
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLMH,Bleomycin hydrolase,39654,-0.00882904958899389,0.0029469432863933,-0.0146050584303248,-0.00305304074766302,0.00273985257592037
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDC,Nuclear migration protein nudC,39636,-0.0171418794044158,0.00573722298611673,-0.0283868364572046,-0.00589692235162697,0.00281409697579672
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XRCC4,DNA repair protein XRCC4,39104,-0.0101527745178608,0.00339907486962108,-0.0168149612623181,-0.00349058777340345,0.00282267088167097
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,36847,-0.0191072154387542,0.00639860429623745,-0.0316484798593796,-0.00656595101812877,0.00283062790337338
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST1,Cystatin-SN,35538,-0.0282936824476257,0.00948021567433082,-0.0468749051693141,-0.00971245972593728,0.00284663720051881
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,37164,-0.0115281570761151,0.00386729831168862,-0.0191080617670248,-0.0039482523852054,0.00287915794314425
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,36763,-0.0166805135185229,0.00559650396985124,-0.0276496612994314,-0.00571136573761448,0.00288318154712105
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,36916,-0.0122037110615917,0.00409823161792649,-0.0202362450327276,-0.0041711770904558,0.00290884575706211
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB2,Carboxypeptidase B2,37241,-0.00604935960801128,0.00203295851960521,-0.0100339583064375,-0.00206476090958506,0.00292921319059969
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,37135,0.00729611451882742,0.00245470720763642,0.00248488839186004,0.0121073406457948,0.00296137345984035
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1,Allograft inflammatory factor 1,39123,-0.0143262871792337,0.00482385252851555,-0.0237810381351242,-0.00487153622334325,0.00298393414462233
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL18,C-C motif chemokine 18,39308,-0.018930499561182,0.00638583921786864,-0.0314467444282046,-0.00641425469415951,0.00303706154987609
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCC1,Regulator of chromosome condensation,37162,-0.013648769751198,0.0046043061622679,-0.0226732098292431,-0.00462432967315292,0.0030388704162222
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,36861,0.00869206170207141,0.00293421736158173,0.00294099567337123,0.0144431277307716,0.00305918983917818
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMA,Repulsive guidance molecule A,39589,-0.0083271916167859,0.0028153571703405,-0.0138452916706533,-0.00280909156291852,0.00310347596348999
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,39187,0.0081628942177215,0.00276354479226014,0.00274634642489162,0.0135794420105514,0.00314406962380644
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,36880,-0.0169681882898715,0.00575911271328201,-0.0282560492079042,-0.00568032737183874,0.00322176498955163
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN2,Neuroligin-2,36823,0.0129846637632825,0.00440800475920956,0.00434497443523172,0.0216243530913332,0.00322824122594888
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,39582,-0.0163772215314836,0.00557658907300402,-0.0273073361145715,-0.0054471069483957,0.00332137701430044
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN2,Contactin-2,39601,-0.0119785097167351,0.00408587902380345,-0.0199868326033899,-0.00397018683008038,0.00337632706195973
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,36847,0.0108157615550356,0.00369147802802809,0.00358046462010051,0.0180510584899706,0.00339659775463058
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,39324,-0.00768368072733107,0.00262338717245745,-0.0128255195853477,-0.00254184186931447,0.00340662576417165
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,39636,-0.0121725135923405,0.00415631644911065,-0.0203188938325973,-0.00402613335208358,0.00340912483811418
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,39589,-0.00923694640141132,0.00315455323448212,-0.0154198707409963,-0.00305402206182636,0.00341513905905197
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,39123,-0.0144823623633264,0.00494597437559657,-0.0241764721394957,-0.00478825258715708,0.00341552366816999
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MELTF,Melanotransferrin,37247,-0.00777326624451268,0.00265496258844529,-0.0129769929178655,-0.00256953957115992,0.00341943351768955
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,39016,0.0100967584133037,0.00344973919211465,0.00333526959675899,0.0168582472298484,0.00342978708673242
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,39104,-0.0159724997632265,0.00546023482556566,-0.0266745600213352,-0.00527043950511778,0.00344718005311382
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D23,TBC1 domain family member 23,39428,-0.0238586503482193,0.00816146054979382,-0.0398551130258152,-0.00786218767062344,0.00346826561195989
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AREG,Amphiregulin,39428,-0.01308002368609,0.00448045231921059,-0.0218617102317428,-0.00429833714043723,0.00351280767639774
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP8,Caspase-8,39549,-0.0164534504233115,0.00563645327393352,-0.0275008988402212,-0.00540600200640178,0.00351546159412955
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,39462,0.0140055339776962,0.00480136313987525,0.00459486222354076,0.0234162057318517,0.00353949423048195
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML2,Trem-like transcript 2 protein,39455,0.00891204161151975,0.00306010549611387,0.00291423483913656,0.0149098483839029,0.00359270409644983
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,36955,-0.0221600284948624,0.00761843852475192,-0.0370921680033762,-0.00722788898634865,0.00363531785886056
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN3,Matrilin-3,39330,0.00824541563730673,0.00283946253989378,0.00268006905911491,0.0138107622154985,0.00369129182469234
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,39654,-0.00905955181053174,0.00313266241856314,-0.0151995701509155,-0.00291953347014799,0.00383382743201657
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFC1,Cryptic protein,39123,-0.0121486858612104,0.00420391776734589,-0.0203883646852083,-0.00390900703721246,0.00385992186995307
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD2,Polycystin-2,36847,-0.0156052710876347,0.00540072703545544,-0.0261906960771274,-0.00501984609814208,0.00386553486590918
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,39462,-0.0125557806710019,0.00434740486342713,-0.021076694203319,-0.00403486713868468,0.00388118970397867
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH1,Neurexophilin-1,39104,0.0099283418038179,0.00344236326121876,0.00318130981182913,0.0166753737958067,0.00393025450744447
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,36880,-0.00998418014687867,0.00346356773629539,-0.0167727729100176,-0.0031955873837397,0.00395047919384989
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,36763,-0.00963559093657002,0.00334563398631961,-0.0161930335497565,-0.0030781483233836,0.00398298816018098
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,37203,0.00955871478769199,0.00332318436935332,0.00304527342375949,0.0160721561516245,0.00402942049651033
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,39355,-0.0143410023685345,0.00499086173401519,-0.0241230913672043,-0.00455891336986476,0.00406586293678988
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL7,C-C motif chemokine 7,39462,-0.0158972827835954,0.00553612518954316,-0.0267480881551,-0.00504647741209079,0.00409030591105596
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,39194,-0.0147130889832692,0.00512659931228652,-0.0247612236353508,-0.00466495433118759,0.00411119227626991
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO1,Roundabout homolog 1,39499,-0.00632211370606145,0.00220377611963118,-0.0106415149005386,-0.00200271251158434,0.00412652385954746
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST5,Cystatin-D,39213,-0.0143938943017613,0.00502364389548886,-0.0242402363369195,-0.00454755226660314,0.00417295042733632
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,39194,-0.00914385897199755,0.00319291443012596,-0.0154019712550444,-0.00288574668895068,0.00419186804668911
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,36847,-0.00966825872067628,0.0033761933578441,-0.0162855977020507,-0.00305091973930185,0.00419484410516075
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,39589,0.0120328255105966,0.00420547784777018,0.00379008892896705,0.0202755620922262,0.00422583260537913
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36A,Interleukin-36 alpha,36880,0.0153214652680109,0.00536254666726461,0.00481087380017226,0.0258320567358495,0.00428207283723201
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,39601,0.0159197204562134,0.00557387242771449,0.00499493049789304,0.0268445104145338,0.00429418784846193
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,37243,-0.00700119897333676,0.00245141726796862,-0.0118059768185553,-0.00219642112811826,0.00429732959263908
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171B,Protein FAM171B,37162,-0.00714831374222483,0.00250500272336287,-0.0120581190800161,-0.00223850840443359,0.00432947045947146
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSL,Cathepsin L1,39485,-0.00628603309745295,0.00220463923342685,-0.0106071259949696,-0.00196494019993633,0.00436035780072648
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,39541,-0.00995243865473926,0.00349131152435279,-0.0167954092424707,-0.00310946806700779,0.0043691819954399
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRD2,Protein ZNRD2,37164,-0.01763273982081,0.0061887003091731,-0.0297625924267892,-0.0055028872148307,0.00439020764226523
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,39549,-0.0187762057379163,0.00659102129770208,-0.0316946074814124,-0.00585780399442021,0.00439499840901303
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG3,Secretogranin-3,39499,0.00869550429598823,0.00305589265755558,0.00270595468717929,0.0146850539047972,0.00444034020021136
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,37243,-0.0101916475754445,0.00358665842031123,-0.0172214980792545,-0.00316179707163449,0.00449666500536433
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,39485,-0.0216647183783183,0.00763734230299128,-0.0366339092921812,-0.0066955274644554,0.00456458057890244
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLASP1,CLIP-associating protein 1,36763,-0.0182761458896463,0.00646032208576992,-0.0309383771777554,-0.0056139146015373,0.00467715723648704
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,39589,-0.0172533909317999,0.00610591997389622,-0.0292209940806365,-0.00528578778296329,0.00472417813515471
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL15,C-C motif chemokine 15,39654,-0.0114423637939568,0.00405156682278254,-0.0193834347666106,-0.00350129282130301,0.0047463074955017
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,39462,-0.0267802002311288,0.00948414802302079,-0.0453691303562495,-0.00819127010600802,0.00475382654287244
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,39541,0.00694726762360669,0.00246434506021869,0.00211715130557807,0.0117773839416353,0.00482192563025849
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,39485,0.00873694459965317,0.0031076191104766,0.00264601114311902,0.0148278780561873,0.00493811737529264
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGLAP,Osteocalcin,37255,-0.0232204140093045,0.00825996045132521,-0.039409936493902,-0.00703089152470712,0.00494318506747142
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN1,Contactin-1,39654,0.00707364311034714,0.00251710031231237,0.00214012649821489,0.0120071597224794,0.00495686285355462
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,36861,-0.0179138621781913,0.00639142356012999,-0.0304410523560461,-0.00538667200033657,0.0050740135276211
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK3,NT-3 growth factor receptor,39589,0.0055514132957699,0.00198075264991755,0.0016691381019315,0.0094336884896083,0.00507445514414159
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,36861,-0.0156216368373098,0.00558408047210165,-0.026566434562629,-0.00467683911199052,0.00515741914368559
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,36847,-0.0255188003524302,0.00912848972383633,-0.0434106402111494,-0.00762696049371095,0.0051897322708141
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,39485,-0.0196211469272168,0.00702090197085748,-0.0333821147900974,-0.00586017906433613,0.00520175513654232
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,37247,-0.0207147742858303,0.00741361850490212,-0.0352454665554384,-0.00618408201622212,0.00521134745961423
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37247,-0.0137404212933255,0.00492263797399788,-0.0233887917223614,-0.00409205086428968,0.00525791447914601
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100P,Protein S100-P,39187,-0.0135849413787389,0.00486827979339437,-0.0231267697737918,-0.00404311298368588,0.00526941307626013
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,39187,0.00531559843235712,0.00190491058085497,0.00158197369388138,0.00904922317083285,0.00526990103634497
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYMP,Thymidine phosphorylase,39387,0.0169512626933474,0.00607502868698603,0.00504420646685475,0.02885831891984,0.00527230411828724
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,36763,-0.0139245184742694,0.00499178638100163,-0.0237084197810326,-0.00414061716750624,0.00528728951365712
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THPO,Thrombopoietin,39187,-0.00966215945138846,0.00347084441097655,-0.0164650144969025,-0.00285930440587443,0.00537935325500844
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,36847,-0.0171361500564805,0.00617279446552619,-0.0292348272089118,-0.00503747290404912,0.00551017778640824
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,39636,-0.0190292148760139,0.00685559529839964,-0.0324661816608772,-0.00559224809115066,0.00551469813971341
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPBP,Platelet basic protein,37197,-0.0211638452046713,0.00762625603160901,-0.036111307026625,-0.00621638338271764,0.00552601911237246
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37162,-0.0121273649484228,0.00437236640021289,-0.0206972030928401,-0.00355752680400554,0.0055514024132568
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",39455,-0.0195625548565814,0.00705392834337054,-0.0333882544095876,-0.00573685530357512,0.00555619840394354
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,39531,-0.021123191811908,0.00762239349067235,-0.0360630830536258,-0.00618330057019017,0.00559181970198443
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,37024,-0.00340774141491564,0.00122982849767213,-0.005818205270353,-0.000997277559478273,0.00559823626023216
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,37221,-0.00943701445827735,0.00340679317674214,-0.016114329084692,-0.00275969983186275,0.00561272927248022
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP7,Caspase-7,37203,-0.0210102856570892,0.00759049485267568,-0.0358876555683336,-0.00613291574584489,0.00564874923420527
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,36880,-0.0140920338775701,0.00509652462341207,-0.0240812221394578,-0.00410284561568245,0.00570018239259475
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAD,Chondroadherin,36955,-0.0134287322366887,0.00485710180941057,-0.0229486517831334,-0.00390881269024396,0.00570477486542539
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRSF1,G-rich sequence factor 1,36690,-0.0198376606035954,0.00718567418152342,-0.0339215819993813,-0.00575373920780948,0.00577593419019946
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLGN,Calmegin,36861,-0.0111600738770496,0.00404463827401221,-0.0190875648941136,-0.00323258285998568,0.00580232537998979
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARC,SPARC,39531,-0.0176881725315319,0.00641320477939295,-0.0302580538991421,-0.00511829116392176,0.00582108616362891
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37247,-0.0185956374981779,0.00674581115400886,-0.0318174273600353,-0.00537384763632054,0.00584849302419384
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,36861,-0.0155632299482518,0.00564682615648519,-0.0266310092149628,-0.00449545068154086,0.00585801099158153
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRIB,Protein scribble homolog,36916,-0.023169512636727,0.00841054966747654,-0.039654189984981,-0.00668483528847297,0.00588104458838777
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",39187,-0.0233196923663449,0.00846529886368284,-0.0399116781391633,-0.00672770659352654,0.00588109789853559
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,39477,0.00996181291261487,0.00362269449343041,0.00286133170549128,0.0170622941197385,0.00596965365448093
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,39103,-0.0070650978898412,0.00257032615480501,-0.012102937153259,-0.00202725862642339,0.00599023700833227
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR3,Folate receptor gamma,39477,0.0460400280793799,0.0167889144984562,0.0131337556624057,0.078946300496354,0.00610851767253767
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,36992,0.00726202606332213,0.00264883632672514,0.00207030686294086,0.0124537452637034,0.00612290680487017
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,39187,-0.0143022471618614,0.00521877610992566,-0.0245310483373157,-0.00407344598640716,0.00614128258264768
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164,Sialomucin core protein 24,39455,-0.00667243955092714,0.00243808783788763,-0.0114510917131869,-0.00189378738866739,0.00621222622203522
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIM,Vimentin,39187,-0.0292018825480011,0.0106916068947931,-0.0501574320617956,-0.00824633303420661,0.00631619401467318
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LXN,Latexin,39312,-0.0165000675095258,0.00604629320451931,-0.0283508021903837,-0.00464933282866801,0.0063609939230871
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,39194,-0.0168638535713915,0.00620191381644241,-0.0290196046516186,-0.00470810249116433,0.00655290975636077
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,39635,-0.00589808434611093,0.00216937983406835,-0.0101500688208849,-0.00164609987133697,0.00655959746220997
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,39654,-0.017746120438839,0.00653608396609666,-0.0305568450123884,-0.00493539586528951,0.00663306012758902
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBN1,Drebrin,36880,-0.0127132188118678,0.00468430358221132,-0.021894453833002,-0.00353198379073364,0.00665670352516207
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,36992,-0.0172085048020863,0.0063539398059974,-0.0296622268218412,-0.0047547827823314,0.00677164395892377
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASN,Vasorin,39251,0.0067800124213757,0.00251008448954976,0.00186024682185817,0.0116997780208932,0.00691873145595842
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,39307,0.0106714438538205,0.00395579599434218,0.00291808370490986,0.0184248040027312,0.00699048393325546
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1B,Meprin A subunit beta,39485,-0.0290482775887586,0.0107877800385853,-0.0501923264643858,-0.0079042287131314,0.00709541253984903
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA,Lymphotoxin-alpha,39462,-0.00987495367359447,0.00366863906732166,-0.0170654862455449,-0.00268442110164401,0.00711631363163215
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST3,Cystatin-C,39497,-0.0068728507639643,0.00255440864376366,-0.0118794917057411,-0.00186620982218752,0.0071405865316999
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,39589,-0.0109626556678139,0.00407616112957933,-0.0189519314817893,-0.00297337985383836,0.00716470348434042
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,39439,-0.00496831355348848,0.00184990897007045,-0.00859413513482657,-0.00134249197215039,0.00724562329618083
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFA,Protransforming growth factor alpha,39462,0.0117367280224809,0.00437478494691462,0.0031621495265282,0.0203113065184335,0.00730858710856249
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2,Complement C2,39498,0.00587673176406344,0.00219103953938888,0.00158229426686124,0.0101711692612657,0.00732270230192952
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",36992,-0.0120420248688675,0.00449172692904168,-0.0208458096497891,-0.00323824008794578,0.00735129564257547
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,39393,-0.00980126521451059,0.00365797853316309,-0.0169709031395102,-0.00263162728951094,0.00738303579727956
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,39355,-0.023102868703707,0.00862666883016899,-0.0400111396108382,-0.00619459779657573,0.00741277535556433
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,39485,0.00653581478716367,0.00244573955568654,0.00174216525801805,0.0113294643163093,0.00754085478984574
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,39571,0.0103832683223256,0.00389162228894109,0.00275568863600111,0.0180108480086502,0.00763610917664605
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,37247,-0.00663386396241979,0.00249387727179539,-0.0115218634151387,-0.00174586450970083,0.00782240515612281
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,36808,-0.0231903158992633,0.0087193295261402,-0.0402802017704981,-0.00610043002802853,0.00783241136496229
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,39428,-0.0052682679478385,0.001984716400517,-0.00915831209285182,-0.00137822380282519,0.00795291962081651
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",39531,-0.0148697272489615,0.00560306075892572,-0.0258517263364559,-0.00388772816146711,0.00796607944790174
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD244,Natural killer cell receptor 2B4,39636,-0.00640556248692113,0.00241751332039285,-0.0111438885948911,-0.00166723637895114,0.00806588206962452
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A11,Protein S100-A11,39342,-0.0108510963241539,0.00409827653047012,-0.0188837183238753,-0.00281847432443244,0.0081121541409063
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,37162,-0.0069996783652972,0.00264695518143265,-0.0121877105209052,-0.00181164620968921,0.00819300316666766
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPO,Myeloperoxidase,39455,-0.0112728563857821,0.00426564561035937,-0.0196335217820864,-0.00291219098947771,0.00823313101386485
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_A,,37221,0.0078623636604616,0.00297669785492199,0.0020280358648145,0.0136966914561087,0.00826881884147671
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,36916,-0.0100020023905324,0.00378859166925552,-0.0174276420622732,-0.0025763627187916,0.00830015132996536
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGR1,Prostaglandin reductase 1,37247,-0.0190624353450499,0.00722553365852656,-0.033224481315762,-0.00490038937433782,0.00834471870262543
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,36880,-0.00958127811211778,0.00364022488344014,-0.0167161188836605,-0.0024464373405751,0.00849745923294638
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP5,Platelet glycoprotein V,36955,0.00851809682478613,0.00323800205532338,0.00217161279635229,0.01486458085322,0.00853226180108405
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",36955,-0.0246972802631686,0.00938993670705509,-0.0431015562089965,-0.00629300431734061,0.00854427207969159
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP1,Guanylate-binding protein 1,37193,-0.0152735972076673,0.00581532724979818,-0.0266716386172718,-0.0038755557980629,0.00863868969209775
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK8,Kallikrein-8,38959,-0.00844372544932188,0.00321973771676325,-0.0147544113741779,-0.00213303952446591,0.00873814063953895
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37164,-0.0244587576113875,0.00934178426554192,-0.0427686547718497,-0.00614886045092534,0.00884970642200645
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELL,L-selectin,37269,0.0055007548110007,0.00210108409153451,0.00138262999159306,0.00961887963040834,0.00885363849833867
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,37203,-0.00635657187306105,0.00243185816360196,-0.0111230138737209,-0.00159012987240121,0.00896271265742224
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,36847,0.00479905476105932,0.00184078929982213,0.00119110773340795,0.00840700178871069,0.00914317710290369
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPE,Carboxypeptidase E,39482,0.00903194838863007,0.00346868839232575,0.00223331913967161,0.0158305776375885,0.0092273416766173
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,39123,-0.0125370938952772,0.00482133095832697,-0.0219869025735981,-0.00308728521695638,0.00932251355001506
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,36763,-0.0118972083106829,0.00457675964554288,-0.0208676572159469,-0.00292675940541882,0.00934757569716081
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,39455,0.00863979848786755,0.00332603497263721,0.00212076994149861,0.0151588270342365,0.00939620661333907
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTO1,Protein LTO1 homolog,39194,-0.00979053418312035,0.00377029028114279,-0.0171803031341602,-0.00240076523208048,0.0094201436408586
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,38907,-0.00726888757494443,0.00280523776697419,-0.0127671535982138,-0.00177062155167501,0.00957424109945928
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,39289,-0.00828999811829544,0.00320324048348997,-0.0145683494659358,-0.00201164677065511,0.00966280443394957
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFR,Epidermal growth factor receptor,39654,0.00385926305574926,0.00149229781708339,0.000934359334265808,0.00678416677723271,0.00971548833596111
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,36992,-0.0101744565168058,0.00393423457296327,-0.0178855562798138,-0.00246335675379778,0.00971709293463829
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,36861,-0.0126857605952456,0.00493548667697314,-0.022359314482113,-0.00301220670837826,0.010172133833552
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,39322,-0.00666153327457451,0.00259629215599736,-0.0117502659003293,-0.00157280064881969,0.0103039044120689
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN1,Ficolin-1,37224,-0.0131044375535362,0.00510946021298375,-0.0231189795709843,-0.00308989553608803,0.0103366334753723
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,36955,-0.0157011760512189,0.00612409252377392,-0.0277043973978158,-0.00369795470462206,0.0103637914398653
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAB2,Disabled homolog 2,39601,-0.0257032922789663,0.0100300203662787,-0.0453621321968725,-0.00604445236106004,0.0103976619764456
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,39516,0.0198331670500015,0.00774401896308574,0.00465488988235349,0.0350114442176496,0.0104439384103425
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF2,Fibroblast growth factor 2,39462,-0.0154705848227574,0.00604098263310008,-0.0273109107836335,-0.00363025886188123,0.0104486730621288
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39123,-0.0158680610588469,0.00620475310806909,-0.0280293771506623,-0.00370674496703149,0.0105556280900954
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,39477,-0.00617504009382844,0.0024160896579501,-0.0109105758234106,-0.00143950436424624,0.0106041760823513
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37221,-0.0109911695721423,0.00430193096872779,-0.0194229542708487,-0.00255938487343579,0.010632144212142
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,39462,-0.0152207891805152,0.00596247106145581,-0.0269072324609686,-0.00353434590006181,0.010696955917927
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMS1,PMS1 protein homolog 1,36861,-0.0121357821417917,0.00475732579444958,-0.0214601406989129,-0.00281142358467053,0.0107543379985368
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCB,Tubulin-folding cofactor B,39355,-0.0233473946883024,0.00915964959289978,-0.041300307890386,-0.00539448148621885,0.0108150311656414
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEC31A,Protein transport protein Sec31A,36916,-0.0176142197162997,0.00691511545111621,-0.0311678460004874,-0.00406059343211188,0.010870856804093
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,36763,-0.0153849332109967,0.00605806769118029,-0.0272587458857101,-0.00351112053628335,0.0111108333456645
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,39194,-0.0137678017415682,0.00542698360002682,-0.0244046895976207,-0.00313091388551561,0.0111935982634919
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,39531,-0.00550998084964055,0.00217329245285421,-0.0097696340572348,-0.0012503276420463,0.0112446427237528
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,37203,-0.00764185703309688,0.00301482699363773,-0.0135509179406268,-0.00173279612556693,0.0112643557362895
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37203,-0.00889700597664126,0.00351577375347015,-0.0157879225334427,-0.00200608941983978,0.0113987910424726
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,39531,-0.016724363113025,0.00661369869770478,-0.0296872125605264,-0.00376151366552361,0.0114572006181494
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,39654,-0.00596970697425518,0.00236083004049992,-0.010596933853635,-0.00134248009487532,0.0114603279929745
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,39182,0.00953806055739637,0.00377466557788274,0.0021397160247462,0.0169364050900465,0.0115190379867904
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,36916,-0.0128018872858838,0.00506631020874381,-0.0227318552950217,-0.00287191927674597,0.0115208060065624
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,39123,-0.017640717993774,0.00698434336352825,-0.0313300309862894,-0.00395140500125864,0.0115555390415111
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",39455,-0.00871826232811453,0.00345353719280635,-0.015487195226015,-0.00194932943021408,0.0115983629784907
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGA,Chromogranin-A,37255,-0.0208101733283935,0.00825162804216123,-0.0369833642910296,-0.00463698236575753,0.0116827375954628
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT1,Angiopoietin-1,39390,-0.0194639608778757,0.00772786554527856,-0.0346105773466217,-0.00431734440912973,0.0117901802777128
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,39568,0.00519646186482164,0.00206456122199866,0.00114992186970426,0.00924300185993901,0.0118467729071494
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,37247,-0.00886149298615079,0.00352203368934867,-0.0157646790172742,-0.00195830695502739,0.0118811187050401
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO1,R-spondin-1,39355,0.00810176592207606,0.00322146007199367,0.00178770418096847,0.0144158276631836,0.0119158361525256
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,39123,-0.0111720624755076,0.00444241675833709,-0.0198791993218483,-0.00246492562916691,0.0119185214751937
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",36916,-0.0221815363031008,0.00882244387442561,-0.039473526296975,-0.0048895463092266,0.0119422009492757
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,39337,0.0092117133905525,0.00367194148854532,0.00201470807300368,0.0164087187081013,0.0121289836023145
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,39123,-0.0138124008449103,0.00550732119063732,-0.0246067503785594,-0.00301805131126115,0.0121521287848555
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,39642,-0.0125846337203907,0.00501963262920419,-0.0224231136736309,-0.00274615376715054,0.0121835803745945
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN6,Dynactin subunit 6,39104,-0.0161704887542992,0.00645495126534534,-0.0288221932343761,-0.00351878427422237,0.0122514221362413
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR2,Complement receptor type 2,39526,-0.0105892045964941,0.00422784130458611,-0.0188757735534829,-0.00230263563950533,0.0122682092130129
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37162,-0.0244729054472395,0.00978430670399417,-0.0436501465870681,-0.0052956643074109,0.0123883844221101
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,36823,-0.0196665546528958,0.00786502825832184,-0.0350820100392066,-0.00425109926658504,0.0124144179669597
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROK1,Prokineticin-1,39462,0.0156017151323365,0.00623985012747769,0.00337160888248027,0.0278318213821928,0.0124181742990247
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,39123,-0.00802670084145121,0.00321444315266475,-0.0143270094206741,-0.00172639226222831,0.0125331735707895
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,37221,-0.0258009436391901,0.0103327202179722,-0.0460530752664155,-0.00554881201196466,0.0125369079305539
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,36847,-0.0191432970283507,0.00766794032902104,-0.034172460073232,-0.00411413398346946,0.0125541379692006
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,39485,-0.0058503584444058,0.00234450616544577,-0.0104455905286795,-0.00125512636013209,0.0125940081991361
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOC,Myocilin,39455,-0.0104298453898115,0.00418287835324144,-0.0186282869621648,-0.00223140381745832,0.0126611239776121
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,37221,-0.0266003194374438,0.0106946400860282,-0.0475618140060591,-0.00563882486882852,0.0128858998898298
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39123,-0.019148502396384,0.00770198118788342,-0.0342443855246355,-0.00405261926813249,0.0129233479860056
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP7,Matrilysin,39160,-0.0109695379390786,0.00441634364355323,-0.0196255714804429,-0.0023135043977143,0.0130080801148737
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,37162,-0.00927192849632495,0.00373773659481954,-0.0165978922221712,-0.00194596477047866,0.0131280146249107
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD70,CD70 antigen,39462,0.0093611308610625,0.003789415004287,0.00193387745265999,0.016788384269465,0.0135096244646084
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,36831,-0.00908914335744488,0.00368082156836753,-0.0163035536314452,-0.00187473308344452,0.013550228640708
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10,Interleukin-10,39194,0.01918750233823,0.00777129630863084,0.00395576157331351,0.0344192431031464,0.0135595359892015
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,39355,-0.0157002312416259,0.0063626862105304,-0.0281710962142655,-0.00322936626898632,0.0136153641676566
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,36916,0.00584841526945817,0.00237193353862296,0.00119942553375718,0.0104974050051592,0.0136889354972247
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK7,Kallikrein-7,36651,-0.00868541836101409,0.00352744123877912,-0.0155992031890212,-0.00177163353300701,0.0138208220418131
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNR,Tenascin-R,39355,0.0095219315719414,0.00387428952695696,0.00192832409910576,0.017115539044777,0.0139933880532402
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,39541,-0.00710646244305102,0.00289414047517313,-0.0127789777743903,-0.00143394711171169,0.0140814174469648
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,36847,-0.0137327219514527,0.00559316227552774,-0.0246953200114871,-0.00277012389141832,0.0140915258576835
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PF4,Platelet factor 4,37195,-0.0216272251712093,0.00881932574113869,-0.0389131036238411,-0.00434134671857747,0.0142097642068445
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,39355,-0.00775489823254711,0.00316415447035796,-0.0139566409944487,-0.00155315547064551,0.0142629613023235
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAA4,Serum amyloid A-4 protein,37269,-0.00722045048594786,0.0029552577976332,-0.0130127557693089,-0.00142814520258679,0.0145688191969082
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX8,Syntaxin-8,39462,-0.0108083082127741,0.00444034211032614,-0.0195113787490133,-0.00210523767653487,0.0149397867788465
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,39194,0.00901026818169757,0.00370554734251876,0.0017473953903608,0.0162731409730343,0.0150457052728279
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,39654,-0.00693089379879848,0.00285159541250804,-0.0125200208073142,-0.00134176679028273,0.0150881646888427
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37128,-0.00689699570584487,0.0028413429154252,-0.0124660278200783,-0.00132796359161148,0.0152224958785528
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL34,Interleukin-34,39079,-0.00793196363746488,0.00327038487683176,-0.0143419179960551,-0.00152200927887463,0.0153039075691117
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH7,Protocadherin-7,37164,-0.00765805293273701,0.0031613014980955,-0.0138542038690042,-0.00146190199646984,0.0154306948794812
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,36847,-0.0147753907161883,0.00610334469146312,-0.026737946311456,-0.00281283512092055,0.0154977764628801
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSG,Basigin,39623,-0.00445886357548901,0.00184483882182547,-0.00807474766626693,-0.000842979484711079,0.0156633421993672
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,37247,-0.0197772306032191,0.00818263882233891,-0.0358152026950034,-0.00373925851143486,0.0156640009157966
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,37162,0.00980985449003238,0.00406237871999512,0.00184759219884195,0.0177721167812228,0.0157576401797251
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYDGF,Myeloid-derived growth factor,37247,-0.0218942741422681,0.0091014704378211,-0.0397331562003975,-0.00405539208413877,0.0161611153137369
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGB,Secretogranin-1,39524,0.00884378191426495,0.00367860810500568,0.00163371002845382,0.0160538538000761,0.0162238450343129
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,39355,-0.0173301542762999,0.00721571831579176,-0.0314729621752518,-0.00318734637734809,0.0163302389094152
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK11,Kallikrein-11,39389,-0.00650104423968871,0.00270814299956193,-0.0118090045188301,-0.00119308396054732,0.0163824181629305
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL21,C-C motif chemokine 21,39541,-0.00934738718417012,0.00389389392811771,-0.0169794192832808,-0.0017153550850594,0.0163836345648034
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSHB,Follitropin subunit beta,36916,-0.0151376270794436,0.00630668312778418,-0.0274987260099006,-0.00277652814898661,0.0163983732538151
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM2,Junctional adhesion molecule B,39589,-0.00570908925280865,0.00237971005279098,-0.010373320956279,-0.00104485754933833,0.016448822161392
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CERT,Ceramide transfer protein,39104,-0.0134571045461473,0.0056095896419133,-0.0244519002442974,-0.00246230884799722,0.0164547408117039
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL11,Interleukin-11,39194,-0.014008875224311,0.00584554168215586,-0.0254661369213365,-0.00255161352728556,0.0165646056192671
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA4,Carboxypeptidase A4,36709,-0.00957626333517531,0.003995974853863,-0.0174083740487468,-0.00174415262160383,0.0165684054034675
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNMT,Histamine N-methyltransferase,39274,-0.010138507046049,0.0042401627722592,-0.0184492260796771,-0.001827788012421,0.0168119516249373
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,39104,-0.0144701659343726,0.00605508397462578,-0.0263381305246391,-0.00260220134410606,0.0168721871039539
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,37203,-0.012180872994876,0.00509786794011193,-0.0221726941574953,-0.00218905183225656,0.0168901125439015
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,39355,-0.00754106496285536,0.00316140036995564,-0.0137374096879684,-0.00134472023774231,0.0170750252934526
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,36880,-0.0122506073650673,0.00513607970271293,-0.0223173235823846,-0.00218389114774997,0.0170844621262754
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,39194,-0.0130266441082085,0.00546539119066513,-0.0237388108419121,-0.00231447737450484,0.0171624557025947
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPLAH,5-oxoprolinase,36916,-0.0146779891346987,0.00617019297563382,-0.026771567366941,-0.00258441090245638,0.0173815164690039
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,39206,-0.00646237671075126,0.00272175119275846,-0.0117970090485578,-0.00112774437294467,0.017592826540165
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF1,Trefoil factor 1,39390,-0.0167655630944965,0.00707736250206231,-0.0306371935985386,-0.00289393259045436,0.0178537284224565
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,37247,-0.00539044167197814,0.00227561713556249,-0.00985065125768063,-0.000930232086275655,0.0178615189834167
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,39516,0.0190591791242138,0.00806434090111601,0.00325307095802644,0.0348652872904012,0.0181212476497265
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF8,SLAM family member 8,39123,0.011543751167096,0.00488594443873946,0.00196730006716666,0.0211202022670253,0.0181580266906971
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,37203,-0.00989890714871273,0.00419139322843495,-0.0181140378764452,-0.00168377642098023,0.0182052044951946
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,36847,-0.0100418004891667,0.00425930176817154,-0.0183900319547829,-0.00169356902355043,0.018408130681399
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP9,Caspase-9,36880,-0.0133846649547873,0.0056789651476432,-0.0245154366441679,-0.00225389326540658,0.0184444021546135
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LUZP2,Leucine zipper protein 2,37162,-0.00958385068416309,0.00406778238225905,-0.0175567041533908,-0.00161099721493534,0.018486115789712
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37203,-0.020595301496487,0.00876098742997521,-0.0377668368592384,-0.0034237661337356,0.0187484040598025
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37247,-0.0130998438913732,0.00559908244012884,-0.0240740454740257,-0.00212564230872069,0.0193175698030684
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTF1,Cardiotrophin-1,39187,-0.0180515572355373,0.00771593846164852,-0.0331747966203684,-0.00292831785070623,0.0193220564657843
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,39601,-0.00806875114331635,0.00345433127239527,-0.0148392404372111,-0.00129826184942162,0.0195127705373438
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,36847,-0.0142452725084382,0.00610250137445237,-0.0262061752023648,-0.00228436981451155,0.0195941623376066
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37221,0.00908191750017434,0.00390364589317434,0.00143077154955263,0.016733063450796,0.0200062935158332
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,36775,-0.0115580660761521,0.00497105600747853,-0.02130133585081,-0.00181479630149415,0.0200842354998632
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37162,-0.0115555114379069,0.00497290604050315,-0.0213024072772931,-0.00180861559852076,0.02015759538951
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,39462,-0.0112216272244817,0.00483107441454847,-0.0206905330769967,-0.0017527213719667,0.0202031140562031
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD160,CD160 antigen,39636,0.00963041749184443,0.00415507578769301,0.00148646894796614,0.0177743660357227,0.0204762593898023
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK2,Protein AHNAK2,36916,-0.005969759561053,0.00258809810296682,-0.011042431842868,-0.000897087279238039,0.0210923163024832
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB9,Serpin B9,39355,-0.00700165596242123,0.00303713688266063,-0.0129544442524361,-0.0010488676724064,0.0211607855891919
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN2,Prefoldin subunit 2,39104,-0.0117422014239,0.00510557387255152,-0.021749126214101,-0.00173527663369904,0.0214690719949668
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,39123,-0.0092835251259143,0.00403980891127344,-0.0172015505920102,-0.00136549965981836,0.0215751651927777
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP2,Caspase-2,39462,-0.0141249611404284,0.00616639803988297,-0.026211101298599,-0.00203882098225782,0.0219983868566704
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,36823,-0.0163107590223851,0.00712865956102095,-0.0302829317619862,-0.00233858628278406,0.0221511577627325
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGRN,Neugrin,37203,-0.00455800632410857,0.00199249359848085,-0.00846329377713103,-0.000652718871086114,0.0221777678110199
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPACAM2,HEPACAM family member 2,37203,-0.00844508935377314,0.00369469152360592,-0.0156866847400407,-0.00120349396750553,0.0222860400209486
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,36861,-0.0151639749114113,0.00663795649816451,-0.0281743696478137,-0.00215358017500884,0.0223628304828078
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP3,Caspase-3,39654,-0.0182871951288223,0.00800754351445227,-0.0339819804171488,-0.00259240984049591,0.0224001935795023
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST6,Cystatin-M,39136,-0.00997275744926025,0.00436833309091158,-0.0185346903074469,-0.00141082459107356,0.0224465753943922
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,39636,-0.00726226705697764,0.00318162601333641,-0.013498254043117,-0.00102628007083828,0.0224697878820796
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,37203,-0.00551701143292914,0.00241775432530642,-0.0102558099105297,-0.000778212955328559,0.0225131644563486
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,37164,-0.0112078480257815,0.0049149279574031,-0.0208411068222916,-0.0015745892292714,0.022602307623853
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,39104,-0.0133863046417574,0.00587142521983124,-0.0248942980726266,-0.00187831121088817,0.0226274970896874
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,39654,0.00322751222409498,0.00141598461314372,0.000452182382333288,0.00600284206585667,0.0226605794236124
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,39123,-0.00835656938373781,0.00367673150824456,-0.0155629631398972,-0.00115017562757846,0.023051090988626
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD69,Early activation antigen CD69,39414,-0.0181568053426747,0.0080001175265179,-0.0338370356946498,-0.00247657499069962,0.0232480157375095
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,39601,-0.00523588456662283,0.00230787711994477,-0.00975932372171457,-0.000712445411531086,0.0233004829582005
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,39541,-0.017661769394485,0.00778708581250571,-0.0329244575869962,-0.00239908120197379,0.0233381221679276
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37255,-0.012831122532519,0.00565906679133108,-0.0239228934435279,-0.00173935162151003,0.023385046526252
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPS,Calcyphosin,37203,-0.0194758809455966,0.00859195551597228,-0.0363161137569022,-0.0026356481342909,0.0234217097820708
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUCB2,Nucleobindin-2,39561,-0.00765705106502889,0.00338536320723543,-0.0142923629512103,-0.00102173917884745,0.0237232438026773
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,36861,0.0101242457973165,0.00448256086315127,0.00133842650554,0.018910065089093,0.0239264841854316
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,36880,0.00657853394296512,0.00291771402862911,0.000859814446852061,0.0122972534390782,0.0241702711929776
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,36916,0.0129319897163402,0.00573985270661108,0.00168187841138252,0.0241821010212979,0.0242753472321899
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRN1,Secernin-1,39462,-0.0115265107234195,0.00512119901945428,-0.0215640608015499,-0.00148896064528915,0.0244161338868698
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPD52L2,Tumor protein D54,36955,-0.0219262409553215,0.00975407171502216,-0.041044221516765,-0.00280826039387811,0.0245995083220455
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,36992,-0.0187976699151096,0.00836386318359293,-0.0351908417549517,-0.00240449807526742,0.0246262604708516
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37247,-0.0183440255693557,0.00816439643867282,-0.0343462425891544,-0.00234180854955692,0.0246677557213182
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEFTY2,Left-right determination factor 2,39568,-0.0105607292957597,0.00470264260232167,-0.0197779087963102,-0.00134354979520925,0.0247375521815927
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,36847,-0.00931924714252875,0.00415318160616539,-0.0174594830906129,-0.00117901119444459,0.024857610227382
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",36992,-0.00909513294082008,0.00405752635217903,-0.017047884591091,-0.00114238129054919,0.0250081331735735
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THTPA,Thiamine-triphosphatase,37146,-0.0179958815673674,0.00803600672014445,-0.0337464547388506,-0.00224530839588433,0.0251467588511856
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLM2,Protein GOLM2,39589,-0.0045692147256861,0.00204132465080392,-0.00857021104126179,-0.000568218410110408,0.0252122178508796
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,36823,0.0125459651667138,0.00560919201897338,0.00155194880952595,0.0235399815239016,0.0253250381252502
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,36955,-0.00816397552345754,0.00365884223694606,-0.0153353063078718,-0.000992644739043263,0.025678907252617
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,39485,-0.0257450279821685,0.0115444253313395,-0.0483721016315939,-0.00311795433274306,0.0257566308388617
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS6,Growth arrest-specific protein 6,39551,0.00521675008911867,0.00234122436760959,0.000627950328603881,0.00980554984963346,0.0258808836143436
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APP,Amyloid-beta precursor protein,39435,-0.0135824808732525,0.00609627938534864,-0.0255311884685358,-0.00163377327796917,0.0258956248476881
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,37164,-0.0175814092041681,0.00794175267135027,-0.0331472444400146,-0.00201557396832154,0.0268605940411547
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA3,Annexin A3,39564,-0.0140424105744114,0.00635034839807664,-0.0264890934346416,-0.00159572771418114,0.0270312327131077
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,39187,-0.0106247093536135,0.00481142686131415,-0.0200551060017892,-0.00119431270543775,0.0272439870120484
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,36882,-0.00774891039289308,0.00350916118256401,-0.0146268663107185,-0.000870954475067616,0.0272489042990338
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN2,Nectin-2,39458,-0.00579453849941506,0.00263027007614008,-0.0109498678486496,-0.000639209150180499,0.0276084565382319
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,36823,-0.0154501168175778,0.00701630237371944,-0.0292020694700679,-0.00169816416508772,0.0276814894906194
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,36992,-0.00734582180292002,0.00334323676032458,-0.0138985658531562,-0.000793077752683846,0.0280230665051088
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,36929,-0.0107337594010539,0.00489943407610752,-0.0203366501902246,-0.00113086861188314,0.0284835302307194
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,36916,0.00530279214361307,0.00242104832829779,0.000557537420149401,0.0100480468670767,0.0285218462793545
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,39296,0.00642037236979632,0.00294149665139881,0.000655038933054654,0.012185705806538,0.0290743367820631
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,39187,-0.0110021579255106,0.00506153915184586,-0.0209227746631285,-0.00108154118789271,0.0297451700053845
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39123,-0.00997142289455403,0.00460210836477127,-0.0189915552895057,-0.000951290499602336,0.0302732044406743
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,36916,-0.0143147719551443,0.00660719373711648,-0.0272648716798926,-0.00136467223039603,0.0302885745439772
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,37221,-0.00690326268740288,0.00319134952267563,-0.0131583077518471,-0.000648217622958643,0.030550670526633
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK12,Kallikrein-12,39123,0.0282327311762876,0.0130757194740512,0.00260432100714724,0.053861141345428,0.0308529598891786
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSPN,Persephin,39462,-0.0195499258260366,0.00905854878451223,-0.0373046814436806,-0.00179517020839267,0.0309301011643609
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,39428,-0.00543022250590453,0.00251725494142674,-0.0103640421911009,-0.000496402820708119,0.0310059369988545
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ULBP2,UL16-binding protein 2,39355,-0.00732216373387415,0.00339561909109521,-0.0139775771524208,-0.000666750315327539,0.0310718217926205
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,37229,0.00947278286833289,0.00440062515510953,0.000847557564318206,0.0180980081723476,0.0313688450875798
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39123,-0.0238419980106284,0.0110800579321567,-0.0455589115576555,-0.00212508446360137,0.0314298802617276
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPA33,Cell surface A33 antigen,39428,-0.0266387156671215,0.0123981849777716,-0.0509391582235539,-0.00233827311068906,0.0316822625552565
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFB,Complement factor B,37040,0.0063870051620084,0.00297497374475674,0.000556056622285191,0.0122179537017316,0.0318193781887864
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,39541,-0.00556788776080202,0.00259735089096091,-0.0106586955070854,-0.000477080014518636,0.0320745143057944
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12A_IL12B,Interleukin-12,39428,-0.0152973514181203,0.00714248781108062,-0.0292966275278383,-0.00129807530840229,0.0322304987891395
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAX,Integrin alpha-X,36992,-0.0107050420552686,0.0049997353909088,-0.0205045234214498,-0.000905560689087297,0.0322834427260739
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,36847,0.00750082340244503,0.00350599280773788,0.000629077499278782,0.0143725693056113,0.0324203979543773
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,37241,0.0036088004458211,0.00168910052786259,0.000298163411210431,0.00691943748043178,0.0326558130416892
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAP3,Cytosol aminopeptidase,39194,-0.00950884241201025,0.00445228322382016,-0.0182353175306978,-0.000782367293322728,0.0327184502143221
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,37162,0.0111592010376211,0.00523406767923991,0.000900428386310844,0.0214179736889313,0.0330233144463616
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37164,-0.00581469040477957,0.00272885855853452,-0.0111632531795072,-0.000466127630051919,0.0331235928827174
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,39531,-0.00487216644210584,0.00228801236639325,-0.0093566706802366,-0.000387662203975079,0.0332346982358994
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LF,CMRF35-like molecule 1,39601,0.0117846029892252,0.00553716770331208,0.000931754290733527,0.0226374516877169,0.0333305720431527
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,39654,0.00804317085753266,0.00378031605553501,0.000633751388684035,0.0154525903263813,0.0333825681814572
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP8,Neutrophil collagenase,39564,0.0141491077946332,0.00666611371405321,0.00108352491508887,0.0272146906741774,0.0338084464161711
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,39589,-0.00445441326432027,0.00209993429579552,-0.00857028448407948,-0.000338542044561052,0.03391987524598
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,39194,-0.00774507480647907,0.00365732652678841,-0.0149134347989843,-0.000576714813973788,0.0342182320388266
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN9,Septin-9,39428,-0.005434093512715,0.00256794208609314,-0.0104672600014576,-0.000400927023972449,0.0343503983628953
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY6D,Lymphocyte antigen 6D,39391,0.00720012779498196,0.00340297620894497,0.000530294425449821,0.0138699611645141,0.0343755520882134
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,39079,0.0103500866387777,0.00489778220448157,0.000750433517993795,0.0199497397595615,0.034598913648569
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,36919,-0.00927757215130222,0.00439189856517425,-0.0178856933390437,-0.000669450963560681,0.0346695336408375
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,36916,-0.0118734055961624,0.00562156527236185,-0.0228916735299917,-0.00085513766233321,0.0346962243901253
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJP3,Tight junction protein ZO-3,36823,0.00851242222380843,0.00403062377153388,0.000612399631602025,0.0164124448160148,0.0347118721736877
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAM,Basal cell adhesion molecule,39455,0.00457023055440073,0.00216439222489076,0.000328021793614835,0.00881243931518662,0.0347412318986573
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA10,Annexin A10,39104,-0.015859407628031,0.00751335726170868,-0.03058558786098,-0.00113322739508194,0.0348039629547266
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,39458,-0.00935674794768033,0.00443999294382636,-0.01805913411758,-0.000654361777780658,0.0351012856219787
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,36955,-0.0212746100130566,0.010105103534553,-0.0410806129407805,-0.00146860708533273,0.0352822074120253
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,37164,-0.0122749853984312,0.00583289763588788,-0.0237074647647715,-0.000842506032090974,0.0353596305702152
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,39104,0.00933735364276603,0.00444153508902784,0.000631944868271469,0.0180427624172606,0.0355457113879826
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD302,CD302 antigen,39428,-0.00574878317779601,0.00273546650677037,-0.0111102975310659,-0.00038726882452609,0.035607338907117
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGCR6,Protein DGCR6,36823,-0.0087111425156058,0.00414865152209305,-0.0168424994989082,-0.000579785532303419,0.0357707968759615
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APCS,Serum amyloid P-component,37146,-0.00680347651153533,0.00324110245472873,-0.0131560373228037,-0.000450915700267013,0.0358256541891917
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12B,Interleukin-12 subunit beta,39636,-0.0103481403891146,0.00493101758684274,-0.0200129348593263,-0.000683345918902789,0.0358703178014759
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",39440,-0.0208941152740473,0.00995660120918086,-0.0404090536440418,-0.0013791769040528,0.0358760285826035
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFAP,Glial fibrillary acidic protein,39102,0.00899866382494586,0.00428847803641535,0.000593246873571778,0.0174040807763199,0.0358926367765533
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",36847,0.00843335697406993,0.00402387780882986,0.000546556468763403,0.0163201574793765,0.0361176547810439
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OBP2B,Odorant-binding protein 2b,39312,0.0126089798112427,0.00603866913419181,0.000773188308226789,0.0244447713142587,0.0368112535781961
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1S,Complement C1s subcomponent,37269,-0.00392858970749842,0.00188383296922327,-0.00762090232717604,-0.000236277087820802,0.037050601530173
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC5D,Netrin receptor UNC5D,36880,0.00499805775543614,0.00239796911896147,0.000298038282271647,0.00969807722860062,0.0371543679649292
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,36880,-0.00622738923802814,0.00298971517640854,-0.0120872309837889,-0.000367547492267393,0.0372773330114052
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",36880,-0.00840915053778571,0.00404081167567928,-0.0163291414221171,-0.000489159653454321,0.0374493151716285
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,36916,-0.0053292870775792,0.0025611419722783,-0.0103491253432447,-0.000309448811913735,0.0374703384061048
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,39355,-0.00557199183285221,0.00268284941366213,-0.01083037668363,-0.000313606982074431,0.0378285037095617
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYGD,Gamma-crystallin D,37203,-0.0180641001422049,0.00869945394603179,-0.0351150298764272,-0.00101317040798258,0.0378710692251849
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLU,Clusterin,37269,0.00621920669160656,0.00299566141318318,0.00034771032176753,0.0120907030614456,0.0379072424931494
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,39654,0.00425046819685612,0.00205774341820051,0.000217291097183115,0.00828364529652912,0.0388834754679513
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASS1,Argininosuccinate synthase,36847,-0.015076583392807,0.00730101310384183,-0.029386569076337,-0.000766597709277025,0.038943859176302
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,36955,-0.0233958948592433,0.0113380184911977,-0.0456184111019909,-0.0011733786164958,0.0390866296580554
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTH3,Cytohesin-3,36763,-0.0139439557743614,0.00676085496665399,-0.0271952315090033,-0.000692680039719628,0.0391854151950044
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,36916,0.00702163158379772,0.00340489319260017,0.000348040926301393,0.013695222241294,0.0392076755298487
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,36823,0.00628495805204409,0.00304964954377074,0.000307644946253441,0.0122622711578347,0.0393354603893955
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,37162,-0.00724979907027467,0.00351945780129333,-0.0141479363608096,-0.000351661779739748,0.0394265697200889
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37247,-0.00615515479922028,0.00298864522599765,-0.0120128994421757,-0.000297410156264883,0.0394652710669786
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,39636,-0.0071692843392457,0.00348118583074779,-0.0139924085675114,-0.000346160110980021,0.0394693653173528
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM,Paralemmin-1,37093,-0.00548359951820234,0.00266466209825255,-0.0107063372307774,-0.000260861805627337,0.0396205014998237
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,37164,-0.0102427197190429,0.00498580280553673,-0.0200148932178949,-0.000470546220190901,0.03995959511754
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,39354,0.0109228011832171,0.00532166066684204,0.000492346276206741,0.0213532560902276,0.0401368310458639
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,39531,-0.0083815351671783,0.00408388911116517,-0.016385957825062,-0.000377112509294574,0.0401537082812023
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,37164,-0.00968564381395157,0.00472133876129414,-0.0189394677860881,-0.000431819841815055,0.0402424890144245
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBZ,Hemoglobin subunit zeta,37247,-0.0195533543070344,0.00953503869311319,-0.0382420301455362,-0.000864678468532509,0.0403180244424975
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,39151,0.00966235561785457,0.00471788426895606,0.000415302450700693,0.0189094087850084,0.0405750565622022
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,36852,-0.0109714076342373,0.00536196217960184,-0.0214808535062569,-0.000461961762217685,0.0407621341979561
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOB,Elongin-B,36847,-0.00746968102475804,0.00365369139078621,-0.014630916150699,-0.00030844589881706,0.0409331214423773
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",36916,-0.0160479085081636,0.00786376497913295,-0.0314608878672642,-0.000634929149063077,0.0412975912093456
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM132A,Transmembrane protein 132A,36916,-0.0116657331148376,0.00571985923554393,-0.0228766572165037,-0.000454809013171546,0.0414197976631185
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,39601,-0.00626922222137024,0.00307475851985178,-0.0122957489202797,-0.000242695522460748,0.04147417945709
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,36916,-0.0188724803111565,0.00926689434118346,-0.0370355932198761,-0.000709367402436937,0.0417163939801327
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,36847,0.00757747537010005,0.00372271251289761,0.00028095884482073,0.0148739918953794,0.0418246757235145
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB1,Heat shock protein beta-1,39256,-0.012479149855366,0.00613228240370373,-0.0244984233666253,-0.000459876344106691,0.0418693871765083
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,39415,-0.00637302655641987,0.00313460593907842,-0.0125168541970136,-0.000229198915826173,0.0420581270167346
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAN,Aggrecan core protein,39356,0.00524753613816188,0.00258135369012283,0.000188082905521136,0.0103069893708026,0.0420841423374584
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37162,-0.00942079987075472,0.00463570714929011,-0.0185067858833633,-0.00033481385814611,0.0421516357864037
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,39187,0.00609381496236643,0.00300047446725449,0.000212885006547629,0.0119747449181852,0.042277937435481
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,36916,-0.0055618366606154,0.0027407673738234,-0.0109337407133093,-0.000189932607921533,0.0424490452839113
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,39355,-0.00930881175447415,0.00459817192262768,-0.0183212287228244,-0.000296394786123887,0.0429407184596872
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YY1,Transcriptional repressor protein YY1,36880,-0.00514853274010222,0.00254586642360534,-0.0101384309303687,-0.000158634549835753,0.0431656486737328
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN1,Tetraspanin-1,39187,-0.00559158420697592,0.00276548293833919,-0.0110119307661207,-0.000171237647831104,0.0432026925636077
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,36847,-0.0214671307811151,0.0106245892946978,-0.0422913257987229,-0.000642935763507341,0.0433515686344516
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYZL2,Lysozyme-like protein 2,36763,-0.00661345051388146,0.00327721621426091,-0.0130367942938328,-0.00019010673393007,0.0436120143062299
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,39355,-0.00757282993377072,0.00375280895612823,-0.0149283354877821,-0.000217324379759378,0.0436185420387566
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF830,Zinc finger protein 830,37162,-0.0148833452532325,0.00737747002418853,-0.029343186500642,-0.000423504005822941,0.0436742396065179
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCT,Secretin,36861,-0.00848723926663827,0.00421303993603965,-0.016744797541276,-0.000229680992000563,0.0439768467073146
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX1,Neuronal pentraxin-1,39455,-0.00726166497956056,0.00360548651375871,-0.0143284185465276,-0.0001949114125935,0.0440210842200669
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,36992,-0.00981373859742044,0.00487938592337951,-0.0193773350072443,-0.000250142187596605,0.0443188204328273
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",36763,-0.00929618576135712,0.00462381361832086,-0.018358860453266,-0.000233511069448232,0.044399868693086
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL21R,Interleukin-21 receptor,36880,-0.0102501784894343,0.00510402100921379,-0.0202540596674933,-0.000246297311375283,0.0446377394441849
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,36847,-0.0095382037117583,0.00475062056032683,-0.0188494200099989,-0.000226987413517711,0.0446882741268221
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPG,Macrophage-capping protein,39306,-0.0105940229269901,0.00527879358049442,-0.0209404583447591,-0.000247587509220991,0.0447781541823829
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37164,-0.0162798949008698,0.00811694841683613,-0.0321891137978686,-0.000370676003870987,0.044912949683574
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C5,Complement C5,37269,0.00279404524868664,0.00139557722701925,5.87138837289058e-05,0.00552937661364437,0.0452980857186627
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,39541,-0.02406905658871,0.0120238545751192,-0.0476358115559436,-0.000502301621476332,0.0453267594066246
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,36847,0.00521784575600121,0.00260665511901167,0.000108801722738333,0.0103268897892641,0.0453344581450727
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,39428,-0.00819243943615316,0.00409374783164856,-0.0162161851861843,-0.000168693686121992,0.0453880291538554
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAFB2,Scaffold attachment factor B2,37221,-0.00506218320041271,0.00252995110879905,-0.0100208873736589,-0.000103479027166566,0.0454241248830159
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH12,Protocadherin-12,37221,-0.00465412249147043,0.00232719443630399,-0.00921542358662625,-9.28213963146077e-05,0.0455337693115772
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANG,Angiogenin,39436,-0.00626513094581872,0.003134862391612,-0.0124094612333782,-0.000120800658259196,0.0456767682532955
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,36847,-0.0113326470005973,0.00567246576206403,-0.0224506798942428,-0.000214614106951829,0.0457564340893542
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,37162,-0.00513184590656969,0.00256916873516504,-0.0101674166274932,-9.62751856462161e-05,0.0457950718486793
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,37162,-0.00642718357598929,0.00322001842457224,-0.0127384196881509,-0.000115947463827702,0.0459543163673489
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWF,von Willebrand factor,39654,0.012951597306761,0.0064983113867467,0.000214906988737447,0.0256882876247845,0.0462714946473912
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37164,0.0184182406757394,0.00924978753203478,0.000288657112951209,0.0365478242385275,0.0464795134417824
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPN1,Epsin-1,36992,-0.00802381999486559,0.00403085636400295,-0.0159242984683114,-0.0001233415214198,0.0465466224896211
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,39462,-0.00615892475371269,0.00310470102414821,-0.0122441387610432,-7.37107463821976e-05,0.0473028349344087
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,39428,0.00648904361881824,0.00327507755684798,6.98916073961948e-05,0.0129081956302403,0.0475713663869001
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE4,Ribonuclease 4,36853,-0.0049182521303884,0.00248786913826292,-0.00979447564138372,-4.20286193930867e-05,0.0480757944049192
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVALB,Parvalbumin alpha,39532,0.0203225119007922,0.0102823041270323,0.000169195811808905,0.0404758279897755,0.0481214540936384
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNLZ,DNL-type zinc finger protein,36823,0.0171176513186312,0.00868346667165041,9.80566421964375e-05,0.0341372459950661,0.0487126988078702
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN5,Contactin-5,39492,0.00664987795110946,0.00337418034852438,3.64844680016789e-05,0.0132632714342172,0.048763596101557
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37221,-0.00849124837807819,0.00431127419898788,-0.0169413458080944,-4.11509480619365e-05,0.0489121274513741
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,39487,0.0088839945487914,0.00451317668001055,3.81682559707202e-05,0.0177298208416121,0.0490338136660592
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,37145,-0.0074278123454551,0.00377653126960411,-0.0148298136338792,-2.58110570310532e-05,0.0492240333175346
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,39194,-0.00689805843897198,0.00351006848736196,-0.0137777926742014,-1.8324203742536e-05,0.0494074726601854
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,39123,0.0083763475319197,0.00426611600247269,1.47601670732207e-05,0.0167379348967662,0.0496116231034273
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,36823,0.012720936824845,0.00648304378561447,1.41710050406401e-05,0.0254277026446494,0.0497632336365826
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IST1,IST1 homolog,37081,-0.0178114104113902,0.00908226432952903,-0.0356126484972671,-1.017232551331e-05,0.0498869651744925
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDM1,Nuclear protein MDM1,36861,-0.00560039673213656,0.00285586571062096,-0.0111978935249536,-2.89993931946834e-06,0.0498995545893502
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAPPA,Pappalysin-1,39194,-0.0083872711567232,0.00428290505737667,-0.0167817650691815,7.22275573508332e-06,0.0502120579053668
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,39531,-0.0121899323629846,0.00624665215834966,-0.0244333705933499,5.35058673807459e-05,0.0510238736059806
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,36847,-0.0123634626689882,0.00634351205151432,-0.0247967462899562,6.98209519798959e-05,0.0513187492205737
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,39068,-0.00775670589653549,0.00398249448344611,-0.0155623950840899,4.89832910188816e-05,0.0514699481396561
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLI2,Zinc finger protein GLI2,36880,0.00587084840156648,0.00301753548002705,-4.35211392865375e-05,0.0117852179424195,0.0517280568382807
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,36823,-0.0176305292221683,0.00906391674044215,-0.0353958060334349,0.000134747589098344,0.0517815235462674
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG3,Proteoglycan 3,37255,0.008809173545829,0.00454005810189781,-8.9340333890707e-05,0.0177076874255487,0.0523625248243058
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDRG1,Protein NDRG1,39104,-0.0121026283656355,0.00623822675107247,-0.0243295527977375,0.000124296066466537,0.0523897266773532
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL6,Fc receptor-like protein 6,39462,-0.0119694153114759,0.00617339810133593,-0.0240692755900944,0.000130444967142467,0.052535910096597
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,36916,-0.0144769768123286,0.00748644968168954,-0.0291504181884401,0.000196464563782897,0.0531655865225939
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PENK,Proenkephalin-A,36955,-0.0054152993581848,0.00280161288689629,-0.0109064606165015,7.58619001319273e-05,0.0532683533166544
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,36992,-0.00794467874114547,0.00411501705841349,-0.0160101121756359,0.00012075469334496,0.0535482344750484
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX2,Neuronal pentraxin-2,37255,0.00571748172343295,0.0029647174738145,-9.33645252434653e-05,0.0115283279721094,0.0538140383592016
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXTL1,Exostosin-like 1,36847,-0.00838045456944779,0.00434654595319303,-0.0168996846377061,0.000138775498810558,0.0538689579747592
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,39123,-0.009928655753625,0.00515420341397418,-0.0200308944450144,0.000173582937764405,0.0540834684876604
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,39194,0.00855695170928349,0.00444563320443153,-0.000156489371402314,0.0172703927899693,0.0542736913403859
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1B,Lithostathine-1-beta,39654,-0.00980006677396763,0.00509204450854904,-0.0197804740107238,0.000180340462788493,0.0543000790668324
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN4,Nectin-4,39531,0.00535844113304953,0.0027886542198885,-0.000107321137931934,0.010824203404031,0.0546856303084048
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,39455,0.00603886323774244,0.00314344986091107,-0.000122298489643267,0.0122000249651281,0.0547387621119287
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMP,Olfactory marker protein,36823,-0.00891352429860363,0.00464761329795494,-0.0180228463625953,0.000195797765388061,0.0551503252181177
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,36847,0.00909690273398061,0.00475151009096005,-0.000216057044301088,0.0184098625122623,0.0555756240814254
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,39608,-0.0055962822820158,0.00292317427918306,-0.0113257038692146,0.000133139305183003,0.055580997118339
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,39462,-0.0105487039480622,0.0055200043767533,-0.0213679125264986,0.000270504630374299,0.0560241774896363
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM106A,Transmembrane protein 106A,37162,-0.0121647502703569,0.00636924968065989,-0.0246484796444503,0.000318979103736456,0.0561661429345203
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17D,Interleukin-17D,39194,-0.00585744659946431,0.00306906515579716,-0.0118728143048267,0.000157921105898123,0.0563403129310661
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY2,Protein canopy homolog 2,39187,-0.0106143907613116,0.00556542915970997,-0.0215226319143431,0.000293850391719941,0.0565140190041012
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,39365,-0.00514122102835672,0.00270450346001106,-0.0104420478099784,0.000159605753264966,0.0573232115629224
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELENOP,Selenoprotein P,37269,0.00390226258494689,0.00205354747483541,-0.000122690465730515,0.0079272156356243,0.0574221628039038
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA11,Integrin alpha-11,39462,0.00587866136244129,0.00310173408938663,-0.000200737452756505,0.0119580601776391,0.0580742215993112
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM25,Transmembrane protein 25,37221,-0.00752448873178353,0.00397240131977574,-0.015310395318544,0.000261417854976929,0.0582221753563515
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EP300,Histone acetyltransferase p300,36880,-0.00512765799798235,0.00271672222904342,-0.0104524335669075,0.000197117570942759,0.0591240638167653
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD84,SLAM family member 5,39462,0.00527449842473241,0.00279784368346413,-0.000209275194857271,0.0107582720443221,0.0594219696295812
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,36992,-0.00635581452543698,0.00337217975426379,-0.012965286843794,0.00025365779292005,0.0594827482560677
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,38992,-0.0207426277019388,0.0110162140380717,-0.0423344072165594,0.000849151812681755,0.0597314274322609
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,39123,-0.0085111025025125,0.00452910038257999,-0.0173881392523693,0.000365934247344289,0.0602364814936437
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACYBP,Calcyclin-binding protein,36928,-0.0174228057664015,0.00927462144346712,-0.0356010637955971,0.000755452262794061,0.0603297685775031
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",37247,-0.00809537736701267,0.00431835762761232,-0.0165593583171328,0.000368603583107476,0.0608646655853222
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGF,Beta-nerve growth factor,39355,-0.00208959266405769,0.00111504847407079,-0.00427508767323643,9.59023451210582e-05,0.060950985795826
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,36992,-0.0101139621406117,0.00539843294439972,-0.0206948907116352,0.000466966430411764,0.0610226632015841
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPK2,Death-associated protein kinase 2,36880,-0.00889881179818042,0.00475622249025749,-0.0182210078790851,0.000423384282724253,0.0613709056632231
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN3,CCN family member 3,39641,-0.00577568691428717,0.00309024553959797,-0.0118325681718992,0.000281194343324844,0.061641234285918
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F12,Coagulation factor XII,37269,-0.00707248152431061,0.00378714256713905,-0.0144952809559031,0.000350317907281924,0.0618548692752661
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR5,Proline-rich protein 5,36880,-0.0081379702227813,0.00435913015295905,-0.016681865322581,0.000405924877018436,0.0619419607827822
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,37164,-0.0048939026033014,0.00262581666672602,-0.0100405032700844,0.000252698063481601,0.0623778893173487
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,36847,-0.00866507873562932,0.00466729102727222,-0.0178129691490829,0.000482811677824243,0.0633983159080599
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS9,Galectin-9,39470,-0.00542732700803577,0.00292405836300815,-0.0111584813995317,0.000303827383460191,0.0634597425950355
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,36763,-0.0131075671455654,0.00706503160055597,-0.0269550290826551,0.000739894791524273,0.0635810419571759
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,36971,-0.00947263637708875,0.00510908476166772,-0.0194864425099575,0.000541169755779987,0.0637516526749779
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,37162,-0.0103412017387348,0.00558176751132094,-0.0212814660609238,0.000599062583454258,0.0639521051077652
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300A,CMRF35-like molecule 8,36955,-0.00496131469579715,0.00267804732091608,-0.0102102874447927,0.000287658053198378,0.0639651784409418
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,39123,-0.00771184024898924,0.00416623970362348,-0.0158776700680913,0.000453989570112783,0.064185129738734
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,39455,0.00484199203907865,0.00261748754343581,-0.000288283546055529,0.00997226762421283,0.0643530217627144
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,39526,-0.00770671629719305,0.00416727911486265,-0.0158745833623238,0.000461150767937736,0.0644282850084385
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1R,Complement C1r subcomponent,37269,-0.00334031729338138,0.00180819412302968,-0.00688437777451954,0.000203743187756782,0.0647234757983389
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMFG,Glia maturation factor gamma,37247,-0.012005210751299,0.00650245818992011,-0.0247500288035424,0.000739607300944413,0.0648779393294343
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHD3,EH domain-containing protein 3,36916,-0.0195115410583183,0.0105853041303507,-0.0402587371538056,0.001235655037169,0.0653137741863635
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOH,Beta-2-glycoprotein 1,39455,0.00595145338258445,0.00323077861811402,-0.000380872708919031,0.0122837794740879,0.0654786125029287
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX18,Sorting nexin-18,37164,-0.00762018744500851,0.0041407631450675,-0.0157360832093408,0.000495708319323787,0.0657495914583719
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,36847,-0.0104018770102618,0.00566694098259682,-0.0215090813361516,0.000705327315627922,0.0664501799796451
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG4,Regenerating islet-derived protein 4,39499,-0.00810757632338742,0.00444374443698162,-0.0168173154198714,0.000602162773096561,0.0680975398142206
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,36823,0.00475633273444626,0.0026083771694093,-0.000356086517595959,0.00986875198648849,0.0682543116829135
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,39123,-0.0130220034750655,0.00714359942673125,-0.0270234583514588,0.00097945140132772,0.0683402355995568
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37247,-0.0161704669912317,0.00887224842819169,-0.0335600739104874,0.00121913992802402,0.0683889121177878
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTB,Lymphotoxin-beta,37162,-0.0058644106751742,0.00321793903385444,-0.0121715711815289,0.000442749831180499,0.068415982431354
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARCO,Macrophage receptor MARCO,39485,-0.00440239926215674,0.00241723469778595,-0.00914017926981721,0.000335380745503722,0.0685880651057177
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,39428,0.0104516356507858,0.00574148231210417,-0.00080166968093839,0.02170494098251,0.068722269597502
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,36916,-0.00535087863796441,0.00294569035662613,-0.0111244317369516,0.000422674461022813,0.0693160469527632
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,37247,-0.0116815298952165,0.00643256871739249,-0.0242893645813058,0.000926304790872729,0.069394120648619
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,39104,-0.00582086860266982,0.00320672642981242,-0.0121060524051022,0.000464315199762531,0.0695127148864998
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPTC,Opticin,39428,0.0074428896848171,0.00410182360780436,-0.000596684586479444,0.0154824639561136,0.0696158785982674
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1B,Interleukin-1 beta,39107,0.00929109419169297,0.00512148149292912,-0.000747009534448111,0.0193291979178341,0.0696763215772986
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,39187,-0.00966982648747087,0.0053428577357364,-0.0201418276495142,0.000802174674572472,0.0703378080585134
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,39455,-0.00448920282565177,0.002488298500098,-0.00936626788584385,0.000387862234540305,0.0712316799032642
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,36823,0.0133127771273367,0.00739378833394209,-0.0011790480071898,0.0278046022618632,0.0718004982150769
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,39428,-0.00348298317761851,0.00194008411637667,-0.00728554804571679,0.000319581690479772,0.0726301601692615
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD10,Frizzled-10,36861,-0.00999908699188847,0.00557566853879525,-0.0209273973279272,0.000929223344150224,0.0729424134086715
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON1,Spondin-1,39499,-0.00537063203055448,0.00300079196133744,-0.0112521842747759,0.000510920213666897,0.0735161088721124
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA6C,Semaphorin-6C,36880,-0.00426177182709375,0.00238211455205483,-0.00893071634912123,0.000407172694933722,0.0736277422575773
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,36955,-0.0141787454385712,0.00792613719327572,-0.0297139743373916,0.00135648346024922,0.0736616536451304
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,39194,0.00622096407147466,0.00348389387434796,-0.000607467922247348,0.0130493960651967,0.0741788683192403
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,39531,-0.014311407354364,0.00802168261607697,-0.0300339052818748,0.00141109057314686,0.0744290706095249
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100G,Protein S100-G,37221,0.0072126729086066,0.00404326205879559,-0.000712120726632751,0.0151374665438459,0.07446776754851
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,39636,0.00949131938420741,0.00532469272805302,-0.00094507836277651,0.0199277171311913,0.0746860352010497
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPO,Lactoperoxidase,38989,-0.00957034020663859,0.00536978729938523,-0.0200951233134337,0.000954442900156468,0.0747282210646428
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",39104,-0.00810256490773424,0.00454779794320631,-0.0170162488764186,0.000811119060950116,0.0748277240905549
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,36992,-0.0118427791147789,0.00665342257035495,-0.0248834873526746,0.0011979291231168,0.0751078701715818
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,39462,0.00762138691784039,0.0042827590766467,-0.000772820872387134,0.0160155947080679,0.0751697483187065
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,36861,-0.00577766868957093,0.00324746630801481,-0.01214270265328,0.000587365274138101,0.0752427232071993
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,37255,-0.00978677957807067,0.00550274056581304,-0.0205721510870642,0.000998591930922886,0.0753408592647233
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,39428,0.00384891377722046,0.0021647891637521,-0.000394072983733661,0.00809190053817458,0.0754303129851935
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,39456,-0.00285733155731565,0.0016083328463207,-0.00600966393610421,0.00029500082147292,0.0756576685014409
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,39559,-0.0131256711586847,0.00739464528905623,-0.027619175925235,0.00136783360786548,0.0759140933023697
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,37247,-0.0043748194377697,0.00246484598142623,-0.00920591756136512,0.000456278685825712,0.0759405614864678
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGMN,Legumain,39541,-0.00572074472656601,0.00322566931780926,-0.0120430565894722,0.000601567136340145,0.0761650213028597
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN2,Transcobalamin-2,39617,0.0048158069624151,0.00271878704976823,-0.000513015655130628,0.0101446295799608,0.0765297179966142
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAEP,Glycodelin,39355,0.0210991653231706,0.0119121150293729,-0.00224858013440028,0.0444469107807414,0.0765419218904091
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99,CD99 antigen,39455,0.00313905089322378,0.00177283444639445,-0.000335704621709343,0.00661380640815689,0.0766409524467765
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAG,S-arrestin,36823,-0.00863929922911498,0.00487944154264341,-0.0182030046526961,0.000924406194466097,0.0766600480570582
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,36861,0.00583646438215341,0.00330030839495166,-0.00063214007195185,0.0123050688362587,0.077008547402897
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,37203,-0.00454249603851514,0.00256985322923966,-0.00957940836782487,0.000494416290794592,0.0771501826252757
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTOA,Otoancorin,36823,0.00883379638897825,0.00500112170497143,-0.000968402152765748,0.0186359949307222,0.0773596242353103
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD9,COMM domain-containing protein 9,37162,-0.00632365135502878,0.00358546486228929,-0.0133511624851158,0.000703859775058231,0.0778080743605376
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL24,C-C motif chemokine 24,39516,-0.0132932581107684,0.00754693153512268,-0.0280852439196088,0.00149872769807206,0.078188926470012
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPSE,Heparanase,37114,-0.0148689783465007,0.00844879713976179,-0.0314286207404338,0.00169066404743243,0.078450105995719
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F3,Tissue factor,39510,0.0044827727686907,0.00254845210546455,-0.000512193358019825,0.00947773889540122,0.0785947828519684
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37203,-0.00998794298210371,0.00567821588559086,-0.0211172461178618,0.00114136015365439,0.0786026502136499
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,36823,0.012692802177036,0.00721756219923222,-0.0014536197334592,0.0268392240875311,0.0786702588171237
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,36847,-0.00616403503687345,0.00350787105083482,-0.0130394622965097,0.000711392222762786,0.0789082152888184
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED8,Protein TMED8,37164,-0.0163472273627833,0.0093107918594464,-0.0345963794072982,0.00190192468173163,0.0791587726944324
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,37249,0.00308982568786271,0.00176182404767318,-0.000363349445576712,0.00654300082130214,0.0794946867043897
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,37221,-0.0135446270228433,0.00773166728233844,-0.0286986948962267,0.00160944085054003,0.0798257061748651
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOSB,Protein fosB,39104,-0.00619878506571808,0.00354020321932016,-0.0131375833755856,0.000740013244149445,0.0799722250049773
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,39428,-0.00618278007632781,0.00353737406219494,-0.0131160332382299,0.000750473085574264,0.0805114364150176
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,39412,-0.005538793634009,0.00316974779190147,-0.0117514993061359,0.000673912038117884,0.0805897887011339
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6,Seizure protein 6 homolog,36861,0.00497360425374313,0.00284672704158001,-0.000605980747753696,0.0105531892552399,0.0806394038684908
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,39545,0.00334267273968556,0.00191503889343839,-0.000410803491453677,0.00709614897082479,0.0809207321969093
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB6,Serpin B6,39552,-0.00947411997028078,0.00543125117170163,-0.020119372266816,0.00117113232625442,0.081114670646939
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",36847,0.00785692405391738,0.00450515556158403,-0.00097318084678732,0.0166870289546221,0.0811864821242627
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA7,Carbonic anhydrase 7,36992,0.0055647786565958,0.00319314009534884,-0.000693775930287925,0.0118233332434795,0.0814054313959974
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMH,Granzyme H,39187,-0.0118806353330496,0.0068401403479384,-0.0252873104150088,0.0015260397489097,0.0824258353995039
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2,Microtubule-associated protein 2,37203,-0.00724669481747991,0.00417940998240719,-0.015438338382998,0.000944948748038187,0.0829593251753796
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",36847,-0.00992656365768015,0.00572655200891459,-0.0211506055951528,0.00129747827979245,0.0830445524758746
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",37203,-0.00955449972959557,0.0055231901814348,-0.0203799524852078,0.00127095302601664,0.0836745081632955
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,36955,-0.00397419766592412,0.00229843342019266,-0.00847912716950174,0.0005307318376535,0.0838177173627648
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,36287,-0.00790689498352892,0.00457846741612868,-0.0168806911191411,0.00106690115208331,0.0841983944478572
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,36847,0.00668770715403471,0.00388455907438416,-0.000926028631758243,0.0143014429398277,0.0851646089417226
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSB,Lupus La protein,39104,-0.00956931783005481,0.00555880523997243,-0.0204645761004008,0.00132594044029116,0.0851866348004777
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,36880,-0.0136753461692603,0.00794410723285233,-0.0292457963456509,0.00189510400713028,0.0851949331291191
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX6,Peroxiredoxin-6,39601,-0.00935028286592329,0.00543569511863176,-0.0200042452984415,0.00130367956659495,0.0854231978540949
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN1,Transcobalamin-1,37031,-0.00515114357403745,0.00299617720806809,-0.0110236509018509,0.000721363753776013,0.0855955324769277
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,37164,-0.00749168885710441,0.00436329501843994,-0.0160437470932467,0.00106036937903786,0.0860072447316104
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,36847,0.00500757526065119,0.00291908589226282,-0.000713833088183934,0.0107289836094863,0.0862859037514166
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,37203,-0.00555679967715182,0.00324717766195491,-0.0119212678945834,0.000807668540279807,0.0870554907658916
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH1,Protocadherin-1,39599,-0.00340344636960252,0.00199011470601847,-0.00730407119339872,0.00049717845419368,0.0872538148715112
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN1,Nectin-1,36880,-0.00496624396684124,0.00291103044633733,-0.0106718636416624,0.000739375707979921,0.0880314005414653
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,39462,-0.0155882754116803,0.00914046494563583,-0.0335035867051265,0.00232703588176592,0.0881379597121621
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,39123,-0.00584819942648205,0.00343114672220826,-0.0125732470020102,0.00087684814904614,0.0883192354981927
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,39432,-0.00293663887178781,0.00172443984305404,-0.00631654096417373,0.00044326322059811,0.0885977317168236
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL4,Delta-like protein 4,36916,-0.0131738997010938,0.00773841455643049,-0.0283411922316976,0.00199339282950993,0.0887047943604516
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECM1,Extracellular matrix protein 1,36932,-0.00571830208332243,0.00336060417700987,-0.0123050862702618,0.000868482103616916,0.0888609786923233
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEG1,Protein LEG1 homolog,36538,0.0107339641658601,0.00630953486521174,-0.00163272416995492,0.0231006525016751,0.0889257025052953
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,36916,-0.00947858986242,0.00558816993159002,-0.0204314029283364,0.00147422320349644,0.0898751498159998
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPN,Asporin,37247,0.00421264752035094,0.00248590575842983,-0.000659727766171528,0.0090850228068734,0.090173247144241
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB118,Beta-defensin 118,36823,0.00905574801516437,0.00535308249521519,-0.00143629367545741,0.0195477897057861,0.0907305706731483
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX5,Sorting nexin-5,36916,-0.00462238239042244,0.00273368351315514,-0.00998040207620652,0.000735637295361637,0.0908811192819307
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,36847,0.00394500532169245,0.00233689516181098,-0.000635309195457067,0.00852531983884196,0.0914095861039183
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",39541,-0.0169402852509941,0.0100601701829424,-0.0366582188095611,0.00277764830757294,0.0922223589412877
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,36955,-0.00437428421105308,0.002599414360396,-0.00946913635742924,0.00072056793532308,0.0924395482914484
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR1,Toll-like receptor 1,36880,0.00401431279317815,0.00238657084348818,-0.000663366060058693,0.00869199164641499,0.0925857859937624
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",36916,-0.0126411261907182,0.00752205506283135,-0.0273843541138676,0.00210210173243125,0.0928770519157293
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,37203,-0.0151998380953137,0.00905033642498992,-0.0329384974882939,0.00253882129766652,0.093083482760727
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,39428,-0.00492126276856377,0.00293136258116519,-0.0106667334276475,0.000824207890520005,0.0932058208154288
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,39187,-0.00967215372662233,0.00576634986853595,-0.0209741994689528,0.00162989201570814,0.0934963962198249
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD248,Endosialin,37255,0.00609535019751008,0.00363508014898224,-0.00102940689449511,0.0132201072895153,0.0936034380868191
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C3,Complement C3,36648,-0.00718682487528499,0.00428715240878343,-0.0155896435965005,0.00121599384593053,0.0936926868594418
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,39462,0.00501665270594558,0.00299281210213497,-0.000849259014238964,0.0108825644261301,0.093713238000277
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,36823,0.00880110796824873,0.00526441680090293,-0.00151714896152101,0.0191193648980185,0.094586960105433
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,39123,-0.00512023071801455,0.00306363767186857,-0.0111249605548769,0.000884499118847843,0.0946854988435777
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,39636,-0.00670439336389155,0.00401204055292689,-0.0145679928476282,0.00115920611984515,0.0947288164902953
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXDNL,Peroxidasin-like protein,37162,-0.00884254233110443,0.00529676230659642,-0.0192241964520334,0.00153911178982456,0.0950579993143196
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,39214,-0.00518486157434048,0.00311365614168337,-0.0112876276120399,0.00091790446335893,0.0958939935201518
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,36763,-0.00853984310390433,0.0051321443722429,-0.0185988460735004,0.00151915986569176,0.09613963714415
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37164,-0.0262264727693482,0.0157908698207668,-0.0571765776180512,0.00472363207935479,0.0967656088799936
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,37203,0.00987492484804941,0.00594630488314688,-0.00177983272291848,0.0215296824190173,0.0968018033287758
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,36992,-0.00613080859137737,0.00369529422364978,-0.0133735852697309,0.00111196808697621,0.0971235976839298
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGN,Mimecan,39455,0.00617389235834192,0.0037239413603974,-0.00112503270803698,0.0134728174247208,0.0973601858590815
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,37143,-0.0105646372688125,0.0063906090173116,-0.0230902309427433,0.00196095640511821,0.098325010909646
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD1,Bromodomain-containing protein 1,36992,0.00464754596635812,0.00281905911460912,-0.000877809898275755,0.010172901830992,0.0992513784270421
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37164,-0.00630387204721412,0.00382453591980881,-0.0137999624500394,0.00119221835561115,0.0993217637774319
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,39123,-0.00713095132056008,0.00432771397850467,-0.0156132707184292,0.00135136807730908,0.0994272659196539
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB1,Beta-crystallin B1,37247,-0.00969785647377596,0.00588774516965415,-0.0212378370062981,0.00184212405874616,0.0995567649612514
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,39187,-0.0120299569565216,0.00732240693943564,-0.0263818745578155,0.00232196064477227,0.100425679832773
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,36741,0.00767244543251874,0.00467084666881411,-0.00148241403835692,0.0168273049033944,0.10048631038218
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN3,Perilipin-3,39485,-0.00636273974816229,0.00387433997615804,-0.0139564461014321,0.00123096660510748,0.10055351033417
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,39499,0.003594439323504,0.00219056982846084,-0.00069907754027925,0.00788795618728724,0.100845398119696
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,39474,-0.0115544992659905,0.00705015031578061,-0.0253727938849205,0.00226379535293949,0.10125479507342
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGR,Progesterone receptor,36880,0.0154093869690229,0.00940566837647826,-0.00302572304887451,0.0338444969869202,0.101382657988193
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAM,Signal transducing adapter molecule 1,37162,-0.00559356651609615,0.00341958289003867,-0.0122959489805719,0.00110881594837964,0.101917673091049
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,39606,0.00497248852120117,0.00304092844868551,-0.000987731238222431,0.0109327082806248,0.102030493999365
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAX,Protein max,39104,-0.0155352721420294,0.00952427250372154,-0.0342028462493236,0.00313230196526485,0.102885590352448
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDK,Midkine,39475,0.00753230806616668,0.00462046925957802,-0.00152381168260624,0.0165884278149396,0.103079325369754
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTF,Ciliary neurotrophic factor,36823,0.00507055771338551,0.00311060814263101,-0.00102623424617127,0.0111673496729423,0.103108853247173
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFIC,Nuclear factor 1 C-type,37221,-0.00649247277577762,0.00398304497523585,-0.0142992409272399,0.00131429537568463,0.103120353530126
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,39455,-0.00436623430234901,0.00267909095324992,-0.00961725257071885,0.000884783966020841,0.103176457178497
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD48,CD48 antigen,39516,-0.0043448097740571,0.0026751089652058,-0.00958802334586046,0.00089840379774626,0.104362204716829
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBS,Cystathionine beta-synthase,36916,-0.00750801540469452,0.00462878293096635,-0.0165804299493886,0.00156439913999952,0.104822650802788
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD9,Enhancer of filamentation 1,36880,-0.00485986216634542,0.00299669892484125,-0.0107333920590343,0.00101366772634344,0.104884707616014
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,39654,0.00319640369850275,0.00197160114532157,-0.000667934546327522,0.00706074194333303,0.104990715754492
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,39608,-0.00668974284595384,0.00412818396807902,-0.0147809834233887,0.00140149773148104,0.105144640314217
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPB2,Coatomer subunit beta',36847,-0.00637397413109801,0.00393376243028038,-0.0140841484944476,0.00133620023225154,0.10518789094747
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,39428,-0.00790959122189725,0.00489423704169189,-0.0175022958236134,0.00168311337981885,0.10609310670298
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSMB,Beta-microseminoprotein,39370,0.0101872919207739,0.00630942869755753,-0.00217918832643887,0.0225537721679867,0.106415459786893
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TUBB3,Tubulin beta-3 chain,36823,0.00409962442261378,0.00254372336825121,-0.000886073379158584,0.00908532222438615,0.107060838560894
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,39485,-0.00644739823797298,0.00400823490521809,-0.0143035386522004,0.00140874217625448,0.107738395134993
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNLY,Granulysin,39455,0.00742688623678549,0.00461772103229868,-0.00162384698651991,0.0164776194600909,0.107780790279356
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPS10,40S ribosomal protein S10,36847,0.00620355655039768,0.00386463033590905,-0.00137111890798406,0.0137782320087794,0.108472316359901
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYT1,Synaptotagmin-1,37203,0.00576389381586664,0.00359486885889489,-0.00128204914756734,0.0128098367793006,0.108878437448315
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,39526,0.00484677755542932,0.00303202038048047,-0.00109598239031239,0.010789537501171,0.109945885345827
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,39428,-0.0168591246610244,0.0105479547163943,-0.0375331159051572,0.0038148665831084,0.109990393317773
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,37164,-0.0186943909420567,0.0117231286139412,-0.0416717230253814,0.004282941141268,0.110813401917724
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11,Coagulation factor XI,37076,-0.00442365114125083,0.00277564481613479,-0.00986391498087501,0.00101661269837335,0.111019721860965
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,36823,-0.00633376831055424,0.00397449853102889,-0.0141237854313709,0.00145624881026238,0.111050781343912
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL1,Fc receptor-like protein 1,39485,-0.00650532720441103,0.00410923073159751,-0.0145594194383421,0.00154876502952008,0.113419485815831
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIFBP,KIF-binding protein,39428,-0.0118323789324205,0.00747718059153101,-0.0264876528918213,0.00282289502698029,0.113564501192703
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",39355,-0.00841359783860889,0.00532229704523499,-0.0188453000472695,0.0020181043700517,0.113940240327826
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTTG1,Securin,36992,0.00597529279329562,0.00378248948193272,-0.00143838659129252,0.0133889721778838,0.114195103942851
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA11,Annexin A11,39433,-0.00962442289975112,0.00609636600652837,-0.0215733002725467,0.00232445447304448,0.114422614418077
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,36861,-0.00865618530500972,0.00548627122710126,-0.0194092769101282,0.00209690630010876,0.114639292203468
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKCQ,Protein kinase C theta type,39194,-0.0063419660896691,0.00402318654933518,-0.0142274117263661,0.00154347954702786,0.114965707407024
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,39123,-0.00683106980089546,0.00433367225197335,-0.0153250674147632,0.0016629278129723,0.114983439766905
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,39654,0.00420272391592294,0.00267342931135405,-0.001037197534331,0.00944264536617688,0.115963291559682
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,39194,-0.00877828466723688,0.00558582970293362,-0.0197265108849868,0.00216994155051301,0.116081645949122
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,36992,-0.0094581304659216,0.00601999230256171,-0.0212573153789425,0.00234105444709935,0.116180001118526
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,39104,-0.00465117200419176,0.00296197648758793,-0.0104566459198641,0.00115430191148058,0.116368472079039
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,39104,0.00734871163480792,0.0046824736990564,-0.00182893681534263,0.0165263600849585,0.116574497384796
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN15,Tetraspanin-15,36847,0.00731413696185758,0.0046629438568734,-0.0018252329976143,0.0164535069213294,0.116774537904464
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,39187,-0.00711750633621574,0.00453937103751624,-0.0160146735697476,0.00177966089731609,0.116914299357934
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK15,Kallikrein-15,37143,-0.0072829931186596,0.00464823372430033,-0.0163935312182883,0.00182754498096906,0.117179311116493
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37221,-0.011379538818136,0.00726819808738539,-0.0256252070694114,0.00286612943313931,0.11745263528771
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,36847,-0.0079216046282249,0.00506160013561721,-0.0178423408940346,0.00199913163758483,0.117599153699371
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,39355,-0.00864913034876047,0.00553257673199325,-0.0194929807434672,0.0021947200459463,0.118001022882794
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,39462,-0.00531389349832937,0.00340074390701252,-0.0119793515560739,0.00135156455941516,0.118175329025662
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,36992,-0.00772843222188313,0.00495060493096118,-0.017431617886567,0.00197475344280078,0.118523350116305
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLC,Galectin-10,39460,0.00930619560933191,0.00596229331410561,-0.00237989928631509,0.0209922905049789,0.118582207480075
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL3,Myosin light chain 3,36916,-0.0096500176400562,0.00620236958053765,-0.02180666201791,0.00250662673779759,0.119766818362399
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,36955,-0.00534479658517886,0.00343581642554824,-0.0120789967792534,0.00138940360889568,0.119825740624661
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,36823,-0.00856514128770393,0.00551041424982395,-0.0193655532173589,0.002235270641951,0.120125283105158
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,37162,-0.00576079305120719,0.00370783375492055,-0.0130281472108515,0.00150656110843709,0.120285284280813
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39068,-0.00674826380198125,0.00436416220386562,-0.0153020217215579,0.00180549411759535,0.122056006716066
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI3,Elafin,39208,-0.00753886319721533,0.00488623005258612,-0.0171158741002841,0.00203814770585346,0.122881508260872
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLN,Mesothelin,39395,-0.00764300562277623,0.00495579655881328,-0.0173563668780503,0.00207035563249779,0.123037539820345
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAG1,Dystroglycan,39541,-0.0066368796570793,0.00430552443767885,-0.0150757075549299,0.00180194824077125,0.123220985521886
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM17,Splicing factor 45,37221,-0.0106561636972313,0.00692662957487281,-0.024232357663982,0.00292003026951943,0.123967268416706
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP4,Caspase-4,36992,-0.023990385870063,0.0155943069915863,-0.0545552275735722,0.00657445583344621,0.123974443467372
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRGN,Neurogranin,37243,-0.0126065275882854,0.00821500702006838,-0.0287079413476195,0.0034948861710486,0.124913493329666
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,39187,-0.00849896986451223,0.00555056711012098,-0.0193780814003494,0.00238014167132489,0.125744041986437
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37164,-0.0106894380333277,0.00698380837347651,-0.0243777024453416,0.00299882637868628,0.125892423495622
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,36955,-0.0164188970909049,0.0107323142292515,-0.0374542329802379,0.00461643879842807,0.126077633965113
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,39123,-0.0106716818628168,0.00698775126944768,-0.0243676743509342,0.00302431062530065,0.126733266330546
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO1,Alpha-enolase,39424,0.0109837587612222,0.00720313180463158,-0.00313437957585567,0.0251018970983001,0.127315447365955
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSHB,Thyrotropin subunit beta,39485,0.0116779637563887,0.00766232413784337,-0.00334019155378431,0.0266961190665617,0.127510781004412
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,39636,-0.00505691583094063,0.00332089317098038,-0.0115658664460622,0.00145203478418092,0.127840147269316
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,36847,-0.00805247505490161,0.00530952966999094,-0.0184591532080838,0.00235420309828063,0.129391191602441
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX2,Sorting nexin-2,37162,-0.0106781957889941,0.00704980524685486,-0.0244958140728297,0.00313942249484141,0.12987844399975
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37221,0.00521424303674709,0.00344411647176941,-0.00153622524792096,0.0119647113214151,0.13006158496768
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC1,Glypican-1,39601,-0.00405235376115246,0.00268071940053746,-0.00930656378620588,0.00120185626390095,0.13063957926177
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,37221,-0.00948258575322086,0.00628512127097151,-0.021801423444325,0.0028362519378833,0.131391124000486
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37255,0.0190413260634625,0.0126232161194103,-0.00570017753058175,0.0437828296575067,0.131467398222022
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD2,Glutamate decarboxylase 2,36880,-0.00648144015333558,0.00429965861919429,-0.0149087710469564,0.00194589074028522,0.131725548301969
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH3,Neurexophilin-3,36880,-0.00414549119691608,0.00275216152749073,-0.00953972779079792,0.00124874539696576,0.132023957817555
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB37,Ras-related protein Rab-37,39194,-0.0114221122073003,0.00760336647780735,-0.0263247105038027,0.00348048608920216,0.133055505919149
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID2,Nidogen-2,39455,-0.0100609403684417,0.00673602770914822,-0.0232635546783722,0.00314167394148885,0.135300864501732
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR2,Toll-like receptor 2,36992,-0.00312352847808803,0.00209235611260138,-0.00722454645878674,0.000977489502610678,0.135507287594397
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL1,Growth-regulated alpha protein,39453,-0.0131915603473101,0.00885726297011509,-0.0305517957687357,0.0041686750741155,0.136416376979861
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,36861,-0.0057164128601587,0.00383824232699195,-0.0132393678210629,0.00180654210074551,0.136425671324683
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,39623,-0.00691139798744622,0.00464224418400871,-0.0160101965881033,0.00218740061321084,0.136559418543649
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300E,CMRF35-like molecule 2,39554,0.00540376037609619,0.0036325493268855,-0.00171603630459939,0.0125235570567918,0.136878744707381
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,39455,0.00487823200321878,0.00328004227993064,-0.00155065086544527,0.0113071148718828,0.136970685535003
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,37126,-0.0072167814266672,0.00485928853959538,-0.0167409869642741,0.00230742411093974,0.13752847121873
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,39462,0.00489276992346213,0.00329578329732796,-0.00156696533930066,0.0113525051862249,0.137682875060281
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",36957,-0.00888754601100592,0.00599429640382773,-0.0206363669625083,0.00286127494049643,0.138188082072666
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,37162,-0.0126655610905587,0.0085531420721726,-0.029429719552017,0.00409859737089958,0.138682535504683
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,39462,-0.00631413950987479,0.00426964623142023,-0.0146826461234584,0.00205436710370886,0.139203072796151
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3,Galectin-3,39499,-0.00397706295304587,0.00269136717577662,-0.00925214261756804,0.0012980167114763,0.139506071537005
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,36757,-0.00833194847023071,0.00564806298696727,-0.0194021519246866,0.00273825498422513,0.140187890562035
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,36861,0.00887885436101507,0.00602842550217099,-0.00293685962324007,0.0206945683452702,0.140821866730453
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCIN,Adseverin,36823,-0.00990272574952951,0.00672548155730906,-0.0230846696018553,0.00327921810279625,0.140933248269977
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,39654,0.00330679624299387,0.00224590085594766,-0.00109516943466354,0.00770876192065127,0.140941787873914
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,39104,-0.00974148385630062,0.00665205307652587,-0.0227795078862913,0.00329654017369008,0.143097221381435
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",36880,-0.00383323757030796,0.00262276998766359,-0.00897386674612859,0.00130739160551267,0.143897364980746
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,37255,-0.0109483232748385,0.00749320122857887,-0.0256349976828531,0.00373835113317604,0.144012285901282
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL8,C-C motif chemokine 8,39582,-0.00801346099851537,0.00549086689089156,-0.0187755601046628,0.00274863810763208,0.144471305235403
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,37243,-0.00342519936632505,0.00234764207493838,-0.00802657783320428,0.00117617910055417,0.144590884850877
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,36893,0.00451696646544705,0.00310292295290308,-0.00156476252224299,0.0105986954531371,0.145497101828128
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHCY,Adenosylhomocysteinase,39485,-0.00900563583307171,0.00618755282153056,-0.0211332393632716,0.00312196769712819,0.145567299656366
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,37030,-0.00591034915450392,0.00406505560632597,-0.0138778581429028,0.00205715983389497,0.145987741822655
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MILR1,Allergin-1,39194,-0.00659487946297666,0.00454513356663738,-0.0155033412535859,0.0023135823276326,0.146807836553086
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,36823,0.00563802429963282,0.00389197136052476,-0.0019902395669957,0.0132662881662613,0.147466439428282
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTBDN,Retbindin,39428,-0.00385539199026422,0.00266708266797087,-0.00908287401948712,0.00137209003895867,0.148325369125301
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,39359,-0.00337656260062886,0.00233813825940663,-0.00795931358906585,0.00120618838780814,0.148724991035313
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANPEP,Aminopeptidase N,39496,0.00372369951828854,0.00258536532898843,-0.00134361652652877,0.00879101556310586,0.149803588065957
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPS,Colipase,39434,0.0089812055113748,0.00624022202217871,-0.00324962965209548,0.0212120406748451,0.150102140043256
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,39571,0.00452733452022622,0.0031600015459803,-0.00166626850989517,0.0107209375503476,0.151964237430396
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH17,Protocadherin-17,39485,-0.00455136475248548,0.00318065234269644,-0.0107854433441705,0.00168271383919954,0.152464405341245
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF6,Fibroblast growth factor 6,36880,-0.00554148574956485,0.00388151502521703,-0.0131492551989902,0.00206628369986053,0.153414721533518
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSM,Oncostatin-M,39390,0.00939760584662159,0.00658901312361344,-0.00351685987566075,0.0223120715689039,0.153815956132807
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,37203,-0.00688129207992921,0.00483421007852704,-0.0163563438338422,0.00259375967398378,0.154628071942288
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,36880,-0.0083404873301118,0.00586893428242068,-0.0198435985236563,0.00316262386343273,0.155305607572973
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,36789,-0.00445615618573736,0.00313924553061213,-0.0106090774257371,0.00169676505426242,0.155778826781401
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",36823,-0.00422110357101948,0.00297563426806015,-0.0100533467364174,0.0016111395943784,0.156053719294917
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,36741,-0.0114974018044379,0.00810706957598683,-0.0273872581733721,0.00439245456449628,0.156159332724423
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,36916,0.00464604163628825,0.0032787536862013,-0.0017803155886663,0.0110723988612428,0.156503671607292
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL14,C-C motif chemokine 14,39436,-0.00504130977469191,0.00356247432727793,-0.0120237594561567,0.00194113990677283,0.157055651621329
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,37162,-0.00517933605344807,0.00366050051162945,-0.0123539170562418,0.00199524494934565,0.157114796089596
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR4,Proline-rich protein 4,36864,0.00884518189768513,0.00625430319819133,-0.00341325237076988,0.0211036161661401,0.157312017961501
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,36847,-0.00596844077987934,0.00422099922874196,-0.0142415992682136,0.00230471770845491,0.15739064428126
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,36955,0.00342220481649782,0.00242040214640727,-0.00132178339046044,0.00816619302345607,0.157416379866688
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROCR,Endothelial protein C receptor,36847,0.00471594630805545,0.00334075928116931,-0.00183194188303639,0.0112638344991473,0.158081365316234
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37164,-0.00655074290303551,0.00464272979355366,-0.0156504932984007,0.00254900749232966,0.158278538494768
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MN1,Transcriptional activator MN1,36861,0.00763584349185933,0.00542606508541526,-0.00299924407555459,0.0182709310592732,0.159377584361607
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",39187,-0.0108063592876653,0.00769575789211295,-0.0258900447562067,0.00427732618087607,0.160281304777701
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRING1,SREBP regulating gene protein,36763,-0.0073749417904471,0.00525624722871093,-0.0176771863587205,0.00292730277782633,0.160617839086434
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRDT,Bromodomain testis-specific protein,36847,-0.00473583375516477,0.00337781890442711,-0.0113563588078419,0.00188469129751237,0.160928650133305
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,36823,0.00732660791443768,0.00523397476700195,-0.00293198262888615,0.0175851984577615,0.16159314113565
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,39589,-0.00348172593837066,0.00248979636080963,-0.00836172680555753,0.00139827492881621,0.162014107408581
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCG22,Protein PBMUCL2,36847,-0.00677351617011456,0.004846443006648,-0.0162725444631446,0.00272551212291553,0.162250331687104
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,36955,0.0067737647033122,0.00484820830636282,-0.00272872357715893,0.0162762529837833,0.16238765259379
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTN,Neuroplastin,39123,-0.0107001672434762,0.0076749289133612,-0.0257430279136642,0.00434269342671171,0.163286931716604
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,39470,-0.0062855372205182,0.00450936095273146,-0.0151238846878719,0.00255281024683546,0.163372514353055
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,36823,-0.00814484215564511,0.00584388709843605,-0.0195988608685798,0.00330917655728956,0.163422049256698
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,37203,0.00449165087216421,0.00322464770023906,-0.00182865862030436,0.0108119603646328,0.163670650111478
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,39123,0.00627624347622522,0.00451465293683967,-0.00257247627998054,0.015124963232431,0.16449106165592
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,36861,0.00493117896827243,0.00355167069806664,-0.00203009559993817,0.011892453536483,0.16503682492089
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD55,Complement decay-accelerating factor,38957,-0.00333703105669336,0.00240425495394009,-0.00804937076641594,0.00137530865302923,0.16516783969761
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,39462,-0.0102161203493331,0.0073794818877635,-0.0246799048493496,0.00424766415068333,0.166258014681335
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN10,Ataxin-10,39104,0.00908639845241029,0.00658724472911757,-0.00382460121666015,0.0219973981214807,0.167794706757418
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,39516,-0.00958490180013607,0.00694876787652666,-0.0232044868381283,0.00403468323785618,0.167802073740742
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,37181,-0.00478397201797049,0.00347183665548427,-0.0115887718627196,0.00202082782677867,0.168246977048025
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",39428,-0.00750622712877288,0.00546574641859173,-0.0182190901092127,0.00320663585166692,0.169672977410069
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,36533,-0.0133755233796075,0.00977082628099501,-0.0325263428903577,0.00577529613114273,0.17104833064027
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORN4,MORN repeat-containing protein 4,36763,-0.00987326343107236,0.00722597355126924,-0.0240361715915601,0.00428964472941534,0.171851724720674
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMB,RGM domain family member B,39589,-0.0032313491175441,0.00236664994829331,-0.00786998301619898,0.00140728478111079,0.17215757190179
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,36763,0.0032658927267776,0.00239545174849841,-0.00142919270027928,0.00796097815383449,0.172790115726317
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,39187,-0.0060941230831219,0.00447064598971545,-0.0148565892229642,0.00266834305672038,0.172858748031122
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",36847,0.00714534849073056,0.00525018013991052,-0.00314500458349407,0.0174357015649552,0.173547261495752
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,39462,-0.00302212573356415,0.00222769914882885,-0.00738841606526871,0.0013441645981404,0.17492459628978
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,36880,-0.00523586616352102,0.00387071921057834,-0.0128224758162546,0.00235074348921251,0.176180699321469
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC16,Mucin-16,39428,-0.022997628789663,0.0170562554365869,-0.0564278894453733,0.0104326318660474,0.177569493778002
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,36861,0.00487664179379789,0.0036210184158541,-0.00222055430127614,0.0119738378888719,0.178082223021678
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,39258,0.0214459477165885,0.0159331180851883,-0.00978296373038069,0.0526748591635576,0.178323716435054
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA7A,Semaphorin-7A,39608,-0.00328596553869225,0.00244265294521942,-0.00807356531132231,0.0015016342339378,0.178566403867528
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN4,Prefoldin subunit 4,36763,-0.00663752691684327,0.00493733273717547,-0.0163146990817072,0.00303964524802065,0.178858456116564
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",39485,-0.00884518004611495,0.00660228181102745,-0.0217856523957288,0.00409529230349885,0.180358069794448
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB2,Plexin-B2,39592,-0.00284210257912713,0.00212335994869061,-0.00700388807856072,0.00131968292030645,0.180755856621347
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,36847,-0.0146258399140768,0.0109300601603494,-0.0360487578283616,0.00679707800020803,0.180878654128696
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,36847,-0.0107683779299563,0.00804986312539732,-0.0265461096557351,0.00500935379582245,0.18101571415501
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEO1,Neogenin,37221,-0.00260260247660136,0.00194571611353259,-0.00641620605912523,0.00121100110592251,0.181048575193958
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBN,Ameloblastin,39194,0.00364285666185634,0.00272376605628654,-0.00169572480846527,0.00898143813217796,0.181101726360588
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF7,SLAM family member 7,39462,-0.0070517370776774,0.0052753182563506,-0.0173913608601246,0.00328788670476978,0.181327275858302
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,36763,-0.00783581845168382,0.00587806034169906,-0.019356816721414,0.00368517981804634,0.182536149768877
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FADD,FAS-associated death domain protein,39485,-0.00925152021432199,0.00695374825674445,-0.0228808667975411,0.00437782636889713,0.183394689628913
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSG1,Tryptase gamma,36880,0.00328262610163201,0.00247077006314659,-0.00156008322213531,0.00812533542539934,0.184009576945293
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHC1,SHC-transforming protein 1,36763,-0.0141272605383107,0.0106465976733009,-0.0349945919779804,0.00674007090135905,0.184557360184609
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,37055,0.00743204262546486,0.00560464832760074,-0.00355306809663259,0.0184171533475623,0.184847243979221
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,37221,-0.0150640548262839,0.0113667365636163,-0.0373428584909719,0.00721474883840416,0.185103581381962
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,36992,-0.00936683371788744,0.00708312694182671,-0.0232497625238678,0.00451609508809292,0.186054095566535
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAVL4,ELAV-like protein 4,36823,-0.0105403559874966,0.00797086827648832,-0.0261632578094137,0.00508254583442045,0.186072806580798
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB1,Calbindin,39428,0.00514059954227352,0.00388825636356404,-0.002480382930312,0.012761582014859,0.186160543171906
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,39401,0.00403080307446717,0.00306382358268993,-0.00197429114760509,0.0100358972965394,0.18832447958606
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,37164,0.0135138650908465,0.0102721173269447,-0.006619484869965,0.0336472150516581,0.188336390439705
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIT2,Slit homolog 2 protein,39104,-0.0062500249961083,0.00477464716957733,-0.0156083334484799,0.00310828345626327,0.190554038809114
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,36992,-0.00415152057294465,0.00317289585915007,-0.0103703964568788,0.00206735531098948,0.19075058113508
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39123,0.00387676514974148,0.00296532409979886,-0.00193527008586429,0.00968880038534725,0.191108784673047
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,39194,-0.00761844422948914,0.00584022522186336,-0.0190652856643413,0.00382839720536305,0.192091083673474
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",39431,-0.00805453917023302,0.00618831160247969,-0.0201836299110932,0.00407455157062718,0.193082418875929
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSND,Barttin,36763,-0.0040383282640625,0.00310345954018003,-0.0101211089628154,0.00204445243469036,0.193202590725326
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,37243,0.00302310195489092,0.00232478822073486,-0.0015334829577494,0.00757968686753124,0.193495096730812
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,36847,-0.00793974006051531,0.00613553304894689,-0.0199653848364512,0.0040859047154206,0.195669248206841
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUK1,Guanylate kinase,36847,0.00475035999447828,0.00367725821906258,-0.00245706611488438,0.0119577861038409,0.196443170287276
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,37221,0.0055607171608029,0.00431004283908429,-0.0028869668038023,0.0140084011254081,0.197012652101598
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,36847,-0.0057222651060431,0.00444040104327873,-0.0144254511508694,0.00298092093878321,0.197532698285214
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,36916,0.00239487605500093,0.00185936075928372,-0.00124947103319515,0.00603922314319702,0.197766243207386
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,36823,0.00590694104274726,0.00459781813876459,-0.00310478250923134,0.0149186645947259,0.198911759209575
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB2,Calretinin,39104,-0.00369433329351783,0.00287646565880006,-0.00933220598476595,0.00194353939773028,0.199046558639569
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO6,Coronin-6,36823,0.00427704990863196,0.0033326840491754,-0.00225501082775182,0.0108091106450157,0.199388285963948
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,39104,0.00574593184169104,0.00448260273133476,-0.00303996951172509,0.0145318331951072,0.199922791074699
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF2,Trefoil factor 2,39516,-0.00659017156583697,0.00516378586464909,-0.0167111918605492,0.00353084872887525,0.201894372407402
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D2,DCN1-like protein 2,36763,-0.00939819958137125,0.00736453944128461,-0.0238326968862891,0.00503629772354659,0.201929330076694
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,36482,-0.00566078706297565,0.00444193616298533,-0.0143669819424269,0.00304540781647561,0.202547615031517
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37203,0.00300026399862385,0.0023624991632856,-0.00163023436141594,0.00763076235866363,0.20412438103945
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37162,-0.00898327487754503,0.00708342836957158,-0.0228667944819053,0.00490024472681527,0.204746186673094
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTL1,Cytokine-like protein 1,37255,0.0026534797865648,0.00209478940154511,-0.00145230744046362,0.00675926701359321,0.20528390690993
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC4,Syndecan-4,39485,0.0052155594904526,0.00412410254377778,-0.00286768149535185,0.0132988004762571,0.206015277431257
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY4,Protein canopy homolog 4,39428,-0.00859314296998786,0.00679545360574244,-0.021912232037243,0.00472594609726733,0.20605489252223
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,39589,0.00323047360327627,0.00255670093493253,-0.0017806602291915,0.00824160743574403,0.206417491290423
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL33,Interleukin-33,39194,-0.0044427550036918,0.00352293153366757,-0.0113477008096802,0.00246219080229663,0.20729420383509
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,39194,-0.00766985180110416,0.00609258433493365,-0.0196113170975741,0.0042716134953658,0.208092472330779
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,36847,-0.00410788052277263,0.00328839920325044,-0.0105531429611435,0.00233738191559824,0.211614160917745
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,36955,-0.00369385556780513,0.00295928336517811,-0.00949405096355422,0.00210633982794396,0.211971539123048
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,36763,-0.00675038420594828,0.00540955974663128,-0.0173531213093456,0.00385235289744904,0.212105321732521
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,37221,-0.00444720634364009,0.0035710640246155,-0.0114464918318865,0.00255207914460628,0.213027852565909
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,39428,-0.00352127970992238,0.0028290917422358,-0.00906629952470455,0.00202374010485978,0.213273323211122
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,39194,-0.00336146553758013,0.00270103985723627,-0.00865550365776322,0.00193257258260295,0.213332465239657
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,36763,-0.00505844327031785,0.00407158543047726,-0.0130387507140533,0.00292186417341758,0.214121236431153
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,36992,-0.00982508780105616,0.00791565229313267,-0.0253397662955962,0.00568959069348387,0.214546686237119
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,36880,-0.00424064635219422,0.00341678131346699,-0.0109375377265895,0.00245624502220107,0.214583688239364
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RYR1,Ryanodine receptor 1,36847,0.00384187527696025,0.00309803211804696,-0.0022302676744118,0.00991401822833229,0.214961209929355
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,36861,0.00361724602471165,0.00291751863345357,-0.00210109049685735,0.00933558254628065,0.21505932843118
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,38979,0.00978853496944655,0.00789558561340545,-0.00568681283282814,0.0252638827717212,0.215088713634299
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,39654,-0.00258206051387235,0.00208677670139341,-0.00667214284860344,0.00150802182085873,0.215978531886651
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSTN,Osteocrin,36861,-0.00480081356283287,0.00388093268008196,-0.0124074416157935,0.00280581449012777,0.216100941520642
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,39187,0.00364146618958987,0.0029453060165932,-0.00213133360293281,0.00941426598211255,0.216343520280802
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM1,Dynamin-1,37164,0.0126852925098727,0.0102769942433481,-0.00745761620708966,0.0328282012268351,0.217099509434646
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,36880,-0.00328678946360832,0.00266847566992889,-0.00851700177666894,0.00194342284945231,0.218080556190399
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF174,Zinc finger protein 174,36880,-0.00430104754571976,0.00349555506304893,-0.0111523354692957,0.00255024037785614,0.218558157148937
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,36955,-0.00704700492267748,0.00574488190501649,-0.0183069734565098,0.00421296361115484,0.219974286693401
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGLL,Monoglyceride lipase,39516,-0.00962732772005274,0.00784966742166506,-0.0250126758665163,0.00575802042641078,0.220043609713843
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,36763,0.0107201780248324,0.00875027859614969,-0.00643036802362097,0.0278707240732858,0.220551869024565
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,36861,0.00334079304663616,0.00272824329987957,-0.0020065638211278,0.00868814991440012,0.220778741734174
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,37203,-0.00660505229991146,0.00539918689977034,-0.0171874586234613,0.00397735402363841,0.221223143032155
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",39455,0.00416102184818327,0.00340352408490284,-0.00250988535822631,0.0108319290545928,0.221514085453258
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,39104,-0.00773051377437367,0.0063245392101204,-0.0201266106262096,0.0046655830774623,0.221612098350075
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS2,Growth arrest-specific protein 2,36992,-0.00600255260034269,0.00491362416055234,-0.0156332559550253,0.00362815075433989,0.221876555137832
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC2,Mucin-2,37255,-0.0100425328948578,0.00822746478305751,-0.0261683638696505,0.00608329807993497,0.222255870838706
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",36916,0.00377570071314321,0.00309629394764332,-0.00229303542423771,0.00984443685052412,0.222705699108515
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",36763,0.00545875927617688,0.0044773966400981,-0.0033169381384154,0.0142344566907692,0.222798660145648
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REST,RE1-silencing transcription factor,36763,-0.00397524556526586,0.00326456948183347,-0.0103738017496595,0.00242331061912773,0.223363745149853
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XCL1,Lymphotactin,39601,-0.00624853336938019,0.00513477014723806,-0.0163126828579668,0.00381561611920641,0.223658883146957
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,36861,0.00463593353278383,0.00381006940058632,-0.00283180249236535,0.012103669557933,0.223719334955104
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,37221,-0.00867384088158444,0.00712965376594784,-0.0226479622628422,0.00530028049967332,0.223784049242764
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37221,-0.00294391371726091,0.00242151194320562,-0.00769007712594392,0.0018022496914221,0.224108850917888
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,39355,0.0115820037445004,0.00953968018932509,-0.00711576942657677,0.0302797769155776,0.224733660513975
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG4,Desmoglein-4,39374,-0.00561311858825289,0.00463275272739242,-0.014693313933942,0.00346707675743627,0.225678488784405
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,36916,-0.00580168562013877,0.00478989674342313,-0.0151898832372481,0.00358651199697057,0.225828713463789
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,37164,-0.00287901625152279,0.00237782561017752,-0.00753955444747072,0.00178152194442514,0.226003441976444
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,39541,-0.00311686922882623,0.00257578816363855,-0.00816541402955779,0.00193167557190534,0.226273187422932
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2,Prothrombin,37269,-0.00162155221278326,0.00134008615327667,-0.00424812107320554,0.00100501664763903,0.226287474013587
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA12,Carbonic anhydrase 12,39428,0.00356278159510123,0.00294490374509121,-0.00220922974527755,0.00933479293548,0.226369914405495
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMB,Granzyme B,39462,0.00692605719088937,0.00573279359037031,-0.00431021824623644,0.0181623326280152,0.227009770329144
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO2,Gamma-enolase,39589,-0.00722127904885192,0.00599025057534566,-0.0189621701765294,0.00451961207882557,0.228027122355772
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLGAP5,Disks large-associated protein 5,37221,-0.00583010516161219,0.00485437092895392,-0.0153446721823619,0.00368446185913749,0.229773024988376
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP3,Stromelysin-1,39455,0.00527803276977936,0.00441257620726057,-0.00337061659645136,0.0139266821360101,0.231663144320536
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,36861,0.00736225522333867,0.00615882569096649,-0.00470904313095564,0.019433553577633,0.231953947181841
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKAP12,A-kinase anchor protein 12,36955,0.00234587779619403,0.00196562646792757,-0.001506750080944,0.00619850567333207,0.232715650690352
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,36763,-0.00505515517808965,0.00423869659168063,-0.0133630004977837,0.00325269014160438,0.233041136643904
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX5,Syntaxin-5,36880,-0.00452237619769703,0.00379886695662648,-0.0119681554326849,0.00292340303729087,0.233890754933143
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37203,-0.00586058268965534,0.00493712885359488,-0.0155373552427013,0.00381618986339062,0.235232898097789
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A16,Protein S100-A16,39079,-0.00668441910113482,0.00563810983515205,-0.0177351143780328,0.0043662761757632,0.235808245900456
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGT1,Protein SGT1 homolog,39123,-0.00878306492330577,0.00741502349682946,-0.0233165109770915,0.00575038113047997,0.23623600719487
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRN,Progranulin,39389,0.00261887419533552,0.00221396665964225,-0.00172050045756329,0.00695824884823432,0.236872436668183
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPA1,Inositol monophosphatase 1,39355,-0.00656560492990253,0.00555598474225884,-0.0174553350247298,0.00432412516492479,0.237336630086131
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,39601,-0.00335494282693942,0.00284132049247801,-0.00892393099219631,0.00221404533831747,0.237713086444776
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171A2,Protein FAM171A2,37221,-0.017231331252559,0.0146121496305126,-0.0458711445283638,0.0114084820232457,0.238321871711889
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,37164,-0.00290683266636893,0.00246546594791834,-0.00773914592428888,0.00192548059155102,0.238412439540669
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,39513,0.00248276416672994,0.00210871402368747,-0.0016503153196975,0.00661584365315739,0.239061253825506
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNN,Tenascin-N,37255,-0.00465684868806808,0.00395625543001209,-0.0124111093308918,0.00309741195475562,0.239183487212379
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2B,Alpha-amylase 2B,38483,0.00516568419874554,0.00440351035054792,-0.00346519608832838,0.0137965644858195,0.240782340010079
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,37243,-0.00769023932086322,0.0065650476484828,-0.0205577327118895,0.00517725407016308,0.241463370698923
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,36847,0.00345023041562081,0.00294604572426137,-0.00232401920393147,0.0092244800351731,0.241565235727989
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,39355,0.00383613933146119,0.00327894171241628,-0.00259058642487473,0.0102628650877971,0.242046983436304
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",37162,-0.0047270404699179,0.00404400416068151,-0.0126532886248537,0.00319920768501786,0.242465446492657
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,37162,-0.00613671795764893,0.00525204882361385,-0.0164307336519321,0.00415729773663421,0.242650166505478
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE,Angiotensin-converting enzyme,37243,-0.00270921742013885,0.00232117483713413,-0.00725872010092174,0.00184028526064405,0.243161431416492
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,39635,0.00289149796907534,0.00247845006002439,-0.00196626414857246,0.00774926008672315,0.243367750445864
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,36880,-0.0072290872957973,0.00619902100896417,-0.0193791684733671,0.00492099388177247,0.243569729883862
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCOR1,REST corepressor 1,39187,-0.00475457123127974,0.0040826327985062,-0.0127565315163519,0.00324738905379241,0.244206039930615
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,37162,-0.00520551448756827,0.0044751847788435,-0.0139768766541015,0.00356584767896499,0.244772057194344
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCC,Netrin receptor DCC,36861,-0.00249883097073406,0.00215247388440976,-0.00671767978417719,0.00172001784270907,0.245700358663391
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37162,-0.00388211717911631,0.00335570454504972,-0.0104592980874138,0.00269506372918114,0.247346822019894
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,36823,-0.00604665745366138,0.00523939427175551,-0.0163158702263022,0.00422255531897943,0.248491441444469
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,39187,0.00347388831587676,0.00301686620189467,-0.0024391694398368,0.00938694607159031,0.249549791963214
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37164,-0.00224085240065717,0.00195095603036287,-0.0060647262201684,0.00158302141885406,0.250745888188231
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD72,B-cell differentiation antigen CD72,36955,-0.00440010735752479,0.00383195513712663,-0.011910739426293,0.00311052471124341,0.250880355386757
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,39355,-0.00601354111694012,0.00523726834879903,-0.0162785870805862,0.00425150484670597,0.250895802397019
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4D,Semaphorin-4D,39589,0.00311181921882857,0.00271460568255033,-0.00220880791897008,0.00843244635662723,0.251678996671257
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,36861,-0.00550525197516123,0.00480364525664966,-0.0149203966781946,0.0039098927278721,0.251793607271065
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM25,RNA-binding protein 25,36763,-0.00485846293624201,0.00424227929482706,-0.0131733303541031,0.00345640448161903,0.2521285993001
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS1,Nephrin,36880,-0.00360413173865765,0.00315298331729566,-0.00978397904055715,0.00257571556324185,0.25302481958032
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP9,Fatty acid-binding protein 9,39462,-0.0058208066897203,0.00509369289533739,-0.0158044447645816,0.00416283138514098,0.253161516518455
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",36916,0.00267757072161252,0.00234353722913908,-0.00191576224750008,0.00727090369072511,0.253254111302046
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,36992,-0.00707538429122267,0.00620493536224353,-0.01923705760122,0.00508628901877465,0.25419006280615
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37255,0.00401216733109207,0.00352065938701456,-0.00288832506745646,0.0109126597296406,0.254471476640123
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,36861,0.00529249076164003,0.00466603644654448,-0.00385294067358716,0.0144379221968672,0.256708108685587
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLLT1,Protein ENL,36763,-0.00745574168920069,0.00658220784231435,-0.0203568690601368,0.00544538568173543,0.257357539446811
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSP90B1,Endoplasmin,39029,0.00722981006050345,0.00638761636414111,-0.00528991801321313,0.01974953813422,0.257717011426828
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37221,-0.00688532613022258,0.00608492136907555,-0.0188117720136107,0.00504111975316551,0.257849528221882
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARTN,Artemin,39194,-0.00457956821723802,0.00406200880592396,-0.012541105476849,0.00338196904237294,0.25958555922823
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPAG1,Sperm-associated antigen 1,37221,-0.00588982434983074,0.00522554886891692,-0.0161319001329079,0.00435225143324643,0.259712628234823
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOM,Apolipoprotein M,39498,-0.0027402224284773,0.0024340618188257,-0.00751098359337567,0.00203053873642107,0.260275857823868
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTD,Deoxycytidylate deaminase,36955,-0.00961868915671083,0.00855623657792785,-0.0263889128494494,0.00715153453602775,0.260961272459217
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,39462,0.00467377834422453,0.00416167093149865,-0.00348309668151283,0.0128306533699619,0.261432813366364
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRH,Corticoliberin,39092,-0.00889178320646846,0.00792351747160244,-0.0244218774508092,0.00663831103787233,0.261795178628638
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",36916,0.00788698016018906,0.00705894466992773,-0.0059485513928693,0.0217225117132474,0.263886323294795
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGT,Angiotensinogen,37243,0.00245315716408494,0.00219654597040909,-0.00185207293791689,0.00675838726608676,0.264090191729169
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO4,Roundabout homolog 4,36916,0.0018164731229859,0.00162647102956685,-0.00137141009496513,0.00500435634093692,0.264093416130426
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA1,Laminin subunit alpha-1,36847,0.00568036934740519,0.00510510561426067,-0.00432563765654572,0.0156863763513561,0.265865747348858
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBD,Thrombomodulin,39485,-0.00280484941389009,0.00252426706464151,-0.00775241286058746,0.00214271403280728,0.266519843877147
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,36823,0.00662591301848497,0.00596311655902998,-0.0050617954372138,0.0183136214741837,0.26652566846108
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN7,Tetraspanin-7,36823,-0.00928141006298144,0.00838139297922308,-0.0257089403022587,0.00714612017629579,0.268150008620051
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,39418,-0.00288241831948705,0.00260446602057445,-0.00798717171981296,0.00222233508083887,0.268432181880865
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FETUB,Fetuin-B,39498,-0.00339545466717745,0.00307080497073921,-0.0094142324098263,0.0026233230754714,0.268864818842225
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,39498,0.00225440707588342,0.00204620030519078,-0.00175614552229051,0.00626495967405735,0.270586745189447
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,39477,-0.00505719803794443,0.00459349075230425,-0.0140604399124608,0.00394604383657191,0.270936587234306
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,39453,0.00223954487833028,0.00203762809530136,-0.00175420618846037,0.00623329594512094,0.271744691860141
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBR1,T-box brain protein 1,36861,-0.00489431153806531,0.00447208595620785,-0.0136596000122327,0.00387097693610208,0.273794879381217
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHDC3L,KH domain-containing protein 3,36763,-0.00681977506963713,0.00623185561719415,-0.0190342120793377,0.00539466194006339,0.273826862812781
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,37269,0.00189032393225635,0.0017349807101155,-0.00151023825957002,0.00529088612408273,0.275938075421097
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,36992,-0.00524095515901729,0.00483261173233779,-0.0147128741543994,0.00423096383636477,0.278165141028331
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,37164,0.00499873298335106,0.00461155606856597,-0.00403991691103825,0.0140373828777404,0.278403989959331
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,36847,0.00613878491005343,0.00566949958404648,-0.00497343427467767,0.0172510040947845,0.278929955122916
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMOD4,Tropomodulin-4,36763,0.00413711382575219,0.00382135350212165,-0.00335273903840624,0.0116269666899106,0.278993671015718
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,36763,-0.00342204924858109,0.00316236048117766,-0.00962027579168931,0.00277617729452712,0.279221005608251
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX9,Transcription factor SOX-9,36861,-0.00269141282167001,0.00248779355458311,-0.00756748818865291,0.0021846625453129,0.279341393298649
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,36992,-0.00693815327043938,0.0064429645979318,-0.0195663638823857,0.00569005734150693,0.281564750794215
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,37164,-0.0092875243654938,0.00863859043318635,-0.0262191616145391,0.00764411288355145,0.282341255131963
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX3,Syntaxin-3,37203,-0.00378165584438829,0.00351801515017432,-0.01067696553873,0.00311365384995337,0.28242185039541
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39104,-0.0109683028286859,0.0102112600457326,-0.0309823725183219,0.00904576686095008,0.282778507188934
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPGN,Epigen,37162,-0.00479489297602649,0.00446977068511639,-0.0135556435188546,0.00396585756680164,0.283409041438586
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,39455,0.0047485093194751,0.00442767066958654,-0.00392972519291453,0.0134267438318647,0.283529744392182
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBB,Inhibin beta B chain,36955,0.0049966923742934,0.00466306168623109,-0.00414290853071952,0.0141362932793063,0.283943980716027
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37162,-0.00427797456620496,0.00399607931407427,-0.0121102900217905,0.00355434088938061,0.284395312480378
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,36847,0.00385015609875448,0.00359648954072983,-0.00319896340107598,0.0108992755985849,0.284400888488265
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDK2,Protein sidekick-2,36955,-0.0036996408869458,0.00346754703993218,-0.0104960330852129,0.00309675131132128,0.286022624792184
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,39404,-0.00249462174563951,0.00233993618999305,-0.00708089667802588,0.00209165318674686,0.286392606956934
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD2,Leiomodin-2,36823,-0.00631318001430228,0.00593724697372149,-0.0179501840827964,0.00532382405419184,0.287658639416185
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,39123,-0.00341553243794616,0.00321631283114253,-0.00971950558698552,0.0028884407110932,0.288280236758912
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD209,CD209 antigen,39509,0.00375826492847128,0.00353966097795126,-0.0031794705883132,0.0106960004452558,0.288362389457175
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,36847,0.00477130835861519,0.00450247911485003,-0.00405355070649087,0.0135961674237212,0.28929859444781
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,36763,-0.00254632244709708,0.00241246250024056,-0.00727474894756856,0.00218210405337441,0.291223432669457
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSN,Gelsolin,37187,0.00182917330076249,0.00173498587763432,-0.00157139901940078,0.00522974562092575,0.291771475687084
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,36847,0.00369727748417226,0.00350766550750099,-0.00317774691052969,0.0105723018788742,0.291877614996177
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",36880,-0.00347525731442029,0.00330329203686481,-0.00994970970667531,0.00299919507783473,0.292793047556756
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,36847,0.00630016328204207,0.00599640328218616,-0.0054527871510428,0.0180531137151269,0.293436619970453
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRAS,GTPase Hras,36976,-0.00944195539624915,0.00900264059736576,-0.027087130967086,0.00820322017458774,0.294291135019026
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFRC,Transferrin receptor protein 1,39513,-0.00376655185066619,0.00359519152789873,-0.0108131272453477,0.00328002354401531,0.294810365113256
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL,Podocalyxin,39428,-0.00144722958178146,0.00138173308961069,-0.00415542643741842,0.0012609672738555,0.29493125326484
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,37269,-0.00166390733404182,0.00159098522136431,-0.00478223836791587,0.00145442369983222,0.295657143216735
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",39541,0.00258575175109966,0.00249546482749848,-0.00230535931079736,0.00747686281299668,0.300134592570379
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,39462,-0.0141570992357705,0.0136727102535891,-0.0409556113328052,0.0126414128612642,0.300486022096961
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37164,0.00309068546861474,0.00298532248317209,-0.00276054659840256,0.00894191753563204,0.300551479114804
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGF,Pro-epidermal growth factor,39448,-0.0096735650388581,0.00934499557291505,-0.0279897563617716,0.00864262628405539,0.300610916918868
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAM,Integrin alpha-M,39455,0.00298036112862548,0.00287979200623396,-0.00266403120359308,0.00862475346084404,0.300721853900065
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,36823,-0.00533204704455102,0.00516645080944973,-0.0154582906310725,0.00479419654197045,0.302067829144978
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",36916,-0.00469356787242271,0.00455885327896828,-0.0136289202992005,0.00424178455435513,0.303241225593179
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOC,Brother of CDO,39187,-0.00221106917932408,0.00214933073513517,-0.00642375742018901,0.00200161906154084,0.303626041003008
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,39462,-0.00572460352638767,0.00557522436953882,-0.0166520432906838,0.00520283623790841,0.304534309173403
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEF,Thyrotroph embryonic factor,36847,-0.00402617761297091,0.00392365072130248,-0.0117165330267238,0.00366417780078195,0.304850107541256
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,36763,0.00569186000603245,0.00555989737806603,-0.00520553885497697,0.0165892588670419,0.305980704859236
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,36847,-0.00311706597148052,0.00304569414365715,-0.00908662649304853,0.00285249455008749,0.306122814123269
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK6,Kallikrein-6,39507,0.00283678863753715,0.00277645950637087,-0.00260507199494976,0.00827864927002406,0.306925694065515
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF12,Fibroblast growth factor 12,36880,-0.00443989525343635,0.00435146898188315,-0.0129687744579273,0.00408898395105462,0.307596100204711
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLON5,IgLON family member 5,36763,0.00878980699135994,0.00862797809873537,-0.00812103008216139,0.0257006440648813,0.308338699350548
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",36847,0.00488116111769808,0.00480265311744003,-0.00453203899248439,0.0142943612278805,0.309484108465572
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37203,-0.00344125386348899,0.00338663298110097,-0.0100790545064469,0.00319654677946892,0.309587538857339
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REN,Renin,39485,-0.00661385970981255,0.00653193295129264,-0.0194164482943461,0.00618872887472103,0.311295033762995
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,36880,-0.00289956473820164,0.00286521656627752,-0.00851538920810558,0.00271625973170231,0.311563499847583
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_E,,39462,0.00265538223780949,0.00262806920129379,-0.00249563339672634,0.00780639787234532,0.312323415955496
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBX2,Chromobox protein homolog 2,36847,0.00377121103962118,0.00373397578042479,-0.00354738149001142,0.0110898035692538,0.312528413255837
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLHL41,Kelch-like protein 41,37221,-0.00437901131694838,0.00434357517632558,-0.0128924186625465,0.00413439602864975,0.313397582042015
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASQ2,Calsequestrin-2,36847,0.0046079257494464,0.00458392621260853,-0.00437656962726632,0.0135924211261591,0.314803047006397
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGN,Biglycan,39099,0.0110961527393406,0.0110694849013094,-0.0106000376672257,0.0327923431459069,0.316162593567588
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,39455,-0.00395824049592614,0.0039493985130568,-0.0116990615815175,0.00378258058966519,0.316244428016828
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS53,Serine protease 53,37203,-0.00334224535170534,0.00334122849816852,-0.00989105320811564,0.00320656250470497,0.317182231852786
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,36847,0.00648027172678978,0.00648029111842925,-0.00622109886533155,0.0191816423189111,0.317331477200267
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSD1,Tryptase delta,37221,-0.00343776598661325,0.00345239116690027,-0.0102044526737378,0.00332892070051127,0.319383814558135
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,36992,-0.00618628804993378,0.00622054780666641,-0.018378561751,0.00600598565113239,0.320002350929709
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,39455,-0.0021514595141248,0.00216345843455228,-0.00639183804584728,0.00208891901759767,0.320018013320442
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37243,-0.00425344250813401,0.0042792130971882,-0.0126407001786229,0.00413381516235487,0.320252513653521
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,39440,0.0022127772413086,0.00223907740244863,-0.00217581446749071,0.00660136895010792,0.323044211811246
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD83,CD83 antigen,39462,-0.00301253234835998,0.00306777667847169,-0.00902537463816448,0.00300030994144453,0.326119586078841
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,39526,-0.00984884034571381,0.0100417690604991,-0.0295307077042921,0.00983302701286447,0.326713344604863
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH4,Myosin-4,36847,0.0042670513272078,0.00435495030094305,-0.00426865126264058,0.0128027539170562,0.327195923840523
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,36847,-0.003617201066368,0.00371004827968699,-0.0108888956945545,0.00365449356181851,0.329592123079657
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,39455,-0.00279536637579961,0.00287458038848462,-0.00842954393722947,0.00283881118563025,0.33084574804592
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RUVBL1,RuvB-like 1,39123,-0.00952806396863906,0.00981657206711237,-0.0287685452201793,0.00971241728290119,0.331758477195006
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRUNE2,Protein prune homolog 2,36992,-0.00259883249897999,0.00268317837384773,-0.00785786211172154,0.00266019711376156,0.332780983404515
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,36861,0.00331095077573412,0.0034265183900059,-0.00340502526867744,0.0100269268201457,0.333926632375815
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,39456,0.00394877821261811,0.00409437501055598,-0.0040761968080716,0.0119737532333078,0.334841020442361
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",36847,-0.00332421886521955,0.00346717673946746,-0.0101198852745758,0.00347144754413668,0.337694223910003
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSS,Cathepsin S,36360,-0.00214571714060592,0.0022393872874104,-0.00653491622393031,0.00224348194271847,0.337995724340182
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,36823,-0.00638987667804031,0.00668331398080524,-0.0194891720804186,0.00670941872433795,0.339043407241724
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,36992,-0.00444325971706068,0.00465198725296803,-0.013561154732878,0.00467463529875666,0.339529595833118
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCA2A,Guanylin,39400,-0.00289504645899379,0.0030491928012434,-0.00887146434943086,0.00308137143144327,0.342408748504585
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA2,Integrin alpha-2,36955,-0.00291993307592082,0.00308071624170879,-0.00895813690967004,0.0031182707578284,0.343244603584423
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE1,Ribonuclease pancreatic,37243,-0.00207551443259208,0.00219098418301903,-0.00636984343130938,0.00221881456612522,0.343504961938888
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1,Programmed cell death protein 1,39568,-0.00378118196631064,0.00399886415179836,-0.0116189557038354,0.00405659177121414,0.344386129339105
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GJA8,Gap junction alpha-8 protein,36763,-0.00539502712140784,0.0057153655210906,-0.0165971435427454,0.00580708929992973,0.345213023039499
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,36823,-0.00346979096249104,0.00367758510636194,-0.0106778577709604,0.00373827584597835,0.345445112002277
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,39485,-0.00241157140379558,0.00255682931853254,-0.00742295686811935,0.00259981406052819,0.345599773011897
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,37019,-0.00477142364076607,0.00506071695011312,-0.0146904288629878,0.00514758158145565,0.345783170378424
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,39485,0.00244154733154131,0.0025941249314846,-0.0026429375341685,0.00752603219725112,0.346626003750476
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,37247,0.00279159237513606,0.00296793443720503,-0.00302555912178579,0.00860874387205792,0.346935714922023
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,36992,-0.00645571623114566,0.00686424035191624,-0.0199096273209015,0.00699819485861017,0.346986870526999
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,36763,-0.00249429469471519,0.00265800386309071,-0.00770398226637297,0.00271539287694259,0.348052682400894
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,36880,-0.00267271472491976,0.00285651705257714,-0.00827148814797095,0.00292605869813144,0.349468979398135
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP10,Bone morphogenetic protein 10,36955,0.00242630288006145,0.00259839970655146,-0.00266656054477941,0.00751916630490231,0.350441535742333
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,39123,0.00395204050696756,0.0042337500293773,-0.00434610955061195,0.0122501905645471,0.350597363513062
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,36880,-0.00412592196370034,0.00442879223622451,-0.0128063547467004,0.00455451081929971,0.35155447891144
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSPN,Claspin,39068,-0.00290490767194086,0.00312026376555473,-0.00902062465242813,0.0032108093085464,0.351878538475019
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,36861,-0.00447424649792469,0.00480901196948615,-0.0138999099581175,0.00495141696226816,0.352188385538026
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,39485,-0.00239160603872269,0.00257240405051659,-0.00743351797773522,0.00265030590028983,0.352532908498399
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HK2,Hexokinase-2,39187,-0.00234864244827642,0.00252636608115541,-0.00730031996734102,0.00260303507078818,0.352566284257293
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XG,Glycoprotein Xg,39578,0.00254645063654214,0.00274089951641743,-0.00282571241563602,0.00791861368872031,0.352874608235406
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,36916,-0.00355070802247673,0.00383918993435674,-0.0110755202938159,0.00397410424886249,0.355057342795195
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,39462,0.00714878652032262,0.00775188886043415,-0.00804491564612831,0.0223424886867736,0.356439448013452
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,38915,-0.00548125045552898,0.00596785824269559,-0.0171782526112123,0.00621575170015439,0.35839241011174
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",36847,0.00741019487029856,0.00806924306172792,-0.00840552153068816,0.0232259112712853,0.358466142311243
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC1,Syndecan-1,39485,0.00335572288749715,0.00365429141639499,-0.00380668828863702,0.0105181340636313,0.358478410618324
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLNL,Mesothelin-like protein,36861,0.00313389111838434,0.00341994643751711,-0.0035692038991492,0.00983698613591788,0.359497601860057
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,37221,-0.00288946257998258,0.00315819661586594,-0.00907952794707982,0.00330060278711467,0.360256669166734
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37221,0.00752227180203841,0.00822306481528533,-0.00859493523592084,0.0236394788399977,0.360325906080846
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",36847,-0.00340414164494228,0.00372130387205843,-0.0106978972341768,0.00388961394429224,0.360329546660618
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNF,Tumor necrosis factor,39162,0.00332318328903515,0.00363683477130209,-0.00380501286271694,0.0104513794407872,0.360859513539379
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B4,Protein ATP1B4,36763,0.00350802195109265,0.00383923117759815,-0.00401687115699972,0.011032915059185,0.360876459731678
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,36880,0.00245216463591279,0.00268371811875782,-0.00280792287685254,0.00771225214867812,0.36088216487895
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,36823,-0.00388125442335225,0.0042606913542447,-0.0122322094776719,0.00446970063096737,0.362342234082939
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGF,Placenta growth factor,39636,-0.00217762879268002,0.00239626422345485,-0.00687430667065153,0.0025190490852915,0.363491310902906
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,38842,0.00390645147660505,0.00430318973677486,-0.00452780040747368,0.0123407033606838,0.363997156079309
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",39654,-0.00235684311991328,0.00259884064942136,-0.00745057079277916,0.00273688455295259,0.364483307653429
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRXN3,Neurexin-3,36861,-0.00289261322264457,0.00319356238111597,-0.00915199548963186,0.00336676904434272,0.365078467285119
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRV1,Acrosomal protein SP-10,36880,-0.00289757785158396,0.00320253892496425,-0.0091745541445139,0.00337939844134598,0.365602021963641
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBI,Acyl-CoA-binding protein,39400,-0.00649681642348962,0.00718268028143158,-0.0205748697750955,0.00758123692811628,0.365738852753397
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GC,Vitamin D-binding protein,37269,0.00213835052160231,0.00236711006243223,-0.00250118520076485,0.00677788624396947,0.366352293191948
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39104,0.0024873915490731,0.00276151247783624,-0.00292517290748592,0.00789995600563213,0.367743922257794
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAP,Cartilage-associated protein,36861,-0.00398218550056805,0.004424770431567,-0.0126547355464394,0.00469036454530326,0.368150691011631
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,39485,-0.00259897747212116,0.00289029108349079,-0.0082639479957631,0.00306599305152077,0.368555433729924
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN7,Septin-7,36992,0.00430045102246153,0.00478245297188806,-0.00507315680243907,0.0136740588473621,0.368555688438909
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37203,-0.00391401975765831,0.00435633829777013,-0.0124524428212878,0.00462440330597114,0.368954384107373
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARCL1,SPARC-like protein 1,39472,0.00226578437896473,0.00252215705211985,-0.00267764344319018,0.00720921220111964,0.369012414031342
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,39455,-0.00726021212128817,0.00810424138283621,-0.0231445252316471,0.0086241009890708,0.370345443334531
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,39531,-0.00647259960433506,0.00723989042390267,-0.0206627848351843,0.00771758562651417,0.37132599359878
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,39485,0.00256702422811692,0.00287384299421397,-0.00306570804054246,0.00819975649677629,0.371744318012329
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,36763,-0.00672684943303307,0.00753319824999871,-0.0214919180030305,0.0080382191369644,0.371895712342925
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",36847,0.00396845034312367,0.00445890950276104,-0.00477101228228796,0.0127079129685353,0.373480644370612
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,39104,-0.00479558178332304,0.00539531762755847,-0.0153704043333377,0.00577924076669156,0.374102903473605
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,36823,-0.00595687272613573,0.00670962795156653,-0.0191077435112061,0.00719399805893467,0.374660388806476
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,36861,0.00642410422008367,0.00726129460925276,-0.00780803321405174,0.0206562416542191,0.376332857296211
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,39303,-0.00212685975946837,0.00240752097912628,-0.00684560087855587,0.00259188135961912,0.377021989395527
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN1,Cerebellin-1,36823,0.00795241355634236,0.00901078736976338,-0.00970872968839386,0.0256135568010786,0.377500011139062
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,36823,0.00584082208819986,0.00662624280215424,-0.00714661380402244,0.0188282579804222,0.378081602303157
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,39506,-0.00958421425205196,0.0108978055970899,-0.0309439132223482,0.0117754847182443,0.379164451112287
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTC,Probetacellulin,39123,-0.00605118063809161,0.00688503421360991,-0.019545847696767,0.00744348642058382,0.379475873143214
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,39654,0.00202311945413674,0.00230234810263853,-0.00248948282703477,0.00653572173530825,0.379566969774243
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRC,Chymotrypsin-C,39481,-0.00500268541062341,0.00569672296327165,-0.0161682624186358,0.00616289159738903,0.379866060305618
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PER3,Period circadian protein homolog 3,36880,-0.00945974701359075,0.0107735863025623,-0.0305759761666129,0.0116564821394314,0.37993358151173
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],39428,-0.00454706705120925,0.00518214217614594,-0.0147040657164553,0.00560993161403679,0.380256718328899
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,39455,0.00211693729647707,0.00241405593842293,-0.00261461234283188,0.00684848693578601,0.380543376471114
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPE4,NXPE family member 4,36847,0.0029163498510036,0.00333512272408472,-0.00362049068820246,0.00945319039020965,0.381898050320142
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2,Interleukin-2,39194,0.00248238209233669,0.00284097085146249,-0.00308592077652979,0.00805068496120317,0.382252579277046
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIF,Leukemia inhibitory factor,39104,-0.00416177950259255,0.00476866189391663,-0.0135083568146692,0.00518479780948405,0.382821681570213
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDHB15,Protocadherin beta-15,37162,-0.00318609589262145,0.00365629520538892,-0.0103524344951837,0.00398024270994083,0.383552207460165
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,39187,-0.00875680184067447,0.0100537999582945,-0.0284622497589316,0.0109486460775827,0.383771488725402
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL19,Interleukin-19,39074,-0.00537539465884381,0.00618137300131535,-0.0174908857414219,0.00674009642373428,0.384526882993776
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,37247,0.00234797077878213,0.00270288390969751,-0.00294968168422498,0.00764562324178924,0.385032488888705
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENG,Endoglin,39654,0.00134838896665963,0.00155336783180761,-0.00169621198368328,0.00439298991700253,0.385384885482843
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLG,Plasminogen,36975,0.00177442052711225,0.0020452335270468,-0.00223423718589949,0.00578307824012398,0.385636418494883
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN1,Prorelaxin H1,37221,0.00646642637260395,0.0074820528220535,-0.0081983971586209,0.0211312499038288,0.387462237866838
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39123,0.00283866352858255,0.00328685691805966,-0.00360357603081438,0.00928090308797948,0.387799397541329
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI1,Neuroserpin,36928,-0.00249798960848136,0.00289474413792452,-0.00817168811881342,0.0031757089018507,0.388187214922661
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",37203,-0.00823091476123634,0.00956483587032496,-0.0269779930670733,0.0105161635446006,0.389508147956184
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",39194,-0.00941017956233642,0.010958952472752,-0.0308897264089303,0.0120693672842574,0.39053375525283
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGM2,Phosphoglucomutase-2,36861,-0.00471449225455217,0.00549455899592356,-0.0154838278865624,0.00605484337745801,0.390892892222031
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,39420,-0.00226930853566215,0.00264818848362292,-0.00745975796356307,0.00292114089223877,0.391498046882048
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMSB10,Thymosin beta-10,39455,0.00591776540691871,0.0069087951335553,-0.00762347305484968,0.0194590038686871,0.391704353528778
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,39330,0.00262278890488765,0.00306755915214071,-0.00338962703330814,0.00863520484308344,0.392560253995639
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD8,Frizzled-8,36823,0.00350806159053684,0.00410822434435037,-0.00454405812438989,0.0115601813054636,0.393170348388911
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,39123,-0.00455261565394247,0.00533636879536702,-0.0150118984928618,0.00590666718497688,0.393601212571822
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,39187,-0.00487064821980759,0.00571013129862613,-0.0160625055651148,0.00632120912549962,0.393682276400256
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",36847,0.00304068917067913,0.00356671423116612,-0.00395007072240647,0.0100314490637647,0.393942955793191
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,37162,0.00330003531519794,0.00387508069213067,-0.00429512284137817,0.010895193471774,0.394449806163557
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,36992,-0.00500951972126621,0.00588504526400831,-0.0165442084387225,0.00652516899619007,0.394658549576551
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,36847,0.00372058296450914,0.0043733675634411,-0.00485121745983541,0.0122923833888537,0.394932233492648
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,39496,0.00440519138819576,0.00519142364610744,-0.00576999895817483,0.0145803817345663,0.396144291034302
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,39564,-0.00215203791533042,0.00253904590919903,-0.00712856789736051,0.00282449206669967,0.396686791488478
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,36763,0.00251754196727786,0.00297038333068998,-0.0033044093608745,0.00833949329543021,0.396706311697359
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANK2,Ankyrin-2,36847,-0.00573845549378643,0.00677421253745033,-0.0190159120671891,0.00753900107961621,0.396954090574399
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD59,CD59 glycoprotein,38827,-0.00174796113386088,0.00206381818458577,-0.00579304477564899,0.00229712250792724,0.39703430325024
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,36992,-0.00433686248141173,0.00512595854637357,-0.0143837412323039,0.00571001626948045,0.39753607113797
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOS,Proto-oncogene c-Fos,36741,-0.00270852467909716,0.00320743568673474,-0.00899509862509724,0.00357804926690293,0.398433453300702
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,36763,-0.00435974533210941,0.00516477936811327,-0.0144827128936114,0.00576322222939259,0.39861315410511
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXOSC10,Exosome component 10,36847,-0.00483515005811622,0.00574728054819002,-0.0160998199325687,0.00642951981633622,0.400199732644683
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPN3,Calpain-3,37162,-0.0028346389396431,0.00337370317462141,-0.00944709716190106,0.00377781928261486,0.400803168065927
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,39571,-0.00228176118396319,0.00272596324600537,-0.00762464914613371,0.00306112677820733,0.402579003553715
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAGE2A,G antigen 2A,36763,-0.00473947790365054,0.00568125860875176,-0.015874744776804,0.00639578896950291,0.404167423237609
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,39355,-0.00453599470080438,0.00544423226801673,-0.0152066899461172,0.0061347005445084,0.404759756712258
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,39531,0.00320863714811928,0.00387860917430057,-0.00439343683350985,0.0108107111297484,0.408100036780717
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,37162,-0.00350458918547421,0.00423761776779719,-0.0118103200103567,0.00480114163940829,0.408241981858883
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCN,Decorin,39187,-0.00171736822994369,0.00207679916473058,-0.00578789459281563,0.00235315813292826,0.408289938753799
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B2M,Beta-2-microglobulin,37269,-0.00235015374733701,0.00285090246309487,-0.00793792257500296,0.00323761508032894,0.409753605233354
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,36992,-0.00283237982619358,0.00343603234201033,-0.00956700321653383,0.00390224356414667,0.409775147482841
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC3,Membrane primary amine oxidase,39526,0.0022837996421501,0.00277509231726611,-0.00315538129969149,0.00772298058399168,0.410541777727449
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",36880,-0.00462805310821069,0.00562722584004749,-0.0156574157547038,0.0064013095382824,0.410842554497309
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,39477,-0.0020945788629914,0.00254780938017146,-0.00708828524812746,0.00289912752214466,0.411027498090514
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,39654,0.00455398659125556,0.00554232654157923,-0.00630897343023973,0.0154169466127508,0.411275246710532
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,37164,-0.00197958129375552,0.00240958781631005,-0.00670237341372322,0.00274321082621217,0.411352143978744
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,36847,-0.00593089568129701,0.00722403602025382,-0.0200900062809945,0.00822821491840048,0.411665045313305
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,36847,-0.00355793781808556,0.00433578984922594,-0.0120560859225684,0.00494021028639728,0.411891417690734
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,36823,0.0028988567630977,0.00353474266879821,-0.00402923886774679,0.00982695239394219,0.412172596727823
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOT,Angiomotin,36955,0.00308213437514607,0.00377284453375189,-0.00431264091100764,0.0104769096612998,0.413986347028891
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN4,Contactin-4,39455,0.00181215321681163,0.00221851516435269,-0.00253613650531964,0.0061604429389429,0.414037660006293
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,39418,-0.00319892240917475,0.00393842928984616,-0.0109182438172732,0.00452039899892372,0.416670841196965
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,39499,0.00247031608661109,0.003045981196024,-0.00349980705759594,0.00844043923081812,0.417373721352811
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,37221,0.00270660555219758,0.00334470063240131,-0.00384900768730899,0.00926221879170415,0.418402503277671
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD7,T-cell antigen CD7,36852,-0.00313920339059162,0.00388470055424831,-0.0107532164769183,0.00447480969573507,0.419051946610291
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",36847,0.00304423474659438,0.00377156506496427,-0.00434803278073559,0.0104365022739243,0.419593111666591
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,39462,0.00293047426201173,0.00364250697109468,-0.00420883940133386,0.0100697879253573,0.421108743974976
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,36823,0.00250413596424334,0.0031280041715138,-0.00362675221192371,0.0086350241404104,0.423405316660446
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD7,FERM domain-containing protein 7,36861,-0.00242160805251776,0.00302808481034282,-0.00835665428078969,0.00351343817575416,0.423890634192275
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,39541,-0.00633374815457809,0.00793222789949101,-0.0218809148375805,0.00921341852842429,0.424602892902619
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRL,Appetite-regulating hormone,39485,0.00574549718396929,0.00720831854911819,-0.00838280717230237,0.0198738015402409,0.425425970285941
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,36861,0.00313043079198758,0.00393013277131814,-0.00457262943979598,0.0108334910237711,0.425744881349061
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,39636,0.00187091357683388,0.00235099653329337,-0.00273703962842113,0.00647886678208889,0.426163072433871
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37162,-0.00683663533692476,0.00863177848337668,-0.0237549211643431,0.0100816504904935,0.42835743694979
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1,Integrin beta-1,39457,0.00157755676830912,0.00199494011989711,-0.00233252586668922,0.00548763940330747,0.429085460146965
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERVV_1,,36847,0.00344336735293467,0.0043730309589795,-0.00512777332666514,0.0120145080325345,0.431057078506656
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRAXIN,Draxin,39355,-0.00308942688461017,0.00393338385673786,-0.0107988592438164,0.00462000547459603,0.432209632179936
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL5,Fc receptor-like protein 5,39455,-0.00401604204972178,0.00512127611085548,-0.0140537432269985,0.00602165912755495,0.432942325796374
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA4,Annexin A4,39410,-0.0051232680258102,0.00653726517402515,-0.0179363077668995,0.00768977171527909,0.433227376663995
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JCHAIN,Immunoglobulin J chain,39194,-0.00438806539457647,0.0056022428842864,-0.0153684614477778,0.00659233065862488,0.43348151429214
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37221,0.00168047127295889,0.0021456188470908,-0.00252494166733907,0.00588588421325685,0.433518018532617
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTPN,Myotrophin,39187,0.00235753475875338,0.00302178263222051,-0.00356515920039882,0.00828022871790558,0.435297389716962
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STEAP4,Metalloreductase STEAP4,36823,0.00535335576346876,0.00686772647762855,-0.00810738813268319,0.0188140996596207,0.435703323684497
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI2B,Protein EVI2B,36763,0.00298691789952637,0.00383246049040231,-0.00452470466166215,0.0104985404607149,0.435774748832434
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37162,-0.00484093910357693,0.00621445882142713,-0.0170212783935741,0.00733940018642024,0.436006001763166
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL19,C-C motif chemokine 19,39589,-0.00927883047556727,0.0119207348401793,-0.0326434707623186,0.0140858098111841,0.436358730461523
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,39541,0.0083804930593763,0.0107833262532963,-0.0127548263970845,0.0295158125158371,0.437069820733086
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39104,-0.00392342496775109,0.00505217664354078,-0.013825691189091,0.00597884125358885,0.437418483448379
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTR,Methionine synthase,36847,0.00458891978214683,0.00596635052048753,-0.00710512723800873,0.0162829668023024,0.44182874562804
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,39462,-0.00373108130932159,0.00485617192899163,-0.0132491782901452,0.00578701567150201,0.44231073702493
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37162,-0.00453803998061347,0.00590986094984271,-0.0161213674423052,0.00704528748107825,0.442575163161015
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,36992,0.00317005937277304,0.00413583224032374,-0.00493617181826149,0.0112762905638076,0.443401339565617
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18BP,Interleukin-18-binding protein,39526,-0.00212619879933319,0.00278196183815113,-0.00757884400210942,0.00332644640344303,0.444712149065016
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39104,0.00345203856176162,0.00452394950822041,-0.00541490247435038,0.0123189795978736,0.445440735936254
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,39477,0.002635379267283,0.00346051690446756,-0.00414723386547341,0.00941799240003941,0.446336676767648
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN3,Centrin-3,37164,-0.00530790721735203,0.00697078151128432,-0.0189706389794693,0.00835482454476523,0.446401975306507
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,36861,-0.00205345468534493,0.00269726909053827,-0.00734010210279995,0.00323319273211008,0.446487114915543
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_DRA,,39411,0.0024914728859937,0.00328509801611987,-0.00394731922560124,0.00893026499758864,0.448213568514583
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,39589,0.00204407235017785,0.00269894538403201,-0.00324586060252488,0.00733400530288059,0.448846207910245
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH22,Cadherin-22,36992,0.00204654318540952,0.00270790516393289,-0.00326095093589894,0.00735403730671798,0.449803583253509
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,39455,-0.00222981980741053,0.00296405427648011,-0.00803936618931154,0.00357972657449048,0.45189022368112
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,39654,0.00187604798575445,0.00250180366710631,-0.00302748720177391,0.00677958317328281,0.453339680530362
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,39477,-0.0199909224023962,0.0267187854744492,-0.0723597419323166,0.0323778971275242,0.45435288703691
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,36823,0.00216375057590799,0.00289429261671394,-0.00350906295285133,0.00783656410466732,0.45472038256797
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37164,-0.00788965251424805,0.0105776331879736,-0.0286218135626763,0.0128425085341802,0.455753273014955
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,36763,0.00606121446760137,0.0081274606628346,-0.00986860843155445,0.0219910373667572,0.455820743057871
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,37255,-0.00398108161142329,0.00534521402152421,-0.0144577010936108,0.00649553787076417,0.456410128044825
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,39568,-0.00449189200425997,0.00603575268597697,-0.0163219672687748,0.00733818326025488,0.456758552583
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3G,Semaphorin-3G,36955,-0.00291706391783632,0.00392563261485963,-0.0106113038429612,0.00477717600728856,0.457446463417088
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA12,Serpin A12,39055,-0.00770780447984963,0.0103741454905669,-0.0280411296413608,0.0126255206816615,0.457504465115617
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,39104,0.00441809692979192,0.0059485331702324,-0.00724102808386358,0.0160772219434474,0.457662884016837
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WIF1,Wnt inhibitory factor 1,39601,-0.00231104990554063,0.00311447928675502,-0.00841542930758047,0.00379332949649921,0.458078165658027
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENSA,Alpha-endosulfine,37162,-0.00354007421322183,0.00478347330632197,-0.0129156818936129,0.00583553346716922,0.459275106867897
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",36763,-0.00390101253237892,0.00527909921837845,-0.0142480470004007,0.00644602193564284,0.459948897631509
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39123,0.00516638569266829,0.00702552041231375,-0.00860363431546665,0.0189364057008032,0.462123451296612
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFP,Alpha-fetoprotein,39309,0.00462236982168014,0.00631342379300733,-0.00775194081261424,0.0169966804559745,0.464088897046466
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",39187,0.00290419132232131,0.00398618528523029,-0.00490873183673005,0.0107171144813727,0.466279950145578
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,39654,-0.00280516141482738,0.00385956121158292,-0.0103699013895299,0.00475957855987515,0.467354542801964
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB2,Lamin-B2,37203,0.0018090124451517,0.0024912138909807,-0.00307376678117046,0.00669179167147387,0.467755847936281
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,36763,0.00288309997868504,0.00397234372911601,-0.00490269373038234,0.0106688936877524,0.467979366634409
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1A,Protein phosphatase 1A,39123,-0.00204403426428195,0.00283225345162706,-0.00759525102947099,0.00350718250090708,0.470491106236942
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM1,Myomesin-1,36823,-0.00309743409883417,0.00429871428850087,-0.0115229141042959,0.00532804590662754,0.471200682448435
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP7,Retinoid-binding protein 7,37164,-0.00381219718902195,0.00529158951912019,-0.0141837126464975,0.00655931826845362,0.47127616559463
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,36992,-0.0023686925872307,0.00329393995486086,-0.00882481489875799,0.0040874297242966,0.472088897887081
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13,Interleukin-13,39194,0.00317975790004628,0.00442324687129737,-0.00548980596769657,0.0118493217677891,0.472229850038026
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML1,Trem-like transcript 1 protein,37243,0.00344549367635243,0.00479301690340064,-0.00594881945431283,0.0128398068070177,0.472242174307492
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,37203,0.0155793909679203,0.021672659780894,-0.0268990222026321,0.0580578041384726,0.472246533742248
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD276,CD276 antigen,39477,0.00235223904210448,0.00327573316034012,-0.00406819795216215,0.00877267603637111,0.472719018061132
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,37243,0.00224254830439891,0.00313671737056791,-0.0039054177419142,0.00839051435071201,0.474662400399747
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,36763,0.00417531726030525,0.00585637411056522,-0.00730317599640257,0.0156538105170131,0.475888589903203
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,39618,-0.00339968233335222,0.00480037358094088,-0.0128084145519963,0.0060090498852919,0.478824478927228
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1F,Protein phosphatase 1F,37247,-0.00336716136812608,0.00475651794374931,-0.0126899365378747,0.00595561380162258,0.479017340617923
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,39531,0.00237372508205287,0.003375019199515,-0.00424131254899653,0.00898876271310228,0.481865993919831
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARFIP1,Arfaptin-1,37221,-0.00438941965596779,0.00624848609322244,-0.0166364523986838,0.0078576130867482,0.482394357033347
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,36916,0.00272407160626514,0.00388046687431708,-0.00488164346739634,0.0103297866799266,0.482694865408616
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP6,Guanylate-binding protein 6,36847,-0.0029919987679854,0.00426217025571772,-0.0113458524691921,0.00536185493322134,0.482698892427516
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",39428,0.00221552810567776,0.0031582411772702,-0.00397462460177184,0.00840568081312736,0.482997605406492
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,36861,-0.00551473851442576,0.00786313835454147,-0.020926489689327,0.00989701266047553,0.483103606860802
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,37247,-0.00189986562741603,0.00271244688141398,-0.00721626151498743,0.00341653026015537,0.48367465908299
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,36861,0.002881029871657,0.00411382556723233,-0.00518206824011837,0.0109441279834324,0.483735218495365
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRN1,Neuritin,37221,-0.00233663506888184,0.0033425442299541,-0.00888802175959189,0.0042147516218282,0.484527996751784
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,39396,0.00146211382426118,0.00209204099245898,-0.00263828652095843,0.00556251416948078,0.484629474498651
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,36847,-0.00618624747501951,0.00887282406057366,-0.0235769826337439,0.0112044876837049,0.485682637704281
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN1,Neuroligin-1,36861,-0.00442845549213033,0.00636643009878304,-0.0169066584857451,0.00804974750148443,0.486695667407699
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,36992,0.00259580418448205,0.00374595133619602,-0.00474626043446215,0.00993786880342625,0.488345854480908
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,39455,0.00271752082887522,0.00392657385871811,-0.00497856393421227,0.0104136055919627,0.48889498774638
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,36823,-0.00380485889299018,0.00551064730009058,-0.0146057276011677,0.00699600981518735,0.489920492596798
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GKN1,Gastrokine-1,38760,0.00175373004923296,0.00254028541822266,-0.00322522937048346,0.00673268946894939,0.489974417490299
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESPL1,Separin,36763,-0.00358579392056766,0.00519476189371271,-0.0137675272322446,0.00659593939110925,0.490036741360715
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",37164,0.00547111987550338,0.00793063440596863,-0.0100729235601951,0.0210151633112019,0.490287496465474
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA2,Adenosine deaminase 2,39388,-0.00263162645402137,0.00382324511749721,-0.0101251868843159,0.00486193397627316,0.491260271537201
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL6B,Myosin light chain 6B,36861,-0.00582999541957892,0.0084726857810811,-0.0224364595504979,0.01077646871134,0.491407107003186
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMCH,Pro-MCH,36847,0.00528233970447041,0.00770239699525257,-0.00981435840622463,0.0203790378151655,0.492849127868587
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PITHD1,PITH domain-containing protein 1,36741,-0.00512315258893038,0.00747243735701055,-0.0197691298086711,0.0095228246308103,0.492974132852928
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D1,DCN1-like protein 1,36823,0.00468752238984566,0.00684299482981892,-0.00872474747659941,0.0180997922562907,0.493350214103402
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",36861,0.00265436109016693,0.00387721840570005,-0.00494498698500516,0.010253709165339,0.493606325224057
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAX,Apoptosis regulator BAX,39079,0.00556071939639739,0.0081409829675739,-0.0103956072200475,0.0215170460128422,0.494584438385176
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,36849,-0.00236336782852536,0.00348013641086376,-0.00918443519381834,0.00445769953676761,0.497085871192741
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUOX2,Dual oxidase 2,39187,-0.00447785537561185,0.00660990589378186,-0.0174332709274243,0.00847756017620059,0.4981335543771
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37162,-0.00311598852148654,0.00460416933153108,-0.0121401604112874,0.00590818336831437,0.498560787456476
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,39541,-0.00256263182482803,0.00378682126832678,-0.00998480151074852,0.00485953786109245,0.498591629065405
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TG,Thyroglobulin,37162,-0.00721837498812036,0.0106899073446739,-0.0281705933836813,0.0137338434074405,0.499528334030328
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,36847,0.00239483075843133,0.00354847328820302,-0.0045601768864466,0.00934983840330925,0.499757952172841
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39123,0.00495319348864509,0.00733979383100662,-0.0094328024201279,0.0193391893974181,0.499787450580194
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN4,Alpha-actinin-4,39194,-0.00198610790248695,0.0029567920310778,-0.00778142028339943,0.00380920447842554,0.501778616844482
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINC1,Antithrombin-III,37241,-0.000895256206649049,0.00133345539344441,-0.00350882877780009,0.00171831636450199,0.501990166987966
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,39319,0.00190441322693691,0.00283898259198016,-0.0036599926533442,0.00746881910721802,0.502353048496934
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP1,Dipeptidase 1,39319,0.00309205204571771,0.00462422277466953,-0.00597142459263456,0.01215552868407,0.503720115398628
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX2,Transcription factor SOX-2,37200,-0.00141233678060999,0.0021254171950714,-0.00557815448294993,0.00275348092172996,0.506383254812093
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPT,Microtubule-associated protein tau,39104,0.00320780603748232,0.00484508756756574,-0.00628856559494652,0.0127041776699112,0.507934272402254
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,37203,0.00240248902147883,0.00363118757727633,-0.00471463862998278,0.00951961667294044,0.508222735397343
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",36763,-0.0054827092934205,0.00831022274308174,-0.0217707458698607,0.0108053272830197,0.509423539400097
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSAP,Gamma-secretase-activating protein,39123,-0.00535530806813019,0.0081376022337881,-0.0213050084463549,0.0105943923100945,0.510487988870959
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6,Interleukin-6,39428,-0.0043680067391074,0.00665011517497258,-0.0174022324820537,0.00866621900383886,0.511299204329852
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,39433,-0.00527404978518052,0.00805250129402655,-0.0210569523214726,0.0105088527511115,0.512504880215079
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",36916,0.00541738854892164,0.00827851271778138,-0.0108084963779299,0.0216432734757731,0.51287166847635
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,36992,-0.0049160591143172,0.0076020446825469,-0.0198160666921091,0.00998394846347471,0.517853557059526
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,36763,0.00177519159549077,0.00275073693168611,-0.003616252790614,0.00716663598159554,0.518711596035041
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,36847,0.00424306213252424,0.00659038791319663,-0.00867409817734115,0.0171602224423896,0.519700278147414
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,36916,-0.00237876794700202,0.00369985160212186,-0.00963047708716086,0.00487294119315682,0.52027742819697
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,36847,-0.00266283416529427,0.0041625905760415,-0.0108215116943356,0.00549584336374707,0.522375577200531
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD177,CD177 antigen,39441,0.00743005337922478,0.0116513451812065,-0.0154065831759399,0.0302666899343895,0.52367925418977
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP12,Macrophage metalloelastase,39463,-0.00299697233538583,0.00471122372540901,-0.0122309708371875,0.00623702616641584,0.524698405878821
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,36992,-0.00265897671478129,0.0041846247569949,-0.0108608412384913,0.00554288780892871,0.525168856254853
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAG,Myelin-associated glycoprotein,36861,0.00270086894545771,0.00426340725116914,-0.00565540926683381,0.0110571471577492,0.526418787175596
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH4,Cadherin-4,36823,0.00287389612113545,0.00453961957650586,-0.00602375824881604,0.0117715504910869,0.526699755546488
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",36916,-0.00369420877994266,0.00586704949281828,-0.0151936257858665,0.00780520822598117,0.528932794129537
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,39413,-0.00183888709653916,0.00294275820676744,-0.00760669318180334,0.00392891898872503,0.532055703159227
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,36992,-0.00419176205326995,0.00671305236472002,-0.0173493446881212,0.00896582058158129,0.532363359418102
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,39578,-0.00148895406199423,0.00238476672346121,-0.0061630968399782,0.00318518871598974,0.532400299037224
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CABP2,Calcium-binding protein 2,36861,-0.0037207670017842,0.00596040171690073,-0.0154031543669096,0.00796162036334124,0.532476407892174
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,36763,-0.00206844546970592,0.00331505435907885,-0.00856595201350046,0.00442906107408862,0.532668555406239
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",36823,-0.00314405001282349,0.00504837177623797,-0.0130388586942499,0.00675075866860294,0.533437322962906
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOP56,Nucleolar protein 56,36847,0.00624811034329185,0.0100345425094313,-0.0134195929751934,0.0259158136617771,0.533519290561934
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7,Interleukin-7,39462,-0.00364758730972162,0.00585895836536045,-0.0151311457058281,0.00783597108638485,0.533579325469783
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",39104,0.00245571465600286,0.00394979111280486,-0.00528587592509467,0.0101973052371004,0.534127258891775
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,36880,-0.00119325942883066,0.00192722109456185,-0.0049706127741719,0.00258409391651057,0.535821893579516
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFD,Complement factor D,37269,0.00107191480360232,0.0017377033022064,-0.00233398366872223,0.00447781327592686,0.537339872401743
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,37235,-0.00136693802153294,0.00222370892400544,-0.0057254075125836,0.00299153146951771,0.538756628850314
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17F,Interleukin-17F,39194,-0.00443793799713677,0.00723032006942533,-0.0186093653332104,0.00973348933893687,0.539359935222838
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPE,Coatomer subunit epsilon,39104,-0.00270326550608576,0.0044152763415931,-0.0113572071356082,0.00595067612343671,0.540379983380474
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,36861,-0.00438401479194307,0.00718307520944097,-0.0184628422024474,0.00969481261856123,0.541657309273751
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7,Complement component C7,36948,0.00174996177315956,0.00287122044695251,-0.00387763030286735,0.00737755384918647,0.542215021467234
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN2,Prorelaxin H2,36929,-0.00770710707730061,0.0126557133731991,-0.0325123052887708,0.0170980911341696,0.542547172679477
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST7,Cystatin-F,39495,0.00511832874928012,0.00841899597064012,-0.0113829033531745,0.0216195608517347,0.543229802436018
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALLD,Palladin,36880,0.0023102407907336,0.00380027099793705,-0.00513829036522302,0.00975877194669023,0.543255125097802
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDAN1,Codanin-1,37203,-0.00128071282945726,0.00211092540141223,-0.00541812661622523,0.0028567009573107,0.544056299640776
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,36861,-0.00370248253421161,0.00610843300149587,-0.0156750112171435,0.00827004614872029,0.544441905310008
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,39524,0.00281746194261246,0.00465883381571093,-0.00631385233618095,0.0119487762214059,0.545349632408427
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,36916,0.00520970533128053,0.00865643413591372,-0.0117569055751104,0.0221763162376714,0.547297975139772
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,37255,-0.00141624487864268,0.00235614982920426,-0.00603429854388303,0.00320180878659766,0.547794422376554
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,36763,-0.00304142715158394,0.0050607520863667,-0.0129605012408627,0.0068776469376948,0.547862218270941
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",37221,-0.00230049360755577,0.00384075383930487,-0.00982837113259331,0.00522738391748177,0.549203988201976
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VGF,Neurosecretory protein VGF,37221,0.00165757671960261,0.00277089157084809,-0.00377337075925963,0.00708852419846486,0.549710027019883
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITM2A,Integral membrane protein 2A,39462,0.00322346818391168,0.00539602463948225,-0.00735274010947354,0.0137996764772969,0.550263830075452
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,36916,-0.0142051055832576,0.0238630351544803,-0.0609766544860389,0.0325664433195237,0.551669425982047
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RA,Interleukin-17 receptor A,39455,-0.00237497433647122,0.00399331351483804,-0.0102018688255538,0.00545192015261133,0.55202774586772
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2R,Proteinase-activated receptor 1,39516,0.00310597653549313,0.00523001395942894,-0.00714485082498759,0.0133568038959738,0.552604383463186
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,36847,0.00323339553140391,0.0054445596576132,-0.00743794139751796,0.0139047324603258,0.552605617193875
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,36763,-0.00223364118736611,0.00376387343936402,-0.00961083312851959,0.00514355075378738,0.552896182546777
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",36847,0.00328897282717667,0.00555035662959149,-0.00758972616682265,0.014167671821176,0.553480012309263
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,39578,-0.00344411881063878,0.0058126322705248,-0.0148368780608674,0.00794864043958982,0.553509223564556
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,36847,0.00202189603788171,0.0034420707753784,-0.00472456268185995,0.00876835475762337,0.556941177417394
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL9,Interleukin-9,36992,-0.00308608146055909,0.00525423766787844,-0.0133843872896008,0.00721222436848265,0.556978607270781
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDHB,Succinate dehydrogenase,37164,-0.00380398495353212,0.00649010345575874,-0.0165245877268193,0.00891661781975502,0.557804712326998
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,37255,0.00175371161051187,0.00299384046442063,-0.00411421569975256,0.00762163892077631,0.558038238214991
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,36823,0.00182236389649495,0.00311277084488125,-0.00427866695947231,0.00792339475246221,0.558257539362051
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,36823,0.00305742188404266,0.00523238122201318,-0.00719804531110318,0.0133128890791885,0.559010951486113
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37221,-0.00174163955659979,0.0029872887891326,-0.00759672558329969,0.00411344647010011,0.55989228528963
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAYN,Layilin,39319,-0.00182321609565153,0.00312881156506474,-0.00795568676317841,0.00430925457187536,0.560091716502292
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2,Brorin,39294,0.00205731776293509,0.00353910350256115,-0.00487932510208476,0.00899396062795494,0.561040083006334
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,36763,-0.00473516214403588,0.00815143876876396,-0.0207119821308132,0.0112416578427415,0.561319200134976
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNG,Interferon gamma,39194,0.00599182960326735,0.0103405770430215,-0.0142757014010548,0.0262593606075895,0.562295588014623
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB2,Beta-crystallin B2,37203,0.00360817808370921,0.00625944101679249,-0.00866032630920408,0.0158766824766225,0.564329510657631
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37162,0.00447275755700368,0.00777901309533531,-0.0107741081098535,0.0197196232238609,0.565316686718576
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BEX3,Protein BEX3,36763,0.00250280622166871,0.00436074569333752,-0.00604425533727284,0.0110498677806103,0.566018914129955
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCL2,Phosducin-like protein 2,36763,0.00283241466814377,0.00495155314508249,-0.00687262949621792,0.0125374588325055,0.567315142957129
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,39589,-0.00243860448745907,0.00426947809849342,-0.0108067815605062,0.00592957258558802,0.567891830872718
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FST,Follistatin,39516,0.00268767713923687,0.00471940335694164,-0.00656235344036875,0.0119377077188425,0.569028679212034
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,36847,-0.00211297440727867,0.00371776327352241,-0.00939979042338259,0.00517384160882525,0.569810615593835
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP6,Platelet glycoprotein VI,39434,0.00453609991994318,0.00800366624232397,-0.0111510859150118,0.0202232857548982,0.57089066118297
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC1,Sialoadhesin,39541,-0.00223438855692149,0.00394476215356853,-0.00996612237791581,0.00549734526407283,0.571117350399748
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA5,Annexin A5,39042,0.00157514080617867,0.00278315031551143,-0.00387983381222373,0.00703011542458107,0.57143235032066
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,36763,-0.00173793290003391,0.00308206027292565,-0.00777877103496819,0.00430290523490037,0.572841490638018
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,39330,-0.0012421694742696,0.00220777093691733,-0.00556940051062756,0.00308506156208836,0.573691846907051
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MESD,LRP chaperone MESD,39455,-0.00620626424355274,0.0110362884736843,-0.0278373896519739,0.0154248611648685,0.573885521942481
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,36823,0.00315860192412262,0.00563473383301154,-0.00788547638858,0.0142026802368252,0.575108219095462
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,36992,-0.0035467369866266,0.00632872265346287,-0.0159510333874138,0.00885755941416063,0.575203625608557
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,39281,0.00591556700053801,0.0105575493953507,-0.0147772298143494,0.0266083638154255,0.575272176654475
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA4,Laminin subunit alpha-4,39541,-0.00167182147653829,0.00299202121800991,-0.00753618306383771,0.00419254011076112,0.576333884817803
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TST,Thiosulfate sulfurtransferase,39066,-0.00384306559610445,0.00690322786391084,-0.0173733922093697,0.0096872610171608,0.57773711622795
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,36861,-0.00273221390486288,0.00492251670749307,-0.0123803466515493,0.00691591884182354,0.578874494376553
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF2,Growth/differentiation factor 2,39485,-0.00180377787930431,0.00325249462776956,-0.00817866734973264,0.00457111159112403,0.57918824332012
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAND5,DAN domain family member 5,36880,0.00275180981655846,0.00498113917507607,-0.00701122296659063,0.0125148425997076,0.580652838835602
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,37162,-0.00264317744383664,0.00478454039088017,-0.0120208766099618,0.0067345217222885,0.580655794265866
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,36880,-0.00210403143031215,0.00382073866222558,-0.00959267920827429,0.00538461634764998,0.581858098799376
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,39541,-0.00338229581810159,0.0061620769781591,-0.0154599666952934,0.00869537505909024,0.583089799630676
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEK,Angiopoietin-1 receptor,39531,0.00107200320526382,0.00195617844552205,-0.0027621065479594,0.00490611295848704,0.583693901210101
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,38700,-0.00190465599610484,0.00347802363756344,-0.00872158232572918,0.0049122703335195,0.583957345925241
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,39404,-0.00300553358284846,0.00549870853375925,-0.0137830023090166,0.00777193514331966,0.584669286199568
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39123,-0.00631036257025866,0.0116012637462851,-0.0290488395129775,0.0164281143724602,0.586492738002725
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3A,Uroplakin-3a,36823,0.00249360230129212,0.00459224450890656,-0.00650719693616474,0.011494401538749,0.587137556290543
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKIV2L,Helicase SKI2W,36847,-0.00200636891776114,0.00371150558686545,-0.00928091986801743,0.00526818203249514,0.58880622006609
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300C,CMRF35-like molecule 6,39589,-0.00167412114564933,0.00310750002400274,-0.00776482119269471,0.00441657890139604,0.590077171318873
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,39541,-0.00125782603670147,0.00235497504502692,-0.00587357712495423,0.00335792505155128,0.593270269805649
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP73,Tumor protein p73,36861,-0.00171078350989909,0.00320384745543606,-0.00799032452255377,0.00456875750275558,0.593366438342624
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,36861,0.00354983531217551,0.00664850428858582,-0.00948123309345271,0.0165809037178037,0.59339959010165
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,39043,-0.00279328372982686,0.00524095793025134,-0.0130655612731195,0.00747899381346577,0.594061093172795
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY75,Lymphocyte antigen 75,39462,-0.00188206768751175,0.00353641364638561,-0.00881343843442756,0.00504930305940405,0.594597642510012
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,39636,0.00352339066850208,0.00665595189405265,-0.00952227504384112,0.0165690563808453,0.596563899081673
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,36880,-0.00298520269275046,0.00569168386080797,-0.0141409030599341,0.00817049767443316,0.59995061868278
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,39104,-0.00403706084402983,0.00774114427741519,-0.0192097036277636,0.0111355819397039,0.602021520506292
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN2,Alpha-actinin-2,36847,-0.00259970406017788,0.00498999068952667,-0.0123800858116502,0.00718067769129439,0.602387398639467
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSC2,Desmocollin-2,39314,0.00160341427905937,0.00308009976276426,-0.00443358125595857,0.00764040981407732,0.602672581465713
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",39477,0.00440240270276787,0.00848550427377446,-0.0122291856738301,0.0210339910793658,0.603897742503028
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,36847,0.00165320239813692,0.00318893992206221,-0.00459711984910501,0.00790352464537885,0.604176231544095
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICOSLG,ICOS ligand,39428,-0.000899347382006647,0.00173814881664185,-0.00430611906262467,0.00250742429861138,0.604872883297891
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATOX1,Copper transport protein ATOX1,39531,-0.00335534371829478,0.0065028746828351,-0.0161009780966516,0.00939029066006202,0.605876970233468
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,39104,-0.00188252073824676,0.00366086204993815,-0.00905781035612553,0.005292768879632,0.60709978244001
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,39104,-0.00261230712854289,0.00508190745006437,-0.0125728457306691,0.00734823147358328,0.60723130625815
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,39477,0.00139294211035385,0.00271344966201319,-0.00392541922719201,0.00671130344789971,0.60771593711072
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,39104,0.00185472085737206,0.00361885326663199,-0.00523823154522663,0.00894767325997075,0.60829752409283
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,39204,-0.00197758374301421,0.00386723758448687,-0.00955736940860847,0.00560220192258005,0.609100654121767
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QL2,Complement C1q-like protein 2,36880,0.00199987159941307,0.00391435654566611,-0.0056722672300925,0.00967201042891864,0.609425354823782
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,36880,-0.00435441645523864,0.00855027439974709,-0.0211129542787429,0.0124041213682657,0.610570532115061
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,39462,0.00565635127833509,0.0111158609550593,-0.0161307361935812,0.0274434387502514,0.610861983588534
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1B,Protein phosphatase 1B,36880,-0.00291064434184981,0.00572812526784601,-0.014137769866828,0.00831648118312837,0.611369720897658
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",36880,0.00130578261982072,0.00256979032507254,-0.00373100641732146,0.00634257165696291,0.611372543454228
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,36763,-0.00229554035380751,0.00454152853772681,-0.0111969362877521,0.00660585558013703,0.613248029671662
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL25,Interleukin-25,36715,-0.00161037238632508,0.00319087503718188,-0.00786448745920156,0.00464374268655141,0.613792332658605
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2,Ataxin-2,36823,-0.00526463975045942,0.0104836983890273,-0.025812688592953,0.0152834090920341,0.615554135471125
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD3,Bromodomain-containing protein 3,36847,-0.00221548032521915,0.00441523852023698,-0.0108693478248836,0.00643838717444533,0.615830886378477
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALCAM,CD166 antigen,39654,0.000886988164890974,0.00176916031464131,-0.002580566051806,0.00435454238158795,0.616124270003327
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,39541,-0.00119455315088199,0.00239384239849826,-0.00588648425193857,0.00349737795017459,0.617779067932547
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,39386,-0.00121174759624867,0.00242953890407698,-0.00597364384823956,0.00355014865574221,0.617958491921294
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF22,Kinesin-like protein KIF22,36847,-0.00552562061651049,0.0111159788882366,-0.0273129392374543,0.0162616980044333,0.619135755856396
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,39654,-0.00149421198347046,0.00300803521686528,-0.00738996100852641,0.00440153704158548,0.619379460471812
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB1,Lamin-B1,37140,0.00256803386377065,0.00518667784560948,-0.00759785471362394,0.0127339224411652,0.620523183999339
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,39485,-0.00387860583298805,0.00783833900097826,-0.0192417502749054,0.0114845386089293,0.620730910855814
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,36861,0.0031544994898123,0.00639304315479961,-0.00937586509359493,0.0156848640732195,0.621719708761777
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM3,Myomesin-3,36955,0.00403371168089592,0.00817959451037214,-0.0119982935594335,0.0200657169212253,0.621920045989061
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,39194,0.00159967682486414,0.00324642250562015,-0.00476331128615136,0.00796266493587964,0.62219611776142
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBQLN3,Ubiquilin-3,36847,-0.00201161926498414,0.00409736422544439,-0.0100424531468551,0.00601921461688687,0.62346734502764
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,36763,0.00283572486189788,0.00580556407836804,-0.00854318073170348,0.0142146304554992,0.625240188577721
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,39461,-0.00416970422118876,0.0085595335252092,-0.0209463899305988,0.0126069814882213,0.626165154605378
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNW1,Interferon omega-1,36847,0.00163878373754503,0.00337643626252546,-0.00497903133700487,0.00825659881209492,0.627430286806236
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,39578,0.00178963037105923,0.00369252962875768,-0.00544772770130582,0.00902698844342429,0.627922841218568
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPT,Dermatopontin,39654,0.00116368808765297,0.00240156433637974,-0.00354337801165132,0.00587075418695725,0.627999589260511
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,39530,0.00106834189362775,0.0022073380122374,-0.00325804061035755,0.00539472439761305,0.628396018481103
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHPK,Sedoheptulokinase,36992,0.00188499596982664,0.0039042427432431,-0.00576731980692985,0.00953731174658312,0.629241163902766
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2,T-cell surface antigen CD2,36847,-0.00167204214398174,0.00346933868996572,-0.00847194597631454,0.00512786168835107,0.629851129546291
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37162,0.00197287902468216,0.00410644066558213,-0.00607574467985881,0.0100215027292231,0.6309261723651
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,39104,0.00288199788656259,0.0060162719260334,-0.00890989508846287,0.0146738908615881,0.631921698562739
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1A,Lithostathine-1-alpha,39404,-0.00211001901747983,0.00445358475825468,-0.010839045143659,0.00661900710869936,0.635663774846076
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,36861,-0.00237254753527614,0.00500888316940274,-0.0121899585473055,0.00744486347675324,0.635745028697459
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,36457,0.00478492070369564,0.0101070316601181,-0.0150248613501358,0.0245947027575271,0.635918659361632
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL4,Early placenta insulin-like peptide,37162,-0.00231718042239751,0.00489578618064557,-0.0119129213364628,0.0072785604916678,0.636006587861557
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPJ,Centromere protein J,36992,-0.00314711520346044,0.00666143218044343,-0.0162035222771296,0.00990929187020868,0.636622246249409
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,36880,-0.00395683106850934,0.00839293262613098,-0.0204069790157261,0.0124933168787074,0.637329140852998
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,36861,0.00185160528846795,0.00394231419742372,-0.00587533053848254,0.00957854111541845,0.638595689845936
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,36880,-0.00173486469352021,0.00369963305587561,-0.00898614548303641,0.005516416095996,0.639128715520868
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17C,Interleukin-17C,39194,-0.00297708455517929,0.00637818627624073,-0.0154783296566111,0.00952416054625254,0.640678233440844
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMD,Osteomodulin,39541,0.00187633696119544,0.0040261087551284,-0.00601483619885622,0.00976751012124711,0.641191954318289
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,36861,-0.00272225379576391,0.00584830010239061,-0.0141849219964495,0.00874041440492169,0.641597508587277
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",37221,-0.00155911594210163,0.00335951112568854,-0.00814375774845116,0.00502552586424791,0.642591087204941
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,39455,-0.00221898390230191,0.00479513808210089,-0.0116174545432196,0.00717948673861583,0.643545239539679
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,36880,-0.00122304404328215,0.00264343130330138,-0.00640416939775284,0.00395808131118855,0.643606942038508
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,39485,-0.00130101103872051,0.00282695441677895,-0.00684184169560726,0.00423981961816623,0.645367492288158
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,39623,-0.00158321437664041,0.00345913907963998,-0.00836312697273476,0.00519669821945394,0.647181517917538
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37255,0.00103375120579465,0.00227457794292125,-0.003424421562331,0.00549192397392031,0.649490765336783
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR1,Folate receptor alpha,39423,-0.00117630385939003,0.00258900592641903,-0.00625075547517133,0.00389814775639128,0.649586573714902
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF5,Fibroblast growth factor 5,39194,-0.00132890654589739,0.00293282253315713,-0.00707723871088537,0.00441942561909059,0.65047244050351
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,36880,-0.00247940757802329,0.00548785781133202,-0.013235608888234,0.00827679373218747,0.651421818045514
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,37164,-0.00226771599467325,0.00502090522446293,-0.0121086902346206,0.0075732582452741,0.651525383504896
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,36992,-0.00309342304830096,0.00690731367390046,-0.0166317578491459,0.0104449117525439,0.654271008055003
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",36763,-0.00226122903787347,0.00506401355233356,-0.0121866956004472,0.0076642375247003,0.655223004815242
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY96,Lymphocyte antigen 96,39355,-0.00140670835039492,0.00317102548629036,-0.00762191830352402,0.00480850160273418,0.65732879484516
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20,Interleukin-20,39194,0.00205297001381602,0.00463333549492283,-0.00702836755623273,0.0111343075838648,0.657709420471046
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37221,-0.00455402745367057,0.0103716539878824,-0.02488246926992,0.0157744143625788,0.660608092301976
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF9,Fibroblast growth factor 9,36741,-0.00163153527487801,0.00371708405028133,-0.00891702001342941,0.0056539494636734,0.660720838070125
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB116,Beta-defensin 116,36823,0.00314059646765659,0.00719849368164468,-0.010968451148367,0.0172496440836802,0.662637410550266
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNB2,Ephrin-B2,36861,0.00231700190990483,0.00531919796935168,-0.00810862611002446,0.0127426299298341,0.663140103248746
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",36847,-0.00263126648609931,0.00606834383111565,-0.014525220395086,0.00926268742288738,0.664582578915893
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,36823,0.00261510080688505,0.00608169586135114,-0.00930502308136318,0.0145352246951333,0.667206529412434
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRND,Prion-like protein doppel,37203,-0.00209638163174941,0.00489043329776849,-0.0116816308953757,0.00748886763187683,0.668170698068338
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,36823,0.00118100064121998,0.00275725341326847,-0.00422321604878622,0.00658521733122619,0.668421957734022
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5,Interleukin-5,39194,0.0056722682177781,0.0132512503975433,-0.0203001825614067,0.0316447189969629,0.668617098862602
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,36992,0.00245576120997229,0.00575369072531993,-0.00882147261165477,0.0137329950315994,0.669521444972559
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX101,Testis-expressed protein 101,36861,0.00150989478424571,0.0036103802585131,-0.00556645052243997,0.00858624009093138,0.67580129652364
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,37221,0.00102496207303519,0.00245618675615727,-0.00378916396903305,0.00583908811510343,0.6764673918504
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD82,CD82 antigen,36992,0.00160072232672415,0.00383748284629662,-0.00592074405201721,0.00912218870546552,0.676591776987772
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,36861,-0.00140270324707798,0.00336388291886391,-0.00799591376805125,0.00519050727389529,0.676693433597112
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A3,Protein S100-A3,37162,-0.00172206909417219,0.00413487952648988,-0.00982643296609235,0.00638229477774796,0.677070349294612
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4,Interleukin-4,39194,0.00342175676863811,0.00823616958140013,-0.0127211356109061,0.0195646491481824,0.677814992224025
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,36992,0.00278201094280048,0.00672195489835136,-0.0103930206579682,0.0159570425435692,0.678976887260408
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGN,Cingulin,36861,-0.00159296583039289,0.00385166148578082,-0.00914222234252328,0.00595629068173751,0.679189692778151
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,39187,-0.0021177799664447,0.00512256465580353,-0.0121580066918196,0.00792244675893022,0.679303612301432
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,36847,-0.00128322043756429,0.00310630385345332,-0.00737157599033279,0.00480513511520421,0.67953900575491
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,39499,-0.00111952804756293,0.00271015207529986,-0.00643142611515066,0.00419237002002479,0.679548906560002
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAL,Galanin peptides,39541,0.00235191945928163,0.00569655157326503,-0.00881332162431783,0.0135171605428811,0.679709758988975
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,36861,-0.00213566329204188,0.00520839220057126,-0.0123441120051616,0.0080727854210778,0.681781690432149
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX1B,Syntaxin-1B,36861,0.00159615669068506,0.0039236005850798,-0.00609410045607134,0.00928641383744147,0.684155168653869
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,39654,-0.00115315435840422,0.0028363183086897,-0.00671233824343603,0.00440602952662759,0.684331520442439
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,36992,0.0020201829800178,0.0049698030418788,-0.00772063098206464,0.0117609969421002,0.684388395645852
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,39497,-0.000992657027005058,0.00244770073855764,-0.00579015047457804,0.00380483642056792,0.68508144429257
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH6,Cadherin-6,39485,-0.00140101006310575,0.00346089262885628,-0.00818435961566405,0.00538233948945255,0.685621637873442
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRTN,Neurturin,39194,0.00180618232401842,0.00446511100150412,-0.00694543523892966,0.0105577998869665,0.68584354946228
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",36823,-0.00316690557034806,0.00783626473216329,-0.0185259844453881,0.012192173304692,0.686120742270877
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,36880,-0.00201373861118116,0.0049946214791643,-0.0118031967103432,0.00777571948798087,0.686821698229579
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM2,Isthmin-2,37255,0.00163233200136802,0.00405852551642047,-0.0063223780108161,0.00958704201355214,0.687544818668019
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID1,Nidogen-1,39482,-0.00144425802314136,0.00360732289635145,-0.00851461089999021,0.0056260948537075,0.688890900602815
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAP1,Antigen peptide transporter 1,36992,-0.00223939358897747,0.00560138408782737,-0.0132181064011191,0.00873931922316417,0.689315869801941
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRG,Histidine-rich glycoprotein,37196,-0.00114357903553837,0.00286622627169191,-0.00676138252805452,0.00447422445697778,0.689911521292388
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM2,Myomesin-2,36847,0.00170228180143457,0.00428442471529111,-0.00669519064053599,0.0100997542434051,0.691139344872314
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELB,Transcription factor RelB,36880,0.00186192951806209,0.00468925681874378,-0.00732901384667571,0.0110528728827999,0.691327957558345
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,36880,-0.00132843085995022,0.00334628440367429,-0.00788714829115184,0.00523028657125139,0.691383984449457
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRBP,Acrosin-binding protein,37162,-0.00136877945875634,0.00345185616949219,-0.00813441755096104,0.00539685863344836,0.691717547637341
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,37144,-0.00315089906315099,0.00795642333225473,-0.0187454887943703,0.0124436906680683,0.692097274482761
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",36955,-0.00319292823726108,0.0080740889273432,-0.0190181425348538,0.0126322860603316,0.692514841106503
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,36880,0.0024821793073207,0.0063027148536357,-0.00987114180580528,0.0148355004204467,0.693715522509401
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,36880,-0.00207924303445656,0.00529265233441253,-0.0124528416099051,0.008294355540992,0.694433582435502
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN1,Calsyntenin-1,39104,-0.00187770811149465,0.00478105432932888,-0.0112485745969793,0.00749315837398996,0.694517726330878
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JUN,Transcription factor AP-1,39194,-0.00184182501318693,0.00469515976270932,-0.0110443381480972,0.00736068812172334,0.694855792422462
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,39485,-0.00205735299327408,0.00524459311548162,-0.012336755499618,0.00822204951306989,0.694856336465392
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,36880,-0.0027922025830057,0.0071246344972511,-0.0167564861976179,0.0111720810316064,0.695132774006113
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,39104,-0.00136586892421037,0.00351088826390275,-0.00824720992145976,0.00551547207303902,0.697253694887177
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",39427,0.00243865628665328,0.00628400423732222,-0.00987799201849827,0.0147553045918048,0.697967067906498
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",39194,-0.00253515592400603,0.00656004486523139,-0.0153928438598595,0.0103225320118475,0.699166002574334
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHIT1,Chitotriosidase-1,39522,0.00522943656370331,0.0136420893327799,-0.0215090585285453,0.031967931655952,0.701479719553891
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",36880,0.00165705499148545,0.00437755847314614,-0.00692295961588098,0.0102370695988519,0.705040360652539
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,36823,0.00171801355030386,0.0045487329564815,-0.00719750304439987,0.0106335301450076,0.705666952235968
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL1,Chordin-like protein 1,39516,0.00104453682601826,0.00277108254936471,-0.00438678497073657,0.00647585862277309,0.706222171152352
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,39470,-0.00316572447092736,0.00847222944803561,-0.0197712941890772,0.0134398452472224,0.708663334460365
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,36880,0.0015080479213127,0.00403730312248838,-0.00640506619876453,0.00942116204138993,0.708761482880105
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPLX2,Complexin-2,36763,-0.00105380755698362,0.00283326430242438,-0.0066070055897354,0.00449939047576817,0.709943074643716
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX1,Peroxiredoxin-1,39093,-0.00301079644090045,0.00810932596003287,-0.0189050753225649,0.012883482440764,0.710437496785794
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,39123,0.00102088515739052,0.00275471092937891,-0.00437834826419213,0.00642011857897318,0.710943729472443
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC2,Stanniocalcin-2,39433,-0.000905083033631732,0.00247325177009849,-0.00575265650302478,0.00394249043576131,0.714408594244025
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,36861,0.00172252773696034,0.00475832061433856,-0.00760378066714323,0.0110488361410639,0.717355732969139
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAV,Integrin alpha-V,39601,0.000538197490229411,0.00149295198845224,-0.00238798840713697,0.00346438338759579,0.718484143007353
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,39636,0.000946720001578972,0.00264364277862796,-0.00423481984453184,0.00612825984768978,0.720264534140491
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH2,Growth hormone variant,39123,-0.00549161599995444,0.0154489316751216,-0.0357715220831928,0.0247882900832839,0.722243389511612
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,39123,-0.000990775599010568,0.00282556975636682,-0.00652889232148953,0.00454734112346839,0.725858746344678
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,39428,-0.0029984065698621,0.00856814146309759,-0.0197919638375334,0.0137951506978092,0.726382416281645
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,37164,0.00155801700777468,0.00445356710072435,-0.00717097450964505,0.0102870085251944,0.726467759634486
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSR,Insulin receptor,36880,-0.000536778109718198,0.00153552661365036,-0.0035464102724729,0.00247285405303651,0.7266653615207
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALB,Ras-related protein Ral-B,36880,-0.000935382577330107,0.0026839236884241,-0.00619587300664134,0.00432510785198113,0.727460777296557
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,36976,0.00318668463183298,0.00918173726647479,-0.0148095204104576,0.0211828896741236,0.72854627413824
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL3,Insulin-like 3,37203,0.00187373604184928,0.00543030228214172,-0.0087696564311485,0.0125171285148471,0.730061055574374
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD3,Extracellular superoxide dismutase,37243,-0.00186234178553573,0.00540169266985657,-0.0124496594184546,0.00872497584738315,0.730272928449192
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCLN,Nicalin,39194,0.00166666938532814,0.00484193859086079,-0.00782353025275901,0.0111568690234153,0.73068928017536
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,36916,-0.00153060750545251,0.00444679326128263,-0.0102463222975665,0.00718510728666144,0.730698092987384
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,36847,0.00149829151292385,0.00436748336362045,-0.00706197587977223,0.0100585589056199,0.731562125241593
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,36968,0.00159149892229982,0.00463965445095506,-0.00750222380157209,0.0106852216461717,0.731588420668489
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM19,Probable RNA-binding protein 19,36847,0.00149820914495696,0.00437328914178185,-0.00707343757293547,0.0100698558628494,0.731918925761361
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,36847,0.00168350350997837,0.00492796968406614,-0.00797531707079127,0.011342324090748,0.732641070532993
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM3,Paralemmin-3,36847,-0.00224920793380602,0.00660828257707738,-0.0152014417848777,0.0107030259172656,0.733589738534047
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,37247,-0.00105355202955293,0.00309814454612474,-0.00712591533995742,0.00501881128085156,0.733817656464599
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBLN2,Fibulin-2,37255,0.000949602361778794,0.00279400802053335,-0.00452665335846657,0.00642585808202416,0.733959235289227
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39104,-0.00142388620150829,0.00425528857726267,-0.00976425181294312,0.00691647940992653,0.737919818933846
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",39319,-0.00289470053686732,0.00867241091802205,-0.0198926259361905,0.0141032248624559,0.738548263435266
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPT1,Translationally-controlled tumor protein,39194,-0.0020259797382992,0.00607070630985953,-0.0139245641056239,0.00987260462902547,0.738587692985907
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,36763,0.00430225145487612,0.0129182806868814,-0.0210175786914113,0.0296220816011636,0.739112842461264
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL24,Interleukin-24,39194,-0.00148417210729592,0.00447185268623554,-0.0102490033723176,0.00728065915772575,0.739975533774519
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR2,Complement factor H-related protein 2,37173,0.00172919131057187,0.0052137762803145,-0.00848981019884455,0.0119481928199883,0.740152880983239
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,37255,-0.000889699049289089,0.00268900612248493,-0.00616015104935956,0.00438075295078138,0.740751583071569
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,36847,-0.00141788481806472,0.00430577386288917,-0.00985720158932749,0.00702143195319805,0.741935651612671
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,37221,-0.00100657620459644,0.00308334392365307,-0.00704993029495645,0.00503677788576358,0.744084704765753
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,37247,-0.000820285850584416,0.00251560553593764,-0.00575087270102218,0.00411030099985335,0.744370004099699
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39104,0.00240721975451495,0.00738317529240143,-0.0120638038185919,0.0168782433276217,0.744397796725182
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,36861,-0.0030852641918211,0.00948708968146591,-0.0216799599674943,0.0155094315838521,0.745030195546145
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK3,Prostate-specific antigen,37255,-0.00168795952233325,0.00521324798497858,-0.0119059255728913,0.00853000652822477,0.746107841340392
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP13,Collagenase 3,39104,-0.000971249323162601,0.00300017316509591,-0.00685158872675059,0.00490909008042539,0.746146252875763
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,36823,0.00319930378525822,0.00990186916495578,-0.0162083597780551,0.0226069673485715,0.746624217203816
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,39485,0.00143012676482778,0.0044496097442923,-0.00729110833398512,0.0101513618636407,0.747907972224384
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX33,Testis-expressed protein 33,36992,0.00115388489484417,0.00362985544646953,-0.00596063178023611,0.00826840156992444,0.750575730569965
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,39187,-0.000785390684543021,0.00247258961275163,-0.00563166632553621,0.00406088495645017,0.750763351834404
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNPO1,Transportin-1,36992,-0.00101346498497114,0.00320611841529842,-0.00729745707895605,0.00527052710901376,0.75192927459985
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,39589,-0.00227292366072202,0.00722485999606181,-0.0164336492530032,0.0118878019315591,0.753071532811085
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,36823,-0.00279936809377208,0.00891225939737528,-0.0202673965126276,0.0146686603250835,0.753448049540482
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,H2AP,Huntingtin-interacting protein M,36763,-0.00148220086111396,0.00473885436087873,-0.0107703554084363,0.00780595368620835,0.75445599611008
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP4,Guanylate-binding protein 4,39104,-0.00140769403802629,0.00451519512274802,-0.0102574764786124,0.00744208840255984,0.755221165718576
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERC2,ERC protein 2,36861,-0.00219155888838748,0.00703524364088851,-0.015980636424529,0.011597518647754,0.755417079328672
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",36742,-0.000716839340483665,0.00230969894146376,-0.00524384926575264,0.00381017058478531,0.756292083926355
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,36861,0.00102650437602752,0.00332981096108825,-0.00549992510770545,0.00755293385976049,0.757876684863242
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABO,Histo-blood group ABO system transferase,37243,0.00398469140351066,0.0131190478044803,-0.0217286422932708,0.0296980251002921,0.761336042569398
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,39431,-0.00111660596756793,0.00369908017053713,-0.0083668031018207,0.00613359116668484,0.762762644847366
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDSN,Corneodesmosin,39579,-0.00117802491396552,0.00392847359037398,-0.00887783315109852,0.00652178332316749,0.764281693299697
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD2,Bromodomain-containing protein 2,36823,0.000953013662008068,0.0031796286825309,-0.0052790585557525,0.00718508587976864,0.764392093837936
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,36880,0.000553142689623612,0.00184854298927009,-0.00307000156934576,0.00417628694859298,0.764768255482436
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",38698,0.000781786380271324,0.00261326554178752,-0.00434021408163221,0.00590378684217486,0.764821788489169
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,37221,-0.00083971210054178,0.00281048025911688,-0.00634825340841086,0.0046688292073273,0.765113640467319
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,39526,-0.000747971855891842,0.00251684210474389,-0.00568098238118986,0.00418503866940618,0.766328113873383
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,36880,-0.000608992236955619,0.00205135210475073,-0.00462964236226704,0.0034116578883558,0.766567990988176
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GM2A,Ganglioside GM2 activator,36993,0.00102902773183017,0.00348491241316351,-0.00580140059797031,0.00785945606163065,0.76778426914522
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFAP1,Actin filament-associated protein 1,36955,0.00225622720230813,0.00772627153231484,-0.012887265001029,0.0173997194056452,0.770276039871014
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR1B,Cornifin-B,36992,0.00226619094188208,0.00780118917809099,-0.0130241398471763,0.0175565217309404,0.771443899668901
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,39589,-0.001890652565505,0.00657556358897489,-0.0147787571998958,0.0109974520688858,0.773712709907639
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,36763,-0.00163560516720391,0.00570865315398086,-0.0128245653490064,0.00955335501459857,0.774489814409425
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX7,Syntaxin-7,36880,0.00130147834702062,0.00454505208780709,-0.00760682374508128,0.0102097804391225,0.774614387296089
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,39194,-0.000977446544084071,0.00341802310688685,-0.0076767718335823,0.00572187874541416,0.774906354839444
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,39194,-0.00170407071878095,0.00604696068224461,-0.0135561136559804,0.0101479722184185,0.778096109344583
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,39428,-0.00219872556563694,0.00781931885010786,-0.0175245905118483,0.0131271393805745,0.77856745077598
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,39462,0.00301851195600753,0.0108032674280273,-0.018155892202926,0.024192916114941,0.779936106927384
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD46,Membrane cofactor protein,39381,0.000722879181943461,0.0026165703843698,-0.00440559877142134,0.00585135713530827,0.782344731146216
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,36823,0.00299538789512795,0.0109119023661006,-0.0183919407424292,0.0243827165326851,0.783700009100488
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,39531,0.000678302772344604,0.00248070025992421,-0.00418386973710686,0.00554047528179606,0.784524920978078
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOL1,Apolipoprotein L1,37243,0.00158983889217585,0.00587008499688938,-0.00991552770172733,0.013095205486079,0.786520419861982
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA8,Carbonic anhydrase-related protein,36880,-0.000669480570645741,0.00247634577036626,-0.00552311828056362,0.00418415713927214,0.786895338915116
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,36823,-0.00186455572671864,0.00691137449971596,-0.0154108497461619,0.0116817382927246,0.787333440643634
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,39480,-0.00244840428835831,0.00908677011823698,-0.0202584737201028,0.0153616651433862,0.787589308074786
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,36992,0.00153707971528616,0.00579675375181156,-0.0098245576382645,0.0128987170688368,0.79088890623854
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC1,Hamartin,36880,-0.00182501981895998,0.00689056221637837,-0.0153305217630616,0.0116804821251416,0.791123325867284
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,36819,0.00212572088853613,0.00803752149343976,-0.0136278212386058,0.0178792630156781,0.791418583597473
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,39654,-0.000839711875100316,0.00317600214937124,-0.00706467608786795,0.00538525233766732,0.791480897972636
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,39455,0.000695240251060307,0.00263567942897632,-0.00447069142973327,0.00586117193185388,0.791952855595995
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEB,Nebulin,36847,-0.000867233110863794,0.00330051351930993,-0.00733623960871126,0.00560177338698367,0.792742228549294
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,36880,0.00158420470993358,0.00603641643330143,-0.0102471714993372,0.0134155809192044,0.792985619241343
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,39531,0.000788352083484388,0.00301356027334393,-0.00511822605226972,0.0066949302192385,0.793632210384016
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,39194,0.000696467101431775,0.00266328292594778,-0.00452356743342587,0.00591650163628942,0.793705213059963
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,37164,-0.00231322784398537,0.0088629902271151,-0.019684688689131,0.0150582330011602,0.794097831968724
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,37221,-0.00179988090530398,0.00699308996877368,-0.0155063372441004,0.0119065754334924,0.796889653157522
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,36763,0.00132859598048285,0.00518280980289757,-0.00882971123319638,0.0114869031941621,0.797687454708695
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",36861,-0.000912334664654188,0.00356173954925159,-0.00789334418118731,0.00606867485187893,0.797840327859515
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37221,-0.00168100643537864,0.00656286003658449,-0.0145442121070842,0.011182199236327,0.797847396042668
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT1,Diamine acetyltransferase 1,36847,-0.00121160023052723,0.00476789742944865,-0.0105566791922466,0.00813347873119213,0.799409962344542
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,36861,0.00160952247093965,0.00634104184553977,-0.0108189195463183,0.0140379644881976,0.799634047152487
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,36880,0.000501426404208246,0.00198335721678881,-0.00338595374069783,0.00438880654911432,0.80041381826749
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C8B,Complement component C8 beta chain,37269,0.000695162463404621,0.00277361681960148,-0.00474112650301429,0.00613145142982353,0.802101169581338
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB2A2,Mammaglobin-A,36847,-0.000724880921620835,0.0028971936393703,-0.00640338045478662,0.00495361861154495,0.802436011642709
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,39554,-0.000630148313102514,0.0025523569948205,-0.00563276802295069,0.00437247139674566,0.804997653130568
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCP1,Plastin-2,37255,-0.00105269664659815,0.00427121485402157,-0.00942427776048043,0.00731888446728412,0.805327754271495
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37247,-0.00162766711904331,0.00666294934935621,-0.0146870478437815,0.0114317136056949,0.807013024575799
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO6,Unconventional myosin-VI,37221,-0.000834576184186893,0.00342260720775814,-0.00754288631139284,0.00587373394301905,0.807356927586321
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NINJ1,Ninjurin-1,39123,0.00125200497602587,0.00515618916954251,-0.00885412579627744,0.0113581357483292,0.80815137276776
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5L,CD5 antigen-like,37196,0.00102769942289828,0.00424414869847409,-0.00729083202611095,0.0093462308719075,0.80867170028232
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,36847,-0.000885992927185788,0.00367750594950712,-0.00809390458821974,0.00632191873384817,0.809619378745415
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,39187,0.000738744900106176,0.00307053517062543,-0.00527950403431967,0.00675699383453202,0.809875025892293
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,37183,0.000834034885377009,0.0035103631762947,-0.00604627694016061,0.00771434671091463,0.812201229495815
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,39462,-0.0019759551063546,0.00834747490809635,-0.0183370059262234,0.0143850957135143,0.812882746265397
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MB,Myoglobin,39654,-0.00106245158160713,0.00449849082723777,-0.00987949360299316,0.00775459043977891,0.813296521965757
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,39428,-0.000568694870128378,0.00241193649649603,-0.00529609040326059,0.00415870066300383,0.8136038832353
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP1,Retinol-binding protein 1,36861,0.00148911578441524,0.0063158873257659,-0.0108900233740859,0.0138682549429164,0.813612701334599
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTN,Titin,36847,-0.00138215641471391,0.00598404317962016,-0.0131108810467694,0.0103465682173416,0.817339069511684
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,37162,-0.00128428993519396,0.00561570522033292,-0.0122910721670465,0.00972249229665857,0.819108798300748
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKZF2,Zinc finger protein Helios,39123,0.00194843440064279,0.00852511635185101,-0.0147607936489852,0.0186576624502708,0.819220137846084
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD27,CD27 antigen,39531,0.000844661475507706,0.00370016921597032,-0.00640767018779412,0.00809699313880953,0.819434430468667
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA6,Integrin alpha-6,39462,-0.00110037820444338,0.00485076688505165,-0.0106078812991446,0.00840712489025786,0.820546399627678
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COLEC12,Collectin-12,39477,-0.000526122343256152,0.00233051658694906,-0.00509393485367631,0.00404169016716401,0.821396193245146
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",36823,-0.000952285418870277,0.00421824349303421,-0.00922004266521733,0.00731547182747678,0.821396471162682
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHISA5,Protein shisa-5,37255,-0.000505866635392634,0.00225155954542021,-0.00491892334441624,0.00390719007363097,0.8222365656899
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,39428,-0.000457681508563726,0.00204766279774338,-0.00447110059214076,0.0035557375750133,0.823138458675116
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDS,Iduronate 2-sulfatase,39636,-0.000175817701032893,0.000789327467737948,-0.00172289953779927,0.00137126413573348,0.823738003410642
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLMP,CXADR-like membrane protein,39601,-0.000411774217358549,0.00185981514175025,-0.00405701189518904,0.00323346346047194,0.824779311008739
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,39187,-0.000983589367608781,0.00444486349981167,-0.00969552182723966,0.00772834309202209,0.824872237842973
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHH,Sonic hedgehog protein,36880,0.000862025831487347,0.00396588493596247,-0.00691110864299909,0.00863516030597379,0.827931156944901
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,36847,0.00138101456455483,0.00637891303235104,-0.0111216549788532,0.0138836841079629,0.82860404474863
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN15,Lipocalin-15,37221,-0.00124323734934041,0.00574999046504262,-0.0125132186608239,0.0100267439621431,0.828823187077032
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,36847,-0.00189789403701671,0.00879974913902993,-0.0191454023495154,0.015349614275482,0.829243917233505
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,36742,0.000944115557973535,0.00446522543153727,-0.00780772628783951,0.00969595740378659,0.832549498280425
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GL3,Endophilin-A3,36926,-0.00159763637658737,0.00756311203588561,-0.0164213359669232,0.0132260632137484,0.832702976641495
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",36823,0.00112008786959643,0.00534222289421636,-0.00935066900306764,0.0115908447422605,0.833931032530732
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRELP,Prolargin,39477,-0.000441288542704632,0.00211910841217404,-0.00459474103056576,0.00371216394515649,0.835042408073006
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",39428,-0.00131153041043941,0.00634147500316847,-0.0137408214166496,0.0111177605957708,0.836154904240336
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37255,0.000481861990269545,0.00234390567759936,-0.00411219313782521,0.0050759171183643,0.837121649721314
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53BP1,TP53-binding protein 1,36880,0.0016512428634734,0.00807337654826401,-0.0141725751711241,0.0174750608980709,0.837943168691486
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR4,Toll-like receptor 4,36880,0.000521935369798444,0.00257458939251998,-0.00452425983954072,0.00556813057913761,0.839352773468721
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCLRE1C,Protein artemis,36763,0.000583611112314087,0.00289834937478225,-0.00509715366225912,0.00626437588688729,0.840420556331294
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,36992,-0.000826877812469362,0.00412097111700771,-0.00890398120180447,0.00725022557686574,0.840974571926701
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI16,Peptidase inhibitor 16,37243,-0.000448605632632912,0.00224076248352777,-0.00484050010034734,0.00394328883508151,0.841325610653517
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLINT1,Clathrin interactor 1,36763,-0.000836624820019871,0.00420986805253123,-0.00908796620298108,0.00741471656294134,0.842477656681732
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNG,Uracil-DNA glycosylase,37162,0.000609123739268399,0.00306536275853593,-0.00539898726746203,0.00661723474599883,0.84249137445568
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40LG,CD40 ligand,39636,0.00137733484993003,0.00696324716073832,-0.0122706295851171,0.0150252992849771,0.843203681441687
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS2,Podocin,36880,0.00187831715052575,0.00952714059355036,-0.016794878412833,0.0205515127138845,0.84370998185298
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH7B,Myosin-7B,36763,0.000817010061766366,0.00417509962322108,-0.00736618519974694,0.00900020532327967,0.844858888140846
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,36955,0.000554515636071593,0.00284888795739809,-0.00502930476042867,0.00613833603257185,0.845675727254063
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAGLN3,Transgelin-3,36763,-0.00108391632876294,0.0055851949737271,-0.0120308984772681,0.00986306581974218,0.846124618364985
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,36992,-0.00118609839785056,0.0061222717670284,-0.0131857510612262,0.0108135542655251,0.846386513014945
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,36763,-0.00151348274945367,0.00782217263139586,-0.0168449411069896,0.0138179756080822,0.846581375513978
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMI,N-myc-interactor,37122,-0.00126062595884641,0.00651792092494137,-0.0140357509717315,0.0115144990540387,0.846641600736631
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA13,Carbonic anhydrase 13,39312,0.00180147728764153,0.00943032240675128,-0.016681954629591,0.020284909204874,0.848504466633563
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF4,Neurotrophin-4,39123,-0.000708354536896797,0.00372061435702515,-0.00800075867666609,0.0065840496028725,0.84900895370518
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,36847,-0.000906548730474236,0.00477623916154605,-0.0102679774871045,0.00845488002615601,0.849465922419747
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF20,Fibroblast growth factor 20,36880,0.000760019661750145,0.00403984695159679,-0.00715808036337956,0.00867811968687985,0.850777184335646
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,36823,0.000870903016580067,0.00464334427108304,-0.0082300517547427,0.00997185778790283,0.851225105914766
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",36916,-0.000787146616883256,0.00419771639362992,-0.0090146707483979,0.00744037751463139,0.85125770741308
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,36992,-0.00127012618715479,0.00680141816738053,-0.0146009057952206,0.012060653420911,0.851864128609683
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,36880,0.00157471526962867,0.00848543630917345,-0.0150567398963513,0.0182061704356086,0.852778276450649
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,36763,0.00107825873748864,0.00581630162559318,-0.010321692448674,0.0124782099236513,0.85292963316661
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,39194,0.000596730504701606,0.00327863922711833,-0.00582940238045033,0.00702286338985354,0.855580880265597
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH3,Cadherin-3,39589,0.00058572699283075,0.00322666057566252,-0.00573852773546778,0.00690998172112928,0.855956134780793
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,39541,0.000458516770734066,0.00253686711092591,-0.00451374276668071,0.00543077630814884,0.856573032893253
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL1,Interferon lambda-1,39104,0.000741174201220902,0.00410780076832167,-0.00731011530468956,0.00879246370713137,0.856816790850129
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39104,0.00110802141863608,0.00619251639311794,-0.0110293107118751,0.0132453535491472,0.857995842702945
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,36823,-0.0014806746621734,0.00831750954829449,-0.0177829933768306,0.0148216440524838,0.858710975622806
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31,Interleukin-31,36880,0.000935681642557488,0.00531482877863136,-0.00948138276355998,0.011352746048675,0.860256637681465
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXN,"Frataxin, mitochondrial",39601,-0.00118055705378302,0.0067294377812327,-0.0143702551049991,0.0120091409974331,0.860742738341967
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WNT9A,Protein Wnt-9a,39194,-0.00045786403676648,0.00261284393126857,-0.00557903814205287,0.00466331006851991,0.86089668960155
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBH,Dopamine beta-hydroxylase,37224,0.0016697758156594,0.00960410286989182,-0.0171542658093286,0.0204938174406474,0.861977713446463
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD1,Leiomodin-1,37221,-0.000564069215697134,0.00325641254044062,-0.00694663779496075,0.00581849936356648,0.862482833625683
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB5,Integrin beta-5,39531,0.000584305283858741,0.00338909999738377,-0.00605833071101346,0.00722694127873094,0.863119716028608
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF75D,Zinc finger protein 75D,36992,0.000931121769129298,0.00543749190460155,-0.00972636236388975,0.0115886059021483,0.864037001674113
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37221,0.000456994888240076,0.00267056335551024,-0.00477730928856,0.00569129906504015,0.864129740559762
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,39194,0.000718760885324024,0.00420240692989996,-0.00751795669727991,0.00895547846792796,0.864198177738589
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRX,Cone-rod homeobox protein,39187,-0.00167215009890209,0.00978223100940997,-0.0208453228773456,0.0175010226795415,0.864275258074844
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,37203,-0.000620106517734232,0.00363108435724984,-0.00773703185794391,0.00649681882247545,0.864401645828129
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,39287,0.000575296914370233,0.00345211099925468,-0.00619084064416895,0.00734143447290941,0.867647124314897
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,37269,-0.00029457089707388,0.00178051687965893,-0.00378438398120538,0.00319524218705762,0.868599315625517
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,39462,0.000504215991222102,0.00305871824355164,-0.00549087176613912,0.00649930374858332,0.869067796255519
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSCA,Prostate stem cell antigen,37164,-0.00387430262710782,0.023632734458682,-0.0501944621661246,0.042445856911909,0.869782578197509
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,39654,-0.00103492995344214,0.0064032636098863,-0.0135853266288193,0.011515466721935,0.871603012801097
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,36763,-0.000593162799622629,0.00372863217046527,-0.00790128185373455,0.00671495625448929,0.873605920494605
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRC1,Macrophage mannose receptor 1,37243,0.000397897610283185,0.00256681719805051,-0.00463306409789582,0.00542885931846219,0.876811187759266
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRK1,Protein BRICK1,39104,0.000625615501442609,0.0040416835019213,-0.00729608416232314,0.00854731516520835,0.876988361036334
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP2,Guanylate-binding protein 2,39194,0.000827494177418503,0.00541321144465918,-0.0097824002541135,0.0114373886089505,0.87850630362736
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTNNA1,Catenin alpha-1,36823,0.000498184639351402,0.00326482658579934,-0.0059008754688153,0.00689724474751811,0.878722952451312
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEFL,Neurofilament light polypeptide,39050,0.000581541219723631,0.00388153736123306,-0.00702627200829316,0.00818935444774042,0.880906810734382
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,36823,-0.000952102432519391,0.00648904724673858,-0.013670635036127,0.0117664301710882,0.883351843786443
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF15,Growth/differentiation factor 15,39654,0.000564027540120565,0.00393230392521158,-0.00714328815329413,0.00827134323353526,0.885949040573173
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",36861,-0.00108819856823039,0.00764904009087998,-0.0160803171463552,0.0139039200098944,0.886872187227142
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP6,Gastrotropin,39163,0.000717808390935825,0.00510685599432759,-0.00929162935794624,0.0107272461398179,0.88822122042599
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,39601,0.000803958952239793,0.00574752690801457,-0.0104611937874688,0.0120691116919484,0.888757365872737
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN6,Prefoldin subunit 6,36861,-0.000846197325318927,0.00606763927153252,-0.0127387702975227,0.0110463756468848,0.889088358818935
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,36916,0.000724719179327386,0.00526321587054223,-0.00959118392693539,0.0110406222855902,0.890483594779715
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKKL1,Dickkopf-like protein 1,39428,0.00109832432127868,0.00801346397554328,-0.0146080650707861,0.0168047137133435,0.890985315528892
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCP11,T-complex protein 11 homolog,36992,0.000750874108806071,0.00550883714760588,-0.0100464467005015,0.0115481949181136,0.891583498512829
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL2,Interferon lambda-2,36823,-0.000809401915998067,0.00594278756124324,-0.0124572655360348,0.0108384617040387,0.89166615617067
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC9,Histone deacetylase 9,36823,0.000777796688503517,0.00577253142883169,-0.0105363649120066,0.0120919582890136,0.892818843174828
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,36823,-0.00056201360456519,0.00420083393078763,-0.00879564810890895,0.00767162089977857,0.893573816826663
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST2,Bone marrow stromal antigen 2,39589,0.000652271718615146,0.00490188819180148,-0.00895542913731575,0.010259972574546,0.894143426456527
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,39104,-0.00171907737579156,0.0129974647851926,-0.027194108354769,0.0237559536031859,0.894778472007044
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,36861,0.00120117411971771,0.00933282577087967,-0.0170911643912064,0.0194935126306419,0.897593776936315
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",39636,-0.000804736311337446,0.00628270508594591,-0.0131188382797914,0.0115093656571165,0.898081383649227
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,39541,-0.000238143801674336,0.00186447694479219,-0.00389251861346703,0.00341623101011836,0.898366828296296
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NENF,Neudesin,37162,-0.0012498771103996,0.00985564617889808,-0.0205669436210398,0.0180671894002406,0.899086151883757
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOB,Apolipoprotein B-100,37243,-0.000251747351831962,0.00203500629115235,-0.00424035968249056,0.00373686497882664,0.901548112230776
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,39123,0.00046623765028379,0.00377963524631445,-0.00694184743249254,0.00787432273306012,0.901827523450331
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,39194,0.000467020704151342,0.00380227765641011,-0.00698544350241247,0.00791948491071516,0.902246111937347
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA6,Carbonic anhydrase 6,39423,-0.000686874838047835,0.00581196969886714,-0.0120783354478274,0.0107045857717318,0.905924405543341
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC8,Histone deacetylase 8,36880,0.000668088657219799,0.00566373567016821,-0.0104328332563099,0.0117690105707495,0.906102041967977
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",39462,-0.000874221996299228,0.00748673260719069,-0.015548217906393,0.0137997739137945,0.907044278922608
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1A,Interleukin-1 alpha,39194,0.000568833527577948,0.00491372211112929,-0.00906206181023547,0.0101997288653914,0.907840933246578
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,36763,-0.000438936801930054,0.00379628743321262,-0.0078796601710268,0.00700178656716669,0.907953499319639
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,36880,0.000530054282269372,0.00460334723466755,-0.00849250629767902,0.00955261486221776,0.908331731343036
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,39531,-0.000243178771678783,0.00222203894439859,-0.00459837510270003,0.00411201755934246,0.912855382896857
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH23,Cadherin-23,37203,0.000261907821638486,0.00240808934076858,-0.00445794728626793,0.00498176292954491,0.913393236570016
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEBP1,Heme-binding protein 1,39187,0.000534551811768334,0.00496486208340794,-0.00919657787171123,0.0102656814952479,0.914261312430976
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS1,Galectin-1,39485,-0.00032614880306006,0.00308097893047458,-0.00636486750679024,0.00571256990067012,0.91569577739421
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVPL,Envoplakin,36992,0.000329981513435696,0.00313109549625059,-0.00580696565921546,0.00646692868608685,0.916069212403252
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",36992,-0.000664719679153161,0.00650787413609934,-0.0134201529859079,0.0120907136276016,0.918646524312405
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39068,0.000412560751183259,0.00428834542556027,-0.00799259628291486,0.00881771778528138,0.923358989982306
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,36992,0.00073943271021982,0.00774794160830135,-0.0144465328420508,0.0159253982624905,0.923970031751099
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDNRB,Endothelin receptor type B,36880,0.000401967679637151,0.00423745168384649,-0.00790343762070197,0.00870737297997628,0.924426993123571
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF7,Fibroblast growth factor 7,36763,0.000688423025578561,0.00739024737629412,-0.0137964618319579,0.015173307883115,0.925783602333768
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF3,Neurotrophin-3,39462,-0.000292732472653792,0.00318474680412183,-0.00653483620873257,0.00594937126342499,0.926765186103953
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,36847,0.000501617162299325,0.00547602381809966,-0.010231389521176,0.0112346238457746,0.927015390275032
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,37221,-0.000494644577299175,0.00543394100154423,-0.0111451689403259,0.0101558797857275,0.927471215428363
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",36861,-0.000621773641207558,0.00716782113420296,-0.0146707030642454,0.0134271557818302,0.930875495427034
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD1,Glutamate decarboxylase 1,36763,-0.000203209925642515,0.0023550754675059,-0.00481915784195408,0.00441273799066905,0.931240509776583
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK1,Kallikrein-1,39342,0.000996549350852454,0.0116477557319534,-0.0218330518837763,0.0238261505854812,0.931819574494577
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,36955,-0.000192467863995322,0.00226898081633043,-0.00463967026400296,0.00425473453601232,0.932401327374391
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39123,0.000366064036075502,0.00438866300507945,-0.00823571545388022,0.00896784352603122,0.93352565086066
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESR1,Estrogen receptor,36880,-0.000433088137021699,0.00526565535828538,-0.010753772639261,0.00988759636521765,0.934451052989111
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB2,Integrin beta-2,39354,0.000213014172296534,0.00261082926578906,-0.00490421118865002,0.00533023953324309,0.934974881140239
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,36823,-0.000309775320417092,0.00380034022409821,-0.00775844215964959,0.00713889151881541,0.935035684649813
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,36847,0.00033732954251406,0.00440299045951916,-0.00829253175814348,0.00896719084317161,0.938932068963076
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,36861,-0.000343817957146872,0.0045500235756819,-0.00926186416548339,0.00857422825118965,0.9397672007467
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF3,Fibroblast growth factor 3,36880,-0.000204193430098414,0.00277819043622978,-0.00564944668510878,0.00524105982491195,0.941410448556398
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBN2,Fibrillin-2,36861,0.000407189521888273,0.00558560567593331,-0.010540597602941,0.0113549766467176,0.941887030135377
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,39608,0.000137747835039188,0.0019022927646386,-0.00359074598365247,0.00386624165373085,0.942275404329589
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,39499,-0.000212070709644862,0.00298820661636436,-0.006068955677719,0.00564481425842928,0.9434231912453
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2BP,LRP2-binding protein,36861,0.000557509642915528,0.00796806050984743,-0.0150598889563854,0.0161749082422165,0.944220218469743
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD109,CD109 antigen,39455,-0.000211949974852473,0.00304705408088743,-0.00618417597339184,0.00576027602368689,0.944545613817505
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",36847,-0.000251805411426494,0.003628992105487,-0.00736462993818102,0.00686101911532803,0.944682578173371
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILPL2,RILP-like protein 2,37247,-0.000603460411835732,0.00882266856583316,-0.0178958908008687,0.0166889699771973,0.945469203526466
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1,Methionine aminopeptidase 1,39104,0.000187199281482802,0.0027914675141593,-0.00528407704626942,0.00565847560923503,0.946533862962441
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,37117,-0.000172602925701027,0.0026364801500383,-0.0053401040197761,0.00499489816837405,0.947803068554703
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,36823,-0.000321242106063095,0.00497190563361079,-0.0100661771479402,0.00942369293581406,0.948484400117136
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,36763,-0.000239761238585068,0.00385019954501998,-0.00778615234682423,0.0073066298696541,0.950346903354432
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP350,Centrosome-associated protein 350,36763,-0.000211550727820149,0.00341548795808112,-0.00690590712565915,0.00648280567001885,0.950612690397528
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,39428,0.000251828892940244,0.0040836326992033,-0.00775209119749822,0.00825574898337871,0.95082815751513
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,36823,-0.0003042910660418,0.00501017092935944,-0.0101242260875863,0.00951564395550271,0.951571502958036
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,39455,0.000218611101422018,0.00384536298731504,-0.00731830035371546,0.0077555225565595,0.954664982157855
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,36992,0.000426155088271105,0.00755161785429607,-0.0143750159061492,0.0152273260826914,0.954998333353117
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37221,-0.000445903993523009,0.0089791664923496,-0.0180450703185282,0.0171532623314822,0.960394234727616
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,39194,0.000171375209226791,0.00346165857815829,-0.00661347560396347,0.00695622602241705,0.960516187823418
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,36880,0.000481806784204028,0.00975040744117527,-0.0186289918004995,0.0195926053689076,0.960590153131799
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTKN2,Rhotekin-2,36847,0.000232387803399101,0.00479201253292937,-0.00915995676114247,0.00962473236794067,0.961322670933919
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,36967,0.000231037204708479,0.00477925127616374,-0.00913629529657245,0.00959836970598941,0.961444680756779
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,39462,-0.000230486101616855,0.00502597356127148,-0.010081394281709,0.00962042207847524,0.96342324625967
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5A,Cytochrome b5,36763,-0.000302627799117856,0.00671259650897733,-0.0134593169567134,0.0128540613584777,0.964041430392767
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,36763,0.000114564966084183,0.00275232896527972,-0.00527999980586406,0.00550912973803242,0.966798528999084
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,36763,-9.34957951225394e-05,0.00230760593323588,-0.00461640342426487,0.00442941183401979,0.967682120534944
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39104,0.000178212672563801,0.00452697352917826,-0.00869465544462559,0.00905108078975319,0.968598448323633
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],39194,0.000203438412294535,0.00522884808416965,-0.010045103832678,0.010451980657267,0.968965120398121
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,36861,-0.000176720763602541,0.00458684350673305,-0.00916693403679933,0.00881349250959425,0.969267525738748
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,36823,0.000170590558213851,0.0045268391790183,-0.00870201423266202,0.00904319534908972,0.969940038479947
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,36847,0.000177396237038469,0.00478224232681209,-0.00919579872351322,0.00955059119759016,0.970410029817691
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHB,Lutropin subunit beta,39123,-0.000278152856642707,0.00773014010743286,-0.0154292274672111,0.0148729217539257,0.971296483682125
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPP1,Osteopontin,39617,0.000150665376536008,0.00433717818481326,-0.00835020386569797,0.00865153461876999,0.972289028391443
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,39123,-0.00010316551742637,0.0030444210506555,-0.00607023077671114,0.0058638997418584,0.972967924696673
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMVK,Phosphomevalonate kinase,39095,-0.000333515867767829,0.0100319713710903,-0.0199961797551048,0.0193291480195692,0.973479429406869
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3,Interleukin-3,36763,-0.000179719543207797,0.00547597334053215,-0.0109126272906508,0.0105531882042352,0.97381893811604
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP1,Caspase-1,39104,-0.000199141907826851,0.00612792451637466,-0.0122098739599212,0.0118115901442675,0.974075793868583
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB5,Serpin B5,39187,0.000141737064865212,0.00445043278384368,-0.00858111119146841,0.00886458532119883,0.974593755975998
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMM2,Phosphomannomutase 2,36847,-0.000174240243257267,0.00549314299688383,-0.0109408005171496,0.010592320030635,0.974696182956787
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,36992,0.00010290840501368,0.00328191805036658,-0.00632965097370481,0.00653546778373217,0.97498598823502
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP15,Matrix metalloproteinase-15,37247,-0.000135153799150327,0.00454826280941269,-0.00904974890559919,0.00877944130729854,0.976294431925633
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,36823,-0.000154160683221291,0.00564030268441836,-0.0112091539446813,0.0109008325782387,0.978195384814223
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTN3,Myeloblastin,39045,-0.000116544737258296,0.00427924085744203,-0.00850385681784467,0.00827076734332808,0.978272744720353
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37247,8.22123616221521e-05,0.00304412797001598,-0.00588427845960918,0.00604870318285348,0.978454677506564
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL28,C-C motif chemokine 28,39401,-0.000139493165710984,0.00542746302380167,-0.0107773206923623,0.0104983343609403,0.979495884404197
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",36916,-0.000136365386826157,0.00622753518002896,-0.0123423343396829,0.0120696035660306,0.98253033400729
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,39355,-7.29689847927603e-05,0.00372202907759215,-0.00736814597687337,0.00722220800728785,0.984359036671195
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",36880,7.66759413022384e-05,0.00418118710296376,-0.00811845078050673,0.00827180266311121,0.985369253141105
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37221,0.000105560395356225,0.00631310666841594,-0.012268128674739,0.0124792494654515,0.986659589271134
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUCL3,Mucin-like protein 3,36763,-4.29972258165623e-05,0.00407937307465067,-0.00803856845213187,0.00795257400049875,0.991590499300068
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,37221,-6.93920614612204e-05,0.00671845593442444,-0.0132375656929331,0.0130987815700107,0.991759299076361
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,36861,1.70758893953291e-05,0.00331203234154638,-0.00647450750003557,0.00650865927882623,0.99588643701064
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,36847,-2.25597029201359e-05,0.00466905958909333,-0.00917391649754306,0.00912879709170279,0.996144918430645
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,36823,-2.52326008451401e-05,0.00591829214111729,-0.011625085197435,0.0115746199957448,0.996598303308165
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRNN,Cornulin,38999,-1.9828555564532e-05,0.00605346095641781,-0.0118846120301434,0.0118449549190144,0.997386520161181
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,36847,-1.95861316449215e-05,0.0060478055402068,-0.0118732849904502,0.0118341127271604,0.99741606613696
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",39104,-2.95712623236138e-06,0.00251947519024922,-0.00494112849912082,0.0049352142466561,0.999063533320434
